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The current emphasis on including correlation when comparing diagnostic test
performance is quite important, however, there are cases in which correlation effects
may be negligible with respect to inference. This proposed work examines the impact
of including correlation between classification systems with continuous features by
comparing the optimal performance of two diagnostic tests with multiple outcomes
as well as providing inference for a sequence of tests. We define the optimal point using
Bayes Cost, a metric that sums the weighted misclassifications within a diagnostic
test using a cost/benefit structure. Through simulation, we quantify the impact of
correlation on standard errors comparing two tests and evaluate the resulting errors
with respect to CI coverage and width under varying diagnostic test accuracy, sample
size, cost/benefit structures, parametric assumptions and correlation levels. When
formulas are required for better inference to include correlation, we provide updated
computational techniques that properly extend the Delta and Generalized method.
Additionally, ,to date, no methods have been applied to quantify the performance of a
sequence of tests. Therefore, the inference methods derived in this work are extended
to sequenced tests where feature correlation is unavoidable and must be accounted
for when developing inference on tests.
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STATISTICAL INFERENCE TO EVALUATE AND COMPARE CORRELATED
MULTI-STATE CLASSIFICATION SYSTEMS
I. Introduction
Decision making under uncertainty is a hallmark of statistical thought in the 21st
century. Whenever we make decisions, we take input information, classify it into a
set of outcomes and develop a cost/benefit for each of those outcomes. This pro-
cess represents a classification system which is weighted by some sort of desirability.
Classification systems are present almost every time a decision is made, whether an
autonomous vehicle is plotting a route or a doctor is diagnosing an illness. When a
decision is important and the classification system is imperfect, statistics and best
practices can be used to compare classification systems and quantify performance so
as to choose the most appropriate classification method available.
The difficulty in making decisions based on imperfect information is uncertainty.
Statistics can support this decision process by making inferences, based on reasonable
assumptions, that can be used to quantify the uncertainty inherent in the data in order
to determine the better course of action. Specifically, when deciding on a diagnostic
test to use in a clinical setting, for instance, comparisons of tests require accurate
inference adjusting the estimate that compares the two tests by a quantifiable measure
of uncertainty, or standard error.
One of the simplifying assumptions often made when comparing classification
systems is independence, though in many settings, statistical independence is rarely
possible. Correlation can manifest with the selection of features to be measured and
compared on the same experimental units. For example, the triglyceride measure and
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total cholesterol measures are highly correlated. If two tests assessing the likelihood of
developing diabetes (especially if we consider multiple “risk” levels) are developed on
the same set of subjects, one using triglycerides and the other using total cholesterol,
it is likely that any inference from the tests could not assume statistical independence
on these features. Whereas assumed independence may be more appropriate, if each
test is conducted on different randomly sampled subjects, though higher triglycerides
would be expected to be associated with higher total cholesterol. However, designs
using repeated measures on the same subjects are useful in removing inter-subject
variability, and therefore, at times preferred.
It is, therefore, important to appropriately estimate and adjust comparisons of
tests for the correlation that exists between them. The risk in not doing so produces
overly conservative statistical inference such that new tests or classification systems
which are inherently more accurate may not be discovered because the error surround-
ing the comparison of the two tests was not appropriately quantified. In contrast,
there exists at times minimal correlation, seemingly negligible, or correlation that
is non-tractable. In such cases, it may still be possible to create appropriate infer-
ence, which is not too conservative, especially when test data already exists and new
samples of paired data are infeasible. Therefore, this work addresses two research
questions:
1. How robust are methodologies against correlation in the evaluation or compar-
ison of classification systems?
2. What is the appropriate adjustment to methodological approaches to account
for correlation when required?
Finally, a diagnostic test (or classification system) is expensive, takes a long time,
or is otherwise difficult to perform. To improve overall detection in these cases,
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a screening test may be used to determine subjects that require continued testing
for classification. These sequenced tests involve the same population subjects and
correlation in this setting is unavoidable. Further, correlation in the sequential setting
can be estimated utilizing similar methodological approaches to the correlation in the
comparison of systems. To date, statistical inferential methods have not been applied
to the performance of sequential systems.
Thus, this dissertation aims to improve the classification system selection and
performance quantification involving three or more classes in a paired setting and
develop inferential methods for performance of sequential tests. Specifically, this re-
search addresses the two research questions by quantifying the need for accounting
for correlation in a comparison of the performance of classification systems, quanti-
fying the uncertainty present in the comparison of paired classification systems, and
developing inferential methods on sequences of classification systems. These aims
translate to the following research goals:
1. Determine the level of correlation at which inference around the comparison
between classification systems is adversely impacted (Overestimates or Mis-
specifies Coverage).
2. Develop correct inferential procedures to account for correlation between fea-
tures in a comparison of classification system.
3. Develop inferential procedures to account for correlation in sequence of subsys-
tems.
The results of this work produces the following contributions to providing inference
in the comparison and evaluation of correlated multi-state classification systems:
1. Under specific scenarios, ignoring correlation on inferential methods is shown
to be a valid approach.
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2. Current methods are extended to compare generalized multi-state systems (any
k) with correlated features.
3. The first statistical inferential methods for sequential systems with respect to
accuracy are developed.
These contributions enables researchers and decision makers to have more accurate





A classification system (G) is a functional map that transforms k partitions of a
set of events, E = {(e1, ..., ek} to k distinct elements of a label set L = {l1, ..., lk}.
Each of these partitions represent a class. This labeling of the events, or data, into
distinct classes occurs because of a set of features, F = {f1, ..., fm)}, that are used
as a part of a functional map that transforms the partitioned event set into the label
set. As such, we assume that there is specific parameter, or vector of parameters,
θ ∈ Θ, that, when varied with respect to each feature, affects the outcome class label
assigned by the classification system. Thus, for every θ ∈ Θ, there is a classification
system (Aθ), and the set of these systems, A = {Aθ,θ ∈ Θ} is called a classification
system family (CSF) [33].
Table 2.1. Two-class contingency table
Positive Negative 


















Consider the two-class contingency table presented in Table 2.1 [4] which con-
tains four states of information with respect to the two truth states of positive and
negative. Two of these states are correct classification: true positive (often referred
to as sensitivity when the number of true positives is divided by the total number
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of positives in the truth data) and true negative (referred to as specificity when the
number of true negatives is divided by the total number of negatives in the truth
data). The other two outcomes are misclassifications: false positive and false nega-
tive. These misclassifications are the result of the classification system assigning an
incorrect predictive label to the respective truth event.
Table 2.2. Three-class contingency table where each entry, i|j, represents a classification
system assigning label i to an event whose truth class is j
CLASS 1 CLASS 2 CLASS 3 
“CLASS 1” 1|1 1|2 1|3 
“CLASS 2” 2|1 2|2 2|3 














Similarly, any classification system with k labels, which is designed to map events
into k classes, contains k2 states of information. Consider the three-class system
included in Table 2.2 [4]. Here, green blocks on the diagonal represent the correct
classifications (k = 3 correct classifications), and the remaining six blocks represent
possible misclassifications (k2−k incorrect classifications). When there are more than
two classes, the terms “true positive” and “false negative” lose meaning, therefore, the
notation i|j is used where j represents the truth label and i represents the classification
system label.
2.2 Optimal Points
Often, the features within a classification system are measured using continuous
data which naturally occurs with variation, and which, when partitioned on a thresh-
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Distribution of feature 
(biomarker) values for 
actually diseased 
individuals 
Distribution of feature 
(biomarker) values for 
actually non-diseased 
individuals 
Threshold (θ) value chosen 
to label elements based 
on biomarker value 
All elements labeled as “Diseased” All elements labeled as “Non-Diseased” 
old, generates the outcome class label for the classification system. Figure 2.1 [4]
represents such a phenomenon for a two class system and the resulting classification
as identified by Table 2.1 [4]. It should be clear to see that there is a compromise
between correct (or incorrect) classifications as the threshold θ moves from left to
right. The point at which θ results in the best classification performance for the CSF
is referred to as the optimal point.
There are many ways to compute optimal points [29]. Although many methods
are based upon the notion of accurate classification, in this work, we refer to the
optimal point as the threshold settings of the classification system that maximizes
classification accuracy. We define this as the “best performance” of the CSF.
Ideally, the definition for best performance of a classification system should have
some flexibility to allow for adjustments based on the requirements of the classifica-
tion system. For example, if the importance of identifying all diseased individuals
far outweighs the importance of mis-identifying non-diseased individuals, this may
suggest a much different value of θ than when the two outcomes are equally impor-
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tant. Extensive work in the literature suggests that these costs (weighted importance
on mis-classification rates) should be taken into account when evaluating optimal
thresholds for a CSF [1, 18, 24, 33, 35, 36, 37, 38]. Similarly, thresholds can also
be affected by the prevalence of each class. For example, a much larger sample of
non-diseased individuals could shift the optimal threshold, and should be included
when determining optimal threshold levels [7, 24]. Finally, when both prevalence and
weighted misclassification costs are incorporated simultaneously into the definition of
“best” performance, the optimal point of the CSF may change [13, 33, 38].
The optimal point for a k-class CSF often corresponds to k − 1 threshold values.
This occurs because separating a continuous set of numbers into k (ordinal) partitions
requires a minimum of k− 1 break points. For example, as described in Batterton [4]
and reproduced here, in order to classify subjects into three categories (HIV negative
(NEG), HIV positive non-symptomatic (NAS), and HIV-positive with AIDS dementia
complex (ADC)), two threshold values (θ1 < θ2) on a biomarker (NAA/Cr) were
used [25]. If a subject’s NAA/Cr level was below θ1 they were classified as ADC,
if the subject’s NAA/Cr level was between θ1 and θ2 they were classified as NAS,
and finally if the subjects NAA/Cr level was greater than θ2 they were classified
as NEG [25] (see Figure 2.2 [4]). The values for θ1 and θ2 are chosen to maximize
the performance of the classification system [29]. Typically, this is accomplished by
collapsing the classification results into an univariate metric and optimizing the value
of the associated metric with respect to the threshold of interest. Two such examples
of such a metric that are the basis for this research are discussed in the Section 2.3.
2.3 Metrics for Optimal Points
For the purposes of this research, two metrics for determining the optimal point
of a classification system are considered: the Youden Index and Bayes Cost. Both
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of these metrics may account for the cost associated with misclassification and class
prevalences and defines for each set of thresholds considered, the classification system
accuracy. Each of these metrics will be described next.
2.3.1 The Youden Index.
The Youden Index (J), first introduced by W.J. Youden in 1950, is a method for
rating classification systems with two classes [42]. Literature has shown J to be a
useful metric in evaluating the performance of classification systems as a function of
correct classifications [14, 28, 30, 42]. In the two-class system, J is defined as the
maximum sum of sensitivity plus specificity (minus one) out of all possible choices of
parameters, θ ∈ Θ, for the CSF:
J = max
θ∈Θ
[sensitivity(θ) + specificity(θ)− 1] . (2.1)
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The performance of a classification system that is worse than a pure guess (sensitivity
and specificity both less than 0.5), is considered poor. Therefore, when considering
only CSFs with both specificity and sensitivity bounded by [0.5,1], systems which
perform better than chance have J ∈ [0, 1] [42].
An important extension to the Youden Index is to a k-class systems. The extended
J is defined as the summation of k correct classification probabilities (no longer










where Pi|j(θ) represents the probability associated with assigning class i to an event
whose truth class is j.
Another useful extension to J using properties discussed in Section 2.2 is to include
the presence of a cost and/or prevalence multiplier to the sum of correct classifications.
Such an extension for the 2-class case is referred to as the Generalized Youden Index
(GYI) [31, 36, 18, 23, 35, 25, 26]. The equation for the GYI is given below:
GY I = max
θ∈Θ
[sensitivity(θ) +m · specificity(θ)− 1] , (2.3)
where m is a weight function of the prevalence of class 1 (p1) and the cost benefit ratio
(using true positive, true negative, false positive, and false negative costs respectively
(CTP , CFP , CTN , CFN)) given by m = [(1−p1)/p1]×[(CFP−CTN)/(CFN−CTP )]. This
weight function takes into account misclassification costs associated with false positive
or false negative results in addition to costs associated with correct classifications as
well as the prevalence of classes 1 and 2 [3].
A review of the literature demonstrates the variations discussed on J for clas-
sification performance which includes incorporating prevalence (with equal weight)
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in a two-class system [31, 36], incorporating prevalence and cost-benefit weights in
a two-class system [18, 23, 35], and incorporating prevalence and cost to a k-class
system [25, 26]. The equation for the GY I extension to k-classes as produced by




J2;(i,i+1) = Jk−1;(1,2,...,k−2) + J2;(k−1,k), (2.4)
where Jk is the sum of the Youden Indices for the adjacent classes with weight function
m fixed to 1 in each comparison Jk [32]. A limitation of this extension to k classes
is that it only considers the pairwise sums of correct classifications cp and therefore
does not consider misclassification in a k class system as distinct. This important
distinction is rendered moot when the costs of misclassifications and prevalences for
each target class are equal between classes.
2.3.2 Bayes Cost.
While the Youden Index maximizes the correct classification rate, the goal of
Bayes Cost (BC) as a metric of performance, is to minimize the misclassifications.
In a two-class framework, these goals are equivalent [4, 5, 28, 37]. When more than
two classes exist, or classes have unequal misclassification costs or prevalence, the
equivalence does not hold because it is no longer feasible to associate directly the
benefit of making the correct decision and the cost associated with making class-
specific incorrect decisions [5, 33, 37]. When a metric is required that accounts for the
information in these k2−k misclassification probabilities, such as in the case of unequal
costs or prevalence, BC loses no information about the classification system [33].
BC is defined as the minimum sum of the weighted misclassification probabilities











where ci|j is the cost of assigning class i to an element from truth class j and pj is
the prevalence of class j. The use of BC allows for any cost/benefit and prevalence
structure to be considered when determining the performance of a classification sys-
tem [4]. As can be seen in Equation 2.5, BC extends to any number of k classes, and
when k = 2 can be written as:
BC = min
θ∈Θ
c1|2p2P1|2 + c2|1p1P2|1, (2.6)
which has been shown to be equivalent to the two-class Youden Index with equal
costs and weights [4, 37].
2.4 Parametric methods for Inference using Confidence Intervals
It is important to characterize uncertainty when estimating the metrics used to
determine optimal points when they are constructed from data. Typically, this is
done by developing confidence intervals (CI) around the metrics used to define the
optimal point (Youden Index, BC, etc.) as well as the thresholds which correspond
to the optimal point [5, 18, 28, 29, 30]. This section will outline the research and
methods of developing inference using confidence intervals on performance metrics of
classification systems.
2.4.1 Confidence Intervals.
A confidence interval on a random sample X can be characterized by L(X) and
U(X) where, for some function of θ, τ(θ), P [L(X) ≤ τ(θ) ≤ U(X)] = 1 − α. Then
L(X) and U(X) forms a confidence interval with a confidence coefficient of 1−α [8, 15].
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CI performance is typically measured with coverage probability, a computed pro-
portion across many trials that calculates the number of times that the parameter
of interest resides within the interval, and width, measured as the distance between
L(X) and U(X). The best CI is the smallest interval that guarantees a 1− α cover-
age probability; however, often width is sacrificed to assure coverage is maintained.
Besides resampling methods, there are two main methods of CI construction for J
and BC, the Delta method and Generalized methods. Each of these are described in
the following sections.
2.4.2 Delta Method (Large Samples).
For large samples, asymptotic normality on the feature space can allow for the use
of the Delta method to construct variance estimates for simple Wald-based inference.
The Delta method is given by the following theorem.
Suppose that θ̂ is Asymptotic-Normalk(θ, b
2
nΣ) with bn → 0 and that g
is a real-valued function with partial derivatives existing in a neighborhood
of θ and continuous at θ with g′(θ) = ∂g(θ)/∂θ not identically zero. Then
as n→∞




The Multivariate Delta method described in Theorem 2.4.2 [6] allows for the
creation of confidence intervals around the Bayes Cost metric and the associated
optimal points by observing that asymptotically, BC is normally distributed and
θˆ∗m ∼ N(θˆm, V ar(θˆm)). The variance of the BC metric, with the assumption of
independence in the feature space, is given in Equation 2.7 and the derivation of the





















Confidence intervals are then calculated using the expected value of BC and vari-
ance from Equation 2.7 along with the appropriate standard normal probability (Z).
2.4.3 Generalized Method.
When the distribution of the features used for classification is normal, or suitably
transformed to normal, the Generalized method for developing inference can be used.
The strategy for developing Generalized Confidence Intervals (GCI) around threshold
values, J and BC, involves developing generalized pivotal quantities for µj and σj,
j = 1, ..., k, and using these pivotal quantities to construct the confidence interval.
We define these general pivotal quantities (GPQs), as in Lai [20]:






















with the sample mean (x¯j) and standard deviation (Sj) from the j
th class, tj ∼ t(nj−1),
a t-distributed random variable, and Vj ∼ χ2(nj−1), a chi-square random variable. The
distribution of X in this case is assumed normal, therefore this method is appropriate
for large or small samples as long as the assumption of normality holds.
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As described by Batterton [4], in order to construct the GCI around BC, Monte
Carlo simulation is used to create a large number (K) of random draws from tj and
Vj for each of the k classes. These K sets of tj and Vj values are then used in the
Equations 2.8-2.11 to determine K values of Rµj and Rσj , j = 1 . . . k. Then the GPQ






































The minimization is inherent in the use of optimal thresholds, θ∗m, the k − 1 optimal
thresholds’ GPQs (Rθ∗m) are found numerically for each of the K sets of Rµj and Rσj
values (this requires K numerical minimizations of Equation 2.12).
2.4.4 Parametric Confidence Interval Inference on BC and J.
This section will summarize the application of those methods for inference un-
der specific (normal) distributional assumptions on the underlying features used for
classification. We start with inferences on a single test.
A large body of research exists on confidence intervals around optimal points and
the thresholds that correspond to the optimal point [18, 28, 33, 30]. All of these require
distributional assumptions on the parameters, typically normal. Jund [18] developed
a Delta method for inference on J and optimal thresholds assuming independent sam-
ples of normal biomarkers that performed well in large samples, but struggled with
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small sample sizes. Perkins [28] developed a Delta method for variance of the 3-class
Youden Index that performed consistently better than bootstrapping by accounting
for measurement error, again, limited by performance on small sample sizes. Schis-
terman [30], compared performance of Delta method and Bootstrapping methods on
J and optimal thresholds for 2-class Normal and Gamma distributed biomarkers,
finding that the Delta method presented a reasonable compromise for maintaining
coverage without excessive width for sample sizes larger than 50. Skaltsa [37] and
Batterton [5] have performed inference on BC including optimal points. Performance
of the Delta, Bootstrap, and Generlized methodologies on BC are similar to the coun-
terparts utilizing J as the metric.
2.4.5 Parametric Confidence Interval on Test Comparisons.
In addition to inference on a single test, the Delta method has been used in recent
literature for the comparison of tests using Youden Index and Bayes Cost [4, 5, 36,
37], all under the assumption of independence between features on compared tests.
The Delta method generally guarantees coverage probability when considering large
samples where the test metric will approach normality. As a result, when applying
this method to smaller sample sizes, the width of the interval is naturally made wider
to compensate for potential violations of assumptions and coverage is not guaranteed.
Literature shows that the Delta method performs well at relatively small samples, as
low as 20 subjects per class, while the Generalized method performs well at even
lower sample sizes.
Whenever considering the difference between two statistical tests, the correlation
between features on compared tests, either incidental based on sampling or the result
of non-independent populations being tested, can have significant impacts on infer-
ence. Zhou includes this feature correlation in a paired Youden Index using bootstrap
16
methods to create CIs on 2 class problems with sample sizes ranging from 20-200, re-
sulting in intervals that maintained coverage [43] with comparable widths that would
be expected using Delta or Generalized methods for CI construction. A few authors
have developed methods to account for correlation in paired tests using the Youden
Index [16, 40, 41]. They attempt to extend the Generalized method and Delta method
to account for correlation between feature distributions between classes; however the
distributional assumptions around the sampling distributions of the multivariate nor-
mal do not match the requirements of the Generalized method. Specifically, Yin
utilized a multivariate normal distribution for the sampling of feature mean values.
However, as this research shows, this decision is inappropriate and therefore led to
confidence bounds that significantly exceed coverage in most of the scenarios pre-
sented [40, 41]. Additionally, in the Delta method extension provided by Yin only J
is considered, without taking into account cost or prevalence, and performs similarly
to the independent assumption counterparts [40, 41].
Because none of these methods correctly extend the Generalized method to k-class
problems and no current research allows for a complex class specific cost/benefit struc-
ture when correlation is present, this research seeks to incorporate feature correlation
in the the calculation of confidence intervals around BC in k-class problems.
2.4.6 Nonparametric Confidence Intervals.
Collapsing a classification system to the number of outcomes with respect to
truth allows for it to be modeled without distributional assumptions. Similarly to
parametric confidence intervals, work has been done on non-parametric confidence
intervals [4, 22]. Batterton [4] developed fiducial intervals that require an assumption
of independence between classes, but performs well on small sample-sizes using the
BC metric. Luo [22] used Gaussian Kernel Smoothing to develop non-parametric
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confidence intervals, and used bootstrapping on the resulting density functions using
J .
Some recent research has been focused on the inclusion of correlation on the
Youden Index using non-parametric methods. Chen [9] used the Delta method to
find an approximate estimate of variance as provided in Equation 2.13. This resulted
in better coverage for the confidence intervals for samples ranging from 20-100 (per
class). Chen’s work was limited to computation for J in two class classification
systems and did not extend either to k-class classification systems nor a class-specific
cost structure as allowed in BC. Using the notation previously described, the expected














(TN + FP )3
, (2.13)
is found by using a Delta method approximation. This research did not extend to
the k class classification system, and, as previously stated, the Youden Index does
not account for the cost of class specific misclassification errors (in k classes). Chen’s
method provided better coverage for two-class problems with correlation by sacrificing
width. The method was identical to previous methods, with V ar(J) substituted as
given in Equation 2.13 [10]. This method maintains coverage of the CI by adjusting
the variance around the estimated value, and subsequently, the width of the CI. It
has been shown to perform better in datasets that include correlated biomarkers [9].
As previously stated, the limitation of this work is that it only extended to the 2-class
case. The research presented in this dissertation will strictly focus on the parametric
approaches to inference on classification systems.
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2.5 Sequencing Classification Systems
The work presented thus far has been concerned with inference on a single clas-
sification system, or a comparison of classification systems. Also of interest in this
research is inference when sequencing of classification systems for diagnostic classifi-
cation purposes [2, 3, 39, 34, 27], as sequences also exhibit inherent correlation and
currently no inferential methods on J (GY I) or BC for a sequence of classification
systems exists. We motivate and present classification system sequences through the
application of sequences of diagnostic tests, yet recognize these concepts are also ap-
plicable to any generic sequence of classification systems. The use of screening tests
and multiple tests in a diagnostic setting is common practice, and the need to exam-
ine strategies that maximize diagnostic accuracy in sequential testing is important.
Using a strategy for sequencing tests can result in a reduction in cost for the overall
testing procedures by eliminating the need for secondary tests, this is in contrast to
a linear combination of tests (like a Bayes Network), where each subject is required
to receive each test. Developing diagnostic results from a sequence of tests involves
setting a strategy for selecting the test sequence.
2.5.1 Strategies for Sequencing Classification Systems.
Three sequential strategies for classification systems using continuous features
and assuming a 2-class outcome, e.g. “positive” or “negative”, are prevalent in the
literature [2, 3, 34, 39]. Because these sequences have been discussed in terms of
medical literature, we describe the 2-class outcome as positive (for disease) or negative
(for non-disease).
In a Believe the Positive strategy (BP) for a sequence of tests, the testing is
concluded when a positive outcome is assigned or the number of tests has been reached
in which case the result of the last test is assumed. In a Believe the Negative strategy
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(a) Believe the Positive (b) Believe the Negative
(c) Believe the Extreme
Figure 2.3. Strategies for Sequencing Systems
(BN) for a sequence of tests, the testing is concluded when a negative outcome is
assigned or the number of tests has been reached in which case the result from the
last test is assumed. In a Believe the Extreme strategy, a threshold is set to conclude a
positive outcome, a threshold is set to conclude a negative outcome, and those values
that do not meet either prescribed threshold are subjected to subsequent testing
until a positive or negative result is reached. Figure 2.3 is a visual depiction of each
strategy. For this research, only BP and BN strategies are considered, as the BE
strategy has been shown to converge to either the BP or BN strategy [3].
Formulas for the false positive and true positive rates of these sequential testing
strategies are readily available [2]. For a 2-class, 2-system sequence of systems, let
FXi,j where i ∈ {1, 2} and j ∈ {N,D} denote the cumulative distribution function
of classification system i for those with a disease, D, and those without the disease,
N . Let FX1D,X2D and FX1N ,X2N denote the joint CDFs of the disease and non-disease
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distributions, respectively, for the system. Then, the formulas for the False Positive
Rate (FPR) and True Positive Rate (TPR) of the BP and BN strategy are given by:
PBPFP (θ


























)− FX2,D (θBN2 )+ FX1,D,X2,D (θBN1 , θBN2 ) (2.17)
where θi corresponds to the threshold values of test i = 1 or 2 respectively, superscript
BP or BN denotes the formula for the BP or BN strategy depicted in Figure 2.3, and
the notation “|−” implies the probability conditioned on the negative, or non-disease,
state.
2.5.2 Correlation in Sequenced Tests.
When considering strategy K (K =BP or BN) and the equations given in 2.17,
we can explicitly state the GYI as:




where m = [(1− p1)/p1]× [(CFP − CTN)/(CFN − CTP )] as defined for Equation 2.3.
Because the equations for PKFP and P
K
TP include evatuations of joint distributions at
fixed values of θ, correlation is included as part of the calculations of these values [2, 3,
17, 34, 39]. Correlation is unavoidable due to the use of the same subjects throughout
the sequence (as subsets of the total population). The expectation in sequential
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classification systems is that the correlation is relatively large (ρ ≥ 0.5); therefore,
any methodological approach must be able to function in the presence of significant
correlation.
2.6 Conclusion
Feature correlation, arising from the use of paired samples in testing, is important
to consider when using methods to examine the inference in comparing tests or in a
sequence of tests. Correlation has been largely ignored for a long time in research
involving comparisons of classification systems. Sometimes low correlation may not
have a large effect on inference. No recommendations exist for when correlation must
be accounted for when comparing tests. When equations must be adjusted to account
for correlation, methods exist for J [16, 40, 41, 43], but none exist for BC when a
complex cost/prevalence structure is present. A clear gap in literature is that the
Generalized method has not been correctly extended to k-class problems. The use of
BC in such calculations, which has not been researched with feature correlation in
consideration, can allow for a more complex cost structure among misclassification
errors. Further, likely due to the number of parameters required for estimation and
the ability to track correlation through the sequence, no inferential methods exist for
sequence classification systems where correlation is inherent and likely large. This
work seeks to address these gaps as given in the goals provided in Chapter I.
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III. The Impact of Correlation on Classification Systems
3.1 Introduction
This chapter addresses the first research goal to determine the level of correlation
at which inference around the comparison between classification systems is adversely
impacted via misspecification of coverage. This goal is achieved by examining the ef-
fect of correlation on inference assuming independent samples rather than dependent
(paired) samples in comparisons of classification systems. While the particular exam-
ple used in this chapter is diagnostic tests, the application extends to all classification
system families. The purpose of this chapter in achieveing the first research goal is
twofold. The first purpose is to quantify the extent of overestimation and misspecifi-
cation of coverage in CIs when correlation is ignored; and second, to provide guidance
on the level of test correlation for which inference remains relatively robust under an
assumption of independence in comparisons of tests. Under the latter purpose, rec-
ommendations on scenarios which do not require modification of existing inferential
methods is offered so as to take advantage of the numerous tests and methods that
currently exist to create CIs on the differences between tests using both the Youden
Index (for the 2-class case) and Bayes Cost (for k-classes).
3.2 Methods
The metric chosen for comparison of the accuracy of diagnostic tests is Bayes
Cost as defined in Equation 2.5. This reseach utilizes the three main parametric
statistical methods used to develop inference in order to compare diagnostic tests,
the Delta method, Generalized method and Bootstrapping. The Delta method and
Generalized method for a single test can be found in Section 2.4.2 and Section 2.4.3,
respectively. Under the assumption of independence, the comparison of diagnostic
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tests using the Delta method is found in Section 3.2.1, the Generalized method in
Section 3.2.2 and a summary of the Bootstrap method is provided in Section 3.2.3.
3.2.1 Delta Method.
Confidence intervals for the difference between two independent test BC values
(test 1 and 2) are calculated using the expected value of the performance metrics and
variances from Equation 2.7 for each of the tests along with the appropriate standard






V ar(B̂C1) + V ar(B̂C2) (3.1)
.
Notice that under the assumption of independence, the variance of the difference
in BC values contains no covariance, that is, covariance of BC1 and BC2 is assumed
to be zero.
3.2.2 Generalized Method.
The vectors for RBC1 and RBC2 are developed independently utilizing the method-
ology for a single test as presented in Section 2.4.3. The resulting vectors can be
subtracted from one another to create a CI for the difference of BC values of size α
using the α
2
· 100% and (1− α
2
) · 100% quantiles from the RBC1 −RBC2 values. Figure
3.1 shows the algorithmic steps for computing a CI around the difference of BC values
under the assumption of independence.
3.2.3 Bootstrapping.
The bootstrap method can be used to create CIs for both large and small data
samples when parametric assumptions are not met. Several authors have used boot-
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• Calculate x¯j and sj,
• For each x¯j, generate g monte carlo samples from a t distribution,
• Generate pivotal quantites for Rµj from x¯j, sj and the generated t distri-
butions,
• For each sj, generate g monte carlo samples from a χ2 distribution,
• Generate pivotal quantities for Rσj from sj,
• Solve for RBC1 and RBC2 using the required pivotal quantites,
• Determine the required α/2 quantiles from the vector RBC = RBC1 −RBC2
for the CI.
Figure 3.1. Algorithmic steps to compute the multivariate Generalized method includ-
ing correlation between tests.
strap methods to create CIs for diagnostics tests and compare them to other, less
robust, methods [4, 5, 43]. Because of its versatility, bootstrapping provides a good
point of comparison.
One boostrap CI assumes asymptotic normality of the parameter estimate. This
is accomplished by estimating the variance of the parameter estimate and creating
a Wald-based confidence interval from the bootstrap samples. This method is gen-
erally known as an asymptotic normal (AN) bootstrap [11]. In addition to AN,
the basic percentile (BP) and bias corrected and accelerated (BCa) methods were
considered for comparison as well, and are perhaps the more common boostrap meth-
ods [12]. Further, because we seek to determine the impact of assuming independence
when comparing tests, the boostrap methods employed assumed independence when
generating the bootstrap samples. Finally, in accordance with the recommended pa-




To quantify the effects of correlation when assuming independent samples, a sim-
ulation was performed where Normal variates representing the distributions for each
class were created by varying the degree of correlation, classification accuracy, sample
size, cost structure, feature distribution, and number of classes. We generate date
with correlation between features used in each test and utilize methodologies pre-
sented in Section 3.2 to develop CIs. Six levels of class-specific correlation between
tests were considered: ρ = −0.3, 0, 0.1, 0.3, 0.5, 0.9, these values were chosen as they
span those utilized in previous works on correlated features [9]. Three test accuracy
settings were created, given in Table 3.1 with the corresponding Bayes Cost (BC) and
Youden Index (J) values. Two comparisons considered tests with the same accuracy,
“Good, Good”, “Fair, Fair”, and two comparisons of tests considered those with dif-
fering accuracy, “Good, Fair”, “Good, Poor”. These were chosen to represent a wide
range of possible and feasible diagnostic test accuracies. To generate the correlated
data, data was drawn from a multivariate Normal using the appropriate marginals
from Table 3.1 along with the associated correlation value for features between each
test. The values listed for BC and J are under the assumption of equal cost and
prevalence.
Four class-specific sample sizes from small to large (nj = 10, 20, 50, 100) were
examined in each of 2-class or 3-class scenarios. In the case of 2-classes, two cost
structures (ci|j), where i is the assigned class and j is the truth class, of equal (C1)
and unequal (C2) weights were examined. All prevalence is assumed to be equal for
testing. Therefore, when using C1, no weights are placed on the Pi|j values in BC.
That is, ci|jpj is equal to 1 for every class. Under C2, a weighting structure placing




Test Accuracy Class 1, Class 2 Class 1, Class 2
Good (BC=0.134, J=0.87) N(0, 1), N(3, 1) G(1, 1.3), G(7, 1.64)
Fair (BC=0.317, J=0.68) N(0, 1), N(2, 1) G(1, 1.3), G(5, 1.85)
Poor (BC=0.617, J=0.38) N(0, 1), N(1, 1) G(1, 1.3), G(3, 1.15)
3-class system
Normal Gamma
Test Accuracy Class 1, Class 2, Class 3 Class 1, Class 2, Class 3
Good (BC=0.267, J=2.73) N(−3, 1), N(0, 1), N(3, 1) G(1, 1.3), G(2.3, 3.7), G(5, 13.70)
Fair (BC=0.635, J=2.37) N(−2, 1), N(0, 1), N(2, 1) G(1, 1.3), G(2, 1.5), G(5, 5.34)
Poor (BC=1.234, J=1.77) N(−1, 1), N(0, 1), N(1, 1) G(1, 1.3), G(2, 1.5), G(3, 1.74)





















Similar to the 2-class case, Pj = 1/3 for all 3 classes producing equal weights on
the probabilities (Pi|j) when using C1 and unequal weights when using C2.
Finally, distribution misspecification was also examined by using Gamma dis-
tributed parameters that matched the BC values for the Normal distributions (Table
3.1). The Gamma variates were generated by applying an inverse distribution func-
tion on CDF values of Normally distributed random variates. For each scenario (a
combination of correlation, accuracy, sample size, feature distribution, and class size),
CIs were developed assuming independence for the inference using each of the previ-
ously described methods: Delta, Generalized and three forms of the Bootstrap (AN,
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BP, BCa). Combined, these factor levels resulted in 3840 scenarios for the simulation
(6 correlations, 4 accuracies, 4 sample sizes, 2 cost structures, 2 class sizes, 5 meth-
ods, 2 distributional assumptions). CIs were generated 10,000 times in each of these
scenarios, with α = 0.05 and both coverage and width were recorded for comparison.
3.4 Simulation Results
Using the results of the simulation, effects of correlation, testing accuracy, cost,
sample size and distribtuion misspecification were estimated for each of the method-
ological approaches comparing diagnostic tests when igonoring correlation. Results
exemplifying findings from the simulation are provided in the text below, and all
simulation results are tabulated in Appendix A.
Table 3.2 and Figure 3.2 demonstrate the coverage for comparisons of “Fair”
accuracy tests based on Normally distributed features in the 2-class case with equal
costs. In comparing these results, coverage is about what is expected (95%) for
correlation up to 0.1 for the Delta and Generalized methods. When the correlation
between diagnostic tests is ≥ 0.3, coverage becomes quite conservative and when
the correlation between tests is negative (-0.3), the coverage is lower than expected.
The Bootstrap methods perform the poorest and only reaches about 0.95 coverage
for correlation levels of 0 or 0.1 when the sample size is 50 or greater with possibly
the exception of the BP bootstrap. In general, though, coverage is maintained for
positive correlation, albeit quite conservative when correlation is 0.3 or higher. The
accuracy had relatively little effect on the the coverage of the Delta, Generalized, or
BP bootstrap methods. Because the BP bootstrap performed better than the BCa
or AN bootstrap, subsequent results focus only on the BP bootstrap; all bootstrap
results can be found in Appendix A.
All test comparisons in the 2-class Normal feature case were not noticeably affected
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.927 0.704 0.950 0.731 0.870 0.639 0.907 0.634 0.852 0.642
0 0.946 0.704 0.962 0.732 0.892 0.633 0.929 0.629 0.879 0.635
0.1 0.951 0.703 0.967 0.731 0.897 0.631 0.934 0.627 0.883 0.632
0.3 0.971 0.703 0.981 0.730 0.932 0.638 0.956 0.633 0.914 0.640
0.5 0.987 0.700 0.990 0.729 0.952 0.628 0.974 0.624 0.941 0.630
0.9 1.000 0.696 1.000 0.726 0.999 0.622 1.000 0.620 0.997 0.622
20 -0.3 0.923 0.509 0.936 0.516 0.896 0.481 0.913 0.480 0.891 0.482
0 0.949 0.509 0.957 0.516 0.925 0.481 0.939 0.480 0.918 0.482
0.1 0.954 0.508 0.962 0.515 0.934 0.479 0.947 0.479 0.928 0.481
0.3 0.969 0.508 0.976 0.515 0.950 0.479 0.962 0.479 0.944 0.480
0.5 0.988 0.508 0.991 0.515 0.974 0.479 0.982 0.479 0.969 0.480
0.9 1.000 0.506 1.000 0.514 1.000 0.477 1.000 0.477 1.000 0.477
50 -0.3 0.928 0.326 0.933 0.327 0.918 0.318 0.925 0.319 0.914 0.319
0 0.949 0.326 0.952 0.327 0.937 0.318 0.945 0.318 0.935 0.319
0.1 0.953 0.326 0.957 0.327 0.945 0.317 0.951 0.318 0.943 0.318
0.3 0.971 0.326 0.974 0.327 0.966 0.318 0.969 0.318 0.964 0.319
0.5 0.989 0.325 0.990 0.326 0.984 0.317 0.987 0.318 0.982 0.318
0.9 1.000 0.325 1.000 0.326 1.000 0.317 1.000 0.317 1.000 0.317
100 -0.3 0.929 0.231 0.932 0.232 0.924 0.229 0.927 0.229 0.923 0.229
0 0.950 0.232 0.952 0.232 0.946 0.229 0.949 0.229 0.945 0.229
0.1 0.956 0.231 0.957 0.232 0.951 0.229 0.954 0.229 0.951 0.229
0.3 0.971 0.231 0.972 0.232 0.969 0.228 0.970 0.229 0.968 0.229
0.5 0.989 0.231 0.989 0.231 0.987 0.228 0.988 0.229 0.987 0.229
0.9 1.000 0.231 1.000 0.232 1.000 0.229 1.000 0.229 1.000 0.229
Table 3.2. Coverage (Cov) and Length (Len) for comparisons of “Fair, Fair” 2-Class
tests with Equal Cost
by an unequal cost structure, with the exception of the Delta method. Figure 3.3
shows the coverage of the Delta method for the Normal features in the 2-class case
for both cost structures and across several test accuracies. In general, unlike the
equal cost comparisons, coverage was not maintained for small samples in the Delta
method when costs were not equal (C2), with minimal exception. Only with large
sample size (nj ≥ 50) is coverage maintained (about 95%) for positive correlation up
to 0.10 and conservative (coverage > 96%) for positive correlation ≥ 0.30. Further,
for the Delta method overall, the effects of differing test accuracies was minimal with
respect to the patterns of achieving or maintaining coverage (Figure 3.3). Cost had
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1. Delta 2. Generalized 3. Bootstrap_AN 4. Bootstrap_BP 5. Bootstrap_BCA



















































Figure 3.3. Delta method coverage for 2-class Normal biomarkers
similar impact on the performance of the Bootstrap. The Generalized method did
not have an appreciable difference in coverage between the cost scenarios.
Interestingly, in the 2-class test comparison, when the features are distributed
as Gamma instead of Normal, comparisons of tests with equal accuracies maintain
coverage at about 95% across all levels of correlation, being conservative on coverage
only for very highly positive correlation, ρ ≥ 0.5 (Figure 3.4). However, when the
accuracies of the tests were disparate (e.g. “Good” vs “Fair” or “Good” vs “Poor”),
coverage could not be achieved for any methods, sample size or correlation level (Fig-
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ure 3.4). The “Good” vs “Poor” comparison had higher coverage, yet, in general,
could not achieve 95% coverage, nor could the unequal cost comparisons (see Ap-
pendix A). In each scenario, the inference on a single test with misspecification is
not good; however, when identical tests are presented the methods create a relatively
good confidence interval around the incorrect point. In a single test, this produces a
very poor result; however, since the center and size of the CI produced is consistent,





























Figure 3.4. Coverage for 2-class Gamma Biomarkers under ”Good, Good” and ”Good,
Fair” accuracies with equal cost
Results for the 3-class comparisons were similar when comparing the effects of
estimation method on coverage, though class-specific sample size had a much larger
impact on coverage for the Bootstrap and Delta methods (Figure 3.5) likely due to
the additional samples included because of the additional (third) class. Coverage is
maintained at 95% with samples of 50 or larger (100 for bootstrap) for all methods
when correlation was greater than or equal to zero. Coverage is conservative for
correlation ρ ≥ 0.3 and too low for ρ ≤ −0.3. Increased accuracy of the comparison
test caused little change in the resulting coverage.
Finally, feature distribution had a larger impact on the coverage in the 3-class case
(Figure 3.6). Comparing Figure 3.4 to Figure 3.6, we see similar, and relatively good
coverage in the “Fair” vs “Fair” test comparison, yet test comparisons continued to
struggle to reach coverage in comparisons of tests with different accuracies.
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Figure 3.5. Coverage for 3-class Normal Biomarkers under “Good, Good” accuracies
with equal cost
CI length for all scenarios are not compared as the method-specific CI length does
not vary by correlation level (by design, standard errors are the same). However,
there is a small correlation effect on length present in small samples for all methods.
This is due to the generation within the simulation of class-specific data. In small
samples with high correlation, outliers in a specific class are exceedingly rare because
they would have a large effect on the correlation, causing standard error on the CI
to be lower, on average. As sample size increases, this effect is less. Additionally,
because the Generalized method has an additional step of generating values from a
t-distribution, which has heavier tails than a Normal distribution, this effect is less





























Figure 3.6. Coverage for 3-class Gamma Biomarkers under “Good, Good” and “Good,
Fair” accuracies with equal cost
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3.5 Discussion
Correlation within the samples when comparing diagnostic tests can cause decision
makers to make incorrect or overly conservative inference, regardless of the inferen-
tial method utilized to make a conclusion. The most concerning scenario is when
correlation between features is negative as this results in CIs with coverage below the
confidence level. Minimal correlation (0 ≤ ρ ≤ 0.1) can be considered negligible with
respect to its impact on CI coverage for most of the methods; however, the choice of
method should be made with other considerations in mind. Sample size, cost struc-
ture, and misspecification of the parameter distributions can still have significant
impact on the resulting inference. In small samples, when Normal features are being
studied, the Generalized method provides more consistent coverage, regardless of the
cost structure; this finding is consistent with other author’s results [5, 20].
In situations with larger correlation (ρ ≥ 0.3), inference will be overly conser-
vative. However, any of the methods may still be applied with the understanding
that intervals will be wider than necessary which may still provide useful inference
in some cases. When this is not adequate, updated inferential methods that can ac-
count for correlation are required in order to maintain a reasonable coverage without
overestimation of width for CIs.
When small samples (nj ≤ 20) are presented with Normal features and minimal
correlation levels (0 ≤ ρ ≤ 0.1), the Generalized method outperforms the Delta
and Bootstrap methods. With larger samples (nj ≥ 50) or larger correlation levels
(ρ ≥ 0.3), the Delta method, with its ease of calculation, is preferred when features
are Normal. When the features are not Normally distributed, none of the methods
described here provide reliable coverage for 2-sided CI in the 2- or 3-class case.
With respect to coverage, it is inferred that accounting for correlation would
provide a 95% CI by reducing the standard error and associated CI length. In such
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cases, this work demonstrates the importance of considering correlation and providing
some practical recommendations for when the use of more complex inference methods
that require the estimation of correlation is needed. Overall, our recommendation is to
include reasonable use of methods assuming independence when comparing diagnostic
tests in which feature distributions are very weakly and positively correlated (0 ≤ ρ ≤
0.1). For other scenarios, especially for any level of negative correlation and moderate
or higher positive correlation, methods that appropriately adjust standard error for
correlation are recommended.
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IV. Accounting for Correlation in Classification System
Comparisons
4.1 Introduction
This chapter addresses the second research goal to develop correct inferential
methods to account for correlation in comparisons of classification system perfor-
mance. Specifically, in this chapter methodologies for the Delta method and Gen-
eralized inference are developed that properly characterize the uncertainty between
correlated classification systems in order to compare the performance of classification
systems using CIs.
The extension of current methodologies is burdensome. Estimation of the vari-
ance within the Delta method requires more assumptions and parameter estimations,
increasing the requirement for samples to reach asymptotic behavior. There is no
true extension for the Generalized method into the multivariate case that meets the
criteria for pivotal quantities. Although other work has attempted such an exten-
sion [41, 40], they mistakenly extend the Generalized method inappropriately for
multivariate distributions. However, by relaxing assumptions of independence among
pivotal quantities, we are able to extend the Generalized method appropriately to in-
corporate a correlation estimation in the creation of CIs that perform at the expected
level of coverage.
4.2 Methods to Compare Two Classification Systems with Correlation
Two main parametric methods, using the BC metric provided in Equation 2.5,
were developed in order to compare classification systems: the Delta method devel-
oped in Section 4.2.1 and the Generalized method developed in Section 4.2.2.
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4.2.1 Delta Method.
With Normal, suitably transformable to Normal or asymptotically Normal features
presented, the Delta method is suitable to construct variance estimates for simple
Wald-based inference. The Wald-based confidence interval for the difference of two
BC values is given by:
E(BC1 −BC2)± z0.975
√
V ar(BC1 −BC2)). (4.1)
Since a normal feature is assumed, the standard subtraction of two correlated,
Normally distributed random variables can be used to develop mean and variance
estimates. The formula
V ar(BC1 −BC2) = V ar(BC1) + V ar(BC2)− 2Cov(BC1, BC2), (4.2)
is used for the variance present in the difference of the performance between the
two classification systems. The process of calculating the covariance in Equation
4.2 follows a natural correlation analysis. Specifically, the marginal and conditional
distributions of the BC value for each test are Normal. Due to the normality of the
features, the conditional distribution of features in the second test can be represented
as a linear combination of those in first test. Conveniently, this result allows for the
application of the law of total variance, which can be used to develop the following
formulas.





The Delta method calculations can be extended using Kline’s approximation for co-
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where 1,2 represent the first and second test respectively from the point estimate of
BC1 −BC2.
The partial derivatives and estimation of all required parameters for the appli-
cation of this methodology can be accomplished as in previous work [5] and are
reproduced in Appendix B of this document.
4.2.2 Generalized Method.
The methodological approach for the Genearlized method is repeated here as it
was presented in Section 2.4.3 specifically to demonstrate how this must be modified
to include correlation. Recall, the Generalized method, in the univariate normal
case, relies on Generalized pivotal quantities to develop sampling distributions for
parameters µ and σ. For k classes, in a single system the pivotal quantities can be
defined as:























The sample mean (xj) and standard deviation (Sj) are from the j
th class, tj ∼ t(nj−
1), a t-distribution random variable with nj − 1 degrees of freedom, and Vj ∼ χ2nj−1,
a chi-square random variable with nj − 1 degrees of freedom. In order to construct
the GCI around BC, monte carlo simulation is used to create a large number (K) of
random draws from tj and Vj for each of the k classes. These K sets of tj and Vj
values are then used in Equations 4.6 and 4.7 to determine K values of Rµj and Rσj ,
j = 1 . . . k.
These parameters are used to calculate K values of RBC utilizing Equation 2.12
and a confidence interval is built from the quantiles of the resulting K values of the
RBC vector.
To achieve the goal of extending the method, the marginal distribution require-
ments may be met with the multivariate counterparts for the univariate distributions,
the multivariate-t and the Wishart distribution. Drawing the t-random variable from
a multivariate t-distribution with a scale matrix equivalent to that of the correlation
matrix in our original sample meets pivotal quantity and correlation requirements for
Rµ. Specifically, we draw:







where P represents the size correlation matrix for the features, by class, where the
i, j element represents the correlation between system features within class. Then
following the standard procedure for for the Generalized method defines






The covariance matrix for a multivariate Normal random sample is distributed as
a Wishart distribtuion,
(n− 1)S ∼ Wishart(n− 1,Σ). (4.12)
With Σ representing the covariance matrices of each feature between tests. The
vector of matrices RΣ, an extenstion of Equation 4.7, can be directly simulated using
the Wishart distribution. Rσi can be constructed by taking the appropriate diagonal
element from the matrices within RΣ, the samples from this Wishart distribution.
Using these new pivotal quantities, RBC can be solved as given in Equation 2.12
for each instance of Rµ and Rσ. Confidence intervals can be built on the quantiles
of these distributions, or when comparing multiple tests, the RBC1 − RBC2 vector
quantiles.
A CI for BC utilizing the Generalized method is then developed by utilizing the
algorithm in Figure 4.1.
• Calculate x¯ and S,
• Generate g monte carlo samples from a multivariate t distribution using
the dispersion matrix from S,
• Generate pivotal quantites for Rµ from x¯ and the generated t distribution,
• Generate g monte carlo samples from a multivariate Wishart distribution
using S, the diagonal elements are the pivotal quantites,
• Solve for RBC1 and RBC2 using the required pivotal quantites,
• Determine the required α/2 quantiles from the vector RBC = RBC1 −RBC2
for the CI.
Figure 4.1. Algorithmic steps to compute the multivariate Generalized method for
including correlation between tests
39
4.2.3 Simulation.
In order to examine the extended Delta method and multivariate Generalized
method, a simulation was performed where normal variates representing the dis-
tribution for each class were created with varying degrees of correlation, classifi-
cation accuracy, sample size, cost structure, biomarker distribution, and number
of classes. Six levels of class-specific correlation between tests were considered:
ρ = −0.3, 0, 0.1, 0.3, 0.5, 0.9. Again, these values span the range of typical corre-
lation values examined in applications of diagnostic test comparisons. Three test
accuracy settings were created, given in Table 4.1 with the corresponding BC and
Youden Index values. Two comparisons considered tests with the same accuracy,
“Good, Good”, “Fair, Fair”, and two comparisons of tests considered those with dif-
fering accuracy, “Good, Fair”, “Good, Poor”. These were chosen to represent a wide
range of possible and feasible diagnostic test accuracies.
2-class system
Normal Gamma
Test Accuracy Class 1, Class 2 Class 1, Class 2
Good (BC=0.134, J=0.87) N(0, 1), N(3, 1) G(1, 1.3), G(7, 1.64)
Fair (BC=0.317, J=0.68) N(0, 1), N(2, 1) G(1, 1.3), G(5, 1.85)
Poor (BC=0.617, J=0.38) N(0, 1), N(1, 1) G(1, 1.3), G(3, 1.15)
3-class system
Normal Gamma
Test Accuracy Class 1, Class 2, Class 3 Class 1, Class 2, Class 3
Good (BC=0.267, J=2.73) N(−3, 1), N(0, 1), N(3, 1) G(1, 1.3), G(2.3, 3.7), G(5, 13.70)
Fair (BC=0.635, J=2.37) N(−2, 1), N(0, 1), N(2, 1) G(1, 1.3), G(2, 1.5), G(5, 5.34)
Poor (BC=1.234, J=1.77) N(−1, 1), N(0, 1), N(1, 1) G(1, 1.3), G(2, 1.5), G(3, 1.74)
Table 4.1. Class specifications for test accuracy .
Four class-specific sample sizes from small to large (nj = 10, 20, 50, 100) were
examined in each of 2-class or 3-class scenarios. In the case of 2-classes, two cost
structures ci|j, where i represents the assigned class and j represents the truth class,
of equal (C1) and unequal (C2) weights were examined. Equal prevalence of all classes
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Finally, distribution misspecification was also examined by using Gamma dis-
tributed parameters that matched the BC and J values for the Normal distributions
in Table 4.1.
For each scenario, CIs were developed to compare values using each of the previ-
ously described methods: Delta, Generalized and three forms of the Bootstrap (AN,
BP, BCa). Combined, these factor levels resulted in 3840 scenarios for the simulation
(6 correlations, 4 accuracies, 4 sample sizes, 2 cost structures, 2 class sizes, 5 meth-
ods, 2 distributional assumptions). CIs were generated 10,000 times in each of these
scenarios, with α = 0.05 and both coverage and width were recorded for comparison.
4.3 Results
Using the results from the data simulation, correlation, testing accuracy, number
of classes, cost, sample size and distribution misspecification effects were estimated
for each of the methodological approaches comparing the diagnostic tests with cor-
related biomarkers. The text below provides results exemplifying findings from the
simulation. Full results are tabulated in Appendix C.
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
100 -0.3 0.947 0.250 0.948 0.249 0.942 0.247 0.944 0.247 0.941 0.247
0 0.950 0.231 0.946 0.230 0.945 0.228 0.948 0.229 0.946 0.229
0.1 0.947 0.223 0.947 0.222 0.941 0.220 0.945 0.221 0.941 0.221
0.3 0.947 0.203 0.951 0.202 0.940 0.200 0.942 0.201 0.937 0.201
0.5 0.948 0.177 0.950 0.176 0.945 0.174 0.946 0.175 0.942 0.175
0.9 0.954 0.084 0.952 0.083 0.948 0.083 0.949 0.083 0.943 0.083
50 -0.3 0.947 0.350 0.950 0.348 0.937 0.343 0.944 0.344 0.937 0.344
0 0.942 0.325 0.953 0.322 0.932 0.318 0.936 0.318 0.929 0.318
0.1 0.943 0.313 0.946 0.310 0.932 0.306 0.938 0.306 0.929 0.306
0.3 0.951 0.286 0.951 0.283 0.939 0.278 0.945 0.279 0.935 0.279
0.5 0.951 0.250 0.948 0.247 0.940 0.243 0.945 0.244 0.936 0.244
0.9 0.954 0.119 0.953 0.117 0.942 0.115 0.945 0.116 0.934 0.116
20 -0.3 0.945 0.543 0.951 0.535 0.918 0.518 0.935 0.517 0.913 0.519
0 0.944 0.503 0.947 0.493 0.919 0.478 0.934 0.478 0.912 0.480
0.1 0.946 0.486 0.948 0.476 0.921 0.462 0.934 0.461 0.911 0.464
0.3 0.949 0.444 0.951 0.434 0.920 0.420 0.935 0.420 0.906 0.422
0.5 0.950 0.390 0.947 0.380 0.917 0.368 0.931 0.368 0.902 0.370
0.9 0.954 0.189 0.948 0.184 0.929 0.178 0.936 0.178 0.902 0.180
10 -0.3 0.931 0.742 0.944 0.728 0.888 0.687 0.915 0.682 0.868 0.693
0 0.940 0.689 0.946 0.672 0.888 0.634 0.919 0.630 0.864 0.641
0.1 0.943 0.666 0.949 0.648 0.894 0.611 0.921 0.607 0.867 0.617
0.3 0.943 0.611 0.949 0.593 0.883 0.560 0.910 0.556 0.855 0.568
0.5 0.947 0.540 0.951 0.522 0.885 0.493 0.911 0.489 0.845 0.501
0.9 0.961 0.268 0.954 0.258 0.909 0.250 0.921 0.245 0.849 0.255
Table 4.2. Coverage (Cov) and Length (Len) of the “Fair, Fair” accuracy test with 2
classes and normal biomarkers with equal cost
Table 4.2 and Figure 4.2 show the coverage and mean length for comparisons
of “Fair” accuracy tests on normally distributed biomarkers with equal costs in the
2-class case. Comparing the methods used to construct the CI resulted in a good
coverage for the difference in BC values with the Generalized method, regardless of
the correlation level. In general, the delta method, too, provided good coverage with
the exception of small samples size (nj = 10) at a lower correlations (ρ ≤ 0.3). The
Generalized and Delta methods had similar lengths, although the generalized CI was
generally slightly tighter than the Delta method. The Bootstrap methods generally
perform the poorest, only reaching the desired accuracy levels at the largest sample
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Figure 4.2. Coverage (Cov) and Length (Len) of the “Fair, Fair” accuracy test with 2
classes and normal biomarkers with equal cost
Delta Generalized Percentile


























Figure 4.3. Coverage and Length of the Generalized, Delta, BP methods on “Fair,
Fair” test comparisons with unequal cost structure.
size examined (nj = 100) for BCa and BP. Of the Bootstrap methods examined,
BP performed better than BCa or AN when considering coverage and in general met
the expected 95% coverage for nj = 100 and for ρ ≥ 0.3 for nj = 50. Therefore,
subsequent results will compare only the results from the BP bootstrap, although all
bootstrap results can be found in the Appendix C. Of note is the drastic decrease in
CI width across all methods and sample sizes as correlation is increased (Figure 4.2).
This is attributable to the growing covariance at higher correlations, and subsequent
lower standard error. Differences in test accuracies did not have an effect on the
coverage of these methods except that for good tests and small sample sizes nj < 50,
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Delta coverage exceeds 95%.
With the introduction of a complex cost structure, a difference in coverage can
be seen in each of the methods. Figure 4.3 shows the resulting coverage and length
of CIs when comparing the Fair test accuracies with unequal cost. The Generalized
method exceeds coverage when nj ≤ 20 in all scenarios, although maintains about
95% coverage for nj > 20. In larger sample sizes (nj ≥ 50) and with some correlation
present (ρ ≥ 0.3) the Delta method maintains coverage. The bootstrap requires a
large sample (nj = 100) to maintain the required coverage. All methods demon-
strate an increasing trend in coverage as correlation becomes higher. In addition, the
Generalized and Delta methods maintain approximately the same width for CIs.
Delta Generalized Percentile

























Figure 4.4. Coverage and Length of the Generalized, Delta and Basic Percentile meth-
ods on 3-class, “Fair, Fair” test comparisons with unequal cost structure.
Figure 4.4 shows the results for a 3-class case for the Fair, Fair test comparisons
of normally distributed biomarkers with an unequal cost structure. The Generalized
method maintains coverage in most scenarios, with the exception of small sample
sizes exhibiting extreme correlation (nj = 10, ρ = 0.9). In general, neither the Delta
method nor BP Bootstrap achieve coverage in any of the scenarios; however, they
both approach the 95% threshold with relatively large sample sizes (nj ≥ 50). The
upward trend in coverage with increasing correlation that showed in the 2-class case
is not present in the 3-class case. With more parameters of estimation from the
inclusion of a third class, the effect of an higher correlation in a specific pairwise set
of samples is minimized. Compared with the 2-class case, the effect of sample size
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in each of the methods is more pronounced in the 3-class case. The requirement of
estimation on the numerous parameters required to accomplish each of the methods
causes an increase in the required number of samples to maintain coverage. Length


























































Figure 4.5. Coverage on Fair, Fair test comparisons with both cost and class structures.
In the 3-class case, cost had a smaller impact on coverage. Figure 4.5 shows both
scenarios in the 2-class and 3-class case. The coverage in the 3-class case does not
drop as significantly as that in the 2-class case, and this effect is constant amongst
all of the methods.
None of the testing methodologies performed well when presented with a set of
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Fair:Fair Good:Good



























Figure 4.6. Coverage of the Generalized Method for 2-class equal cost with Gamma
distributed biomarkers.
Gamma distributed biomarkers (Table 4.3). The individual test, as shown by Bat-
terton [4], does not maintain coverage in these scenarios. As a result, comparisons of
tests were not reliable in maintaining coverage. A notable exception to this outcome
when tests are equal, the methods will at times maintain or exceed coverage (e.g.
Generalized and BP for 3-class in Table 4.3).
For instance, Table 4.3 shows a comparison of the results from the 2-class and
3-class Gamma misspecification. Here, the BP Bootstrap has the most consistent
coverage, with the Delta method providing good coverage in the 2-class problem and
the Generalized and BP methods maintain coverage across all sample sizes for the
3-class problem.
4.4 Discussion
While accounting for correlation is burdensome computationally, Chapter III
showed that assuming independence would result in overestimating the width of a
confidence interval. Adjusting for correlation, in certain scenarios, can maintain ef-
fective coverage at a reasonable length of the CI. This chapter has fully extended the
common parametric methods to account for correlation in multiple testing scenarios,
with reasonable coverage and minimal width.
In situations with moderate correlation levels (ρ ≥ 0.3), care should be made
to account for correlation using these equations. When in-class samples are small
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2-class Coverages 3-class Coverages—
nj ρ Delta Gen BP Delta Gen BP
10 -0.3 0.973 0.911 0.930 0.822 0.953 0.969
0 0.974 0.914 0.927 0.830 0.962 0.977
0.1 0.977 0.919 0.930 0.825 0.966 0.979
0.3 0.974 0.920 0.929 0.839 0.970 0.982
0.5 0.975 0.928 0.928 0.838 0.978 0.987
0.9 0.977 0.925 0.931 0.871 0.993 0.990
20 -0.3 0.960 0.877 0.931 0.896 0.964 0.956
0 0.955 0.876 0.927 0.893 0.966 0.961
0.1 0.954 0.874 0.929 0.891 0.972 0.959
0.3 0.954 0.878 0.929 0.896 0.976 0.964
0.5 0.954 0.875 0.927 0.898 0.983 0.967
0.9 0.955 0.865 0.923 0.899 0.994 0.973
50 -0.3 0.947 0.854 0.942 0.916 0.987 0.949
0 0.938 0.852 0.933 0.915 0.988 0.954
0.1 0.939 0.858 0.937 0.912 0.990 0.951
0.3 0.939 0.855 0.938 0.908 0.990 0.953
0.5 0.939 0.854 0.938 0.902 0.989 0.953
0.9 0.936 0.851 0.939 0.902 0.971 0.958
100 -0.3 0.940 0.858 0.943 0.912 0.981 0.947
0 0.935 0.850 0.937 0.910 0.973 0.953
0.1 0.933 0.857 0.936 0.905 0.971 0.947
0.3 0.931 0.847 0.940 0.910 0.963 0.953
0.5 0.926 0.851 0.934 0.904 0.957 0.955
0.9 0.929 0.838 0.942 0.891 0.921 0.956
Table 4.3. Coverages for the Gamma distributed “Fair, Fair” test using all three
methods for 2-class and 3-class problems.
(nj ≤ 20), the Generalized method performs superior to other methods accross all
methods, Delta and Generalized methods appropriately extended performs better
than the Bootstrap. Comparing these results to those presented by Yin [40], the
Delta method performs similarly, but the Generalized method, as presented in this
chapter, maintains coverage at a much more reasonable rate, whereas Yin’s General-
ized method is overly conservative, exceeding 97% coverage in most scenarios. While
length of these methods and those cannot be directly compared due to choice of pa-
rameters, any overestimation of coverage would be the result of overly wide confidence
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intervals.
Finally, all of these methods are numerical in nature, and extreme correlation
(ρ ≥ 0.9) can present numerical issues due to the nature of the methodologies used. In
a practical sense, we suggest a correlation greater than 0.9 could make the estimation
of a CI of the comparison of tests somewhat unreliable, specifically, as ρ → 1 the
tests become identical as the features are perfectly linearly correlated.
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V. Inference on Sequential Systems
5.1 Introduction
This chapter addresses the third research goal to develop inferential procedures to
account for correlation in sequences of classification systems. A brief motivation for
sequential classification systems utilizing the typical language associted with medical
testing follows. Several techniques exist that improve the overall diagnostic process.
Sequential testing combines multiple diagnostic tests sequentially in order to classify
subjects in one of two groups of the classification system. Sequential methods are
generally used to increase accuracy or reduce operational cost in a diagnostic setting,
where operational cost is akin to the number of tests required in order to classify a
subject [2, 3, 27, 34, 38]. This is in contrast to a linear combination of tests, like a
Bayes Network, where each subject is required to receive each test.
While sequential testing can achieve the goals of reducing costs and increasing
overall diagnostic accuracy, there are no current methods for developing inference
on sequential systema for a metric, such as Bayes Cost (BC) or Youden Index (J).
The use of sequential testing is common practice, however, and the need to exam-
ine strategies that maximize diagnostic accuracy in sequential testing is important.
Thereby, methods for inference and to compare diagnostic accuracy of sequences is
important.
5.1.1 Sequenced Tests.
We alter the notation of the formulas in Equation 2.17 as we need it for readability
to develop the CI around BC. Therefore, we restate Equation 2.17 as it given in
Equation 5.1.
The calculation of the optimal point for sequential tests using these strategies
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is straightforward and readily available [2]. Let FXi,j where i ∈ {a, b} and j ∈
{1, 2} denote a cumulative distribution function (CDF). Here, a small, but significant
notational change is made for this chapter for simplicity of reading the derivations.
The disease classes j, formerly 1 and 2, have been replaced with a and b. Let FXa,1,Xa,2
and FXb,1,Xb,2 denote the joint CDFs for the system. Then, the formulas for the false
positive rate (PFP ) and the true positive rate (PTP ) of each strategy are found in
Equation 5.1.
PBPFP (θ






















)− FXb,2 (θBN2 )+ FXb,1,Xb,2 (θBN1 , θBN2 ) (5.1)
where θi corresponds to the threshold values, superscripts BP and BN refer to the
respective strategy.
5.1.2 Bayes Cost.
The performance metric, BC, minimizes misclassification errors. It allows for the
application of a cost associated with specific misclassifications as well as differing class
prevalences. BC in the 2-class case is defined here, by Equation 5.2.
BC = min
θ∈Θ
cb|apa (1− PTP (θ)) + ca|bpb (PFP (θ)) , (5.2)
where ca|b is the cost of assigning a class a element from truth class b, pb is the
prevalence of class b, and PTP and PFP are the true and false positive rates for the
classifier at each parameter setting, θ. Depending on the strategy chosen for a specific
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sequence of tests, PTP and PFP are substituted in Equation 5.2 with the specific PTP
and PFP , as computed from equations given in 5.1, associated with that particular
strategy.
5.2 Methods for Inference on Sequenced Tests
Two methods of inference are considered for developing CIs on sequenced diagnos-
tic tests; the Delta method and the Generalized method. Each of these methods has
a set of assumptions that are required to make inferences utilizing that method. In
addition, theory for each of these methods have been extended in the previous chapter
to be able to handle the correlation induced by performing a testing sequence.
5.2.1 Delta Method.
With Normal, suitably transformable to Normal or asymptotically Normal features
presented, the Delta method is suitable to construct variance estimates for simple
Wald-based inference. The Wald-based confidence interval for the BC of a sequence




The value of E(BC) is the optimal BC value determined by applying Equation
5.2 to the sample. The V ar(BC) requires more calculation. An application of the
method developed by Klein [19] may be used to derive an estimate of the variance
utilizing the partial derivatives of the BC equation under the assumption that the
total variance of BC is small.
The chain rule for higher order functions is required for the calculation and is




























































































































































































































The application of Equation 5.8 requires estimation of parameters as given in Equa-
tions 5.9-5.13. Equation 5.11 is an asymptotic variance provided by Lehman and
Casella [21]. The assumption of variance of ρ requires asymptotic Normality of the
parameter, however, as we see in Figure 5.1, the distributional assumption of asymp-
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totic Normality is not robust at extreme correlation levels. This may affect perfor-
mance (coverage or length) of the Delta method at extreme correlation levels. This
was not an issue in Chapter IV when the standard error for the difference in the





, ∀i ∈ {a, b}, j ∈ {1, 2}, (5.9)
V ar(σ2i,j) =
σ2i,j





, ∀i ∈ {a, b}, (5.11)
Cov(µi,1, µi,2) =ρˆ
√




V ar(σi,1)V ar(σi,1), ∀i ∈ {a, b}. (5.13)


















(a) Sample Correlation when ρ=0.1










(b) Sample Correlation when ρ=0.9
Figure 5.1. Distributional Comparisons of ρ
The partial derivatives and estimation of all required parameters for the appli-
cation of this methodology for BP and BN strategies are provided in Appendix D.
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With all of the partial derivatives in place, it is now possible to develop the variance
required for the Wald-based CI developed by the Delta method by using Equation
5.14
V ar(BC) = V ar
[
cb|apa (1− PTP (θ)) + ca|bpb (PFP (θ))
]
, (5.14)
substituting the appropriate PTP and PFP equations for the BP and BN strategies.
For a two-test system, both BP and BN require estimates for 10 parameters. The
BN strategy, however, requires the estimates in multiple terms within both the PTP
and PFP equations.
5.2.2 Generalized Method.
The Generalized method relies on pivotal quantities that match a set of required
distribution assumptions in the features associated with the BC value. When Y ∼
N(0,Σ) and U ∼ χ2ν then
µ+ Y
√
ν/U ∼ t(µ,Σ) (5.15)
is a multivariate t-distributed random variable. With Σ being a dispersion matrix
ν/(ν − 2) times the Normal covariance matrix.
Similarly, the multivariate sampling distribution for a covariance matrix of a Nor-
mal distribution is
(n− 1)S ∼ Wishart(n− 1,Σ). (5.16)
The Generalized method is then developed, using these pivotal quantities. Define:
Rµj = t(x¯j,Σj, ν) (5.17)
with µj, the mean vector, xj, the observed mean vector for class j, Σj, the dispersion
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(scale) matrix for the jth class, and ν as the degrees of freedom. Next, define
RΣj = W (ν − 1,Sj)/(ν − 1) (5.18)
with Σj as the covariance matrix for the j
th class and Sj the observed covariance
matrix for the jth class. Then
RBC = c1pa (1− F1(θ1, θ2)) + c2pbF2(θ1, θ2). (5.19)




1− Φ [(Rθ∗ −Rµ1)TR−1Σ1 (Rθ∗ −Rµ1)])
+ ca|bpbΦ
[
(Rθ∗ −Rµ2)TR−1Σ2 (Rθ∗ −Rµ2)
]
. (5.20)
From this vector of RBC values of k length, the confidence interval for BC can be
accomplished with the α/2 vector quantiles. The Generalized algorithm consists of
the approach found in Figure 5.2
5.2.3 Simulation.
Simulations were performed with normal variates representing the distributions for
each class in each test in a sequence with varying degrees of correlation, classification
accuracy, sample size and cost structure for each strategy, BP and BN. Four levels of
correlation between class-specific distributions in test 1 and test 2 were considered,
ρ = 0, 0.2, 0.5, 0.8. These correlation levels they are common in medical applications
for sequenced testing. Three combinations of test accuracies were considered (Table
5.1) to represent sequences of two Good tests, two Poor tests and a Poor (Test
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• Calculate x¯ and S,
• Generate g monte carlo samples from a multivariate t distribution using
the dispersion matrix from S,
• Generate pivotal quantites for Rµ from x¯ and the generated t distribution,
• Generate g monte carlo samples from a multivariate Wishart distribution
using S, these are the pivotal quantites,
• Solve for RBC using the required pivotal quantites,
• Determine the required α/2 quantiles from the vector RBC for the CI
Figure 5.2. Algorithmic steps to compute the multivariate Generalized method for
sequential systems
1) and Good (Test 2) sequence of tests. The BC values for these scenarios were
identical for both BP and BN strategies. Four class sample sizes were considered,
nj = 50, 100, 250, 500. Finally, two cost structures were considered, one with equal
cost for misclassification, and one that weights false positive results twice as heavily
as false negative results, which was performed on the “Poor, Good” test scenario.
BC at ρ =
Accuracy Test 1 Test 2 0 0.2 0.5 0.8
Poor, Poor N(0, 1), N(2, 1) N(0, 1), N(2, 1) 0.54 0.56 0.58 0.61
Poor, Good N(0, 1), N(1, 1) N(0, 1), N(2, 1) 0.31 0.32 0.32 0.32
Good, Good N(0, 1), N(1, 1) N(0, 1), N(1, 1) 0.22 0.25 0.28 0.30
Table 5.1. Testing accuracies considered in the simulation
For each scenario, CIs were developed utilizing the Delta method and the General-
ized method for inference. Combined, these factor levels resulted in 128 scenarios for
the simulation (4 correlation, 3 accuracies, 4 sample sizes, 2 strategies and an addi-
tional cost scenario for one accuracy). CIs were generated 2000 times in each of these
scenarios with α = 0.05 and both coverage and width were recorded for comparison.
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5.3 Results
5.3.1 Results for BP Strategy.
Generlized Delta Generlized Delta
ρ nj Cov Len Cov Len ρ nj Cov Len Cov Len
0 1000 0.935 0.056 0.5 1000 0.922 0.566
500 0.946 0.084 0.933 0.079 500 0.95 0.089 0.912 0.08
250 0.943 0.119 0.928 0.112 250 0.942 0.126 0.925 0.114
100 0.939 0.187 0.926 0.178 100 0.945 0.198 0.932 0.184
50 0.93 0.263 0.933 0.253 50 0.923 0.281 0.916 0.263
0.2 1000 0.920 0.056 0.8 1000 0.914 0.057
500 0.954 0.087 0.936 0.08 500 0.946 0.091 0.912 0.082
250 0.948 0.122 0.929 0.113 250 0.946 0.129 0.923 0.118
100 0.935 0.192 0.927 0.18 100 0.943 0.204 0.934 0.19
50 0.922 0.271 0.916 0.256 50 0.945 0.291 0.931 0.271
Table 5.2. Results for the BP strategy for a “Poor, Poor” test comparison at equal
cost
Delta Generalized

























Figure 5.3. Coverange and Length for BP strategy for a “Poor, Good” test comparison
at equal cost
Table 5.2 and Figure 5.3 show the results for the BP strategy in “Poor, Poor”
and “Poor, Good” test comparison, respectively, at equal cost. The Generalized
method achieves coverage for most correlation settings at a sample size of between
100 ≤ nj ≤ 250, while the Delta method fails to achieve coverage even at samples
sizes of nj ≥ 500 in most testing scenarios. The Generalized method always has wider
CI lengths when compared to the Delta method in all scenarios.
When presented with an unequal test accuracy (Table 5.3), there is a slight in-
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Generlized Delta Generlized Delta
ρ nj Cov Len Cov Len ρ nj Cov Len Cov Len
0 1000 0.946 0.064 0.5 1000 0.952 0.071
500 0.951 0.093 0.947 0.091 500 0.950 0.100 0.948 0.100
250 0.943 0.131 0.936 0.128 250 0.945 0.141 0.941 0.141
100 0.949 0.206 0.939 0.201 100 0.943 0.222 0.941 0.221
50 0.941 0.288 0.931 0.282 50 0.945 0.313 0.933 0.308
0.2 1000 0.944 0.068 0.8 1000 0.955 0.071
500 0.948 0.097 0.945 0.096 500 0.955 0.100 0.957 0.100
250 0.942 0.137 0.936 0.135 250 0.954 0.141 0.952 0.141
100 0.945 0.215 0.942 0.212 100 0.950 0.223 0.945 0.222
50 0.932 0.301 0.921 0.294 50 0.945 0.317 0.935 0.313
Table 5.3. Results for the BP strategy for a “Poor, Good” test comparison at unequal
cost
crease in coverage with the Delta method meeting coverage for nj = 500, and nj > 100
for ρ = 0.8. When presented with an unequal cost scenario, in general, coverage is
similar to the equal cost scenarios.
Overall, the Generalized method meets coverage faster than the Delta method at
a cost of a slightly wider confidence interval. Full results can be found in Appendix
E.
5.3.2 Results for BN Strategy.
Delta Generalized

























Figure 5.4. Coverange and Length for BP strategy for a “Poor, Good” test comparison
at equal cost
Table 5.4 and Figure 5.4 show the analogous results for the BN strategy to those
presented for the BP strategy in Table 5.2 and Figure 5.3. There is a slight drop in
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Generlized Delta Generlized Delta
ρ nj Cov Len Cov Len ρ nj Cov Len Cov Len
0 1000 0.935 0.056 0.5 1000 0.922 0.057
500 0.952 0.084 0.935 0.079 500 0.950 0.089 0.927 0.081
250 0.939 0.119 0.926 0.113 250 0.951 0.126 0.937 0.116
100 0.937 0.187 0.932 0.181 100 0.933 0.198 0.927 0.190
50 0.924 0.263 0.929 0.259 50 0.931 0.281 0.929 0.276
0.2 1000 0.921 0.056 0.8 1000 0.914 0.057
500 0.947 0.087 0.922 0.080 500 0.940 0.091 0.921 0.084
250 0.949 0.122 0.930 0.114 250 0.938 0.129 0.922 0.133
100 0.941 0.192 0.932 0.183 100 0.938 0.204 0.934 0.202
50 0.926 0.270 0.923 0.264 50 0.910 0.290 0.909 0.289
Table 5.4. Results for the BN strategy for a “Poor, Poor” test comparison at equal
cost
coverage at nj ≤ 100 and ρ ≥ 0.8 in both the Generalized and Delta methods. This
drop in coverage can be attributed to the increase in the quantity of estimable pa-
rameters present in the functional forms of BC for the BN strategy. The Generalized
method for BN meets coverage at a slightly larger sample size than BP (nj ≥ 250),
and the Delta method does not meet coverage in most settings within this strategy.
5.4 Discussion
To support decision making under the circumstances where sequential testing is
appropriate, accuracy in the method is important. For this reason, in the testing
scenarios considered, the Generalized method is preferred. The Generalized method
achieved coverage at smaller sample sizes and maintained a comparable width to CIs
developed using the Delta method.
Sample size requirements were noticeably higher than in diagnostic test compar-
isons presented in Chapter IV, as correlation is an integral part of the functional form
of BC derived from sequential tests, instead of being involved in just the comparison,
the simultaneous estimable parameter requirement is much higher with sequential
testing, requiring the estimation of ρ, which also affects covariance matrices (as op-
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posed to only taking variance estimates in the previous method). In most practical
situations, an increase of sample size requirements in discovering appropriate diagnos-
tic settings and choosing the correct testing scenario may be preferable to a drastic




The performance of classification systems at their optimal point is important to
classification methods. Current methods of stratification, the Youden Index and
Bayes Cost, allow for summarizing a classification system’s performance at the opti-
mal thresholds. In particular, the use of Bayes Cost minimizes the misclassification
rates and has been shown to be a more flexible metric for characterizing performance
due to the ability to impose a complex cost structure on the misclassifications. This
classification is critical to compare and pick the best classification system, which
requires new methods to be able to accomplish this.
Although estimation of BC is of interest, quantifying the uncertainty in the system
performance is of great practical use. In such cases as when a new or varying test
requires a comparison to the current “gold standard” test, inference on the difference
between the tests is critical to decision methods. It is desirable in these scenarios to
test the same group of people in order to avoid unintended variation and reduce overall
sample sizes. This introduces a covariance of BC values into the system that must be
identified and my require a methodological adjustment. This work has determined
the impact of correlation on paired testing in order to characterize the situations that
require a methodological adjustment. Additionally, methods have been developed
that account for correlation in the system and adjust CIs accordingly.
Sequential testing involves multiple tests on the same group of people in order to
avoid expensive or intrusive testing when possible. In sequential tests, the character-
ization of uncertainty is of great practical use. This work has developed inferential
methods that allow for the creation of confidence intervals on BC values in sequential
testing scenarios.
The results of this work produces the following contributions to providing inference
in the comparison and evaluation of correlated multi-state classification systems:
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1. Under specific scenarios, ignoring correlation on inferential methods is shown
to be a valid approach.
2. Current methods are extended to compare generalized multi-state systems (any
k) with correlated features.
3. The first statistical inferential methods for sequential systems with respect to
accuracy are developed.
Future work may consider different distributional assumptions on the features of
interest, allowing for inference without the requirement of transforming data. Also,
this work assumed known prevalence structures for each class. Future work may
consider a distribution on prevalence for situations where the prevalence of each class
is not known. Finally, future work can expand sequential testing to include the Believe
the Extreme strategy, as discussed in Section 2.5, account for testing scenarios that
involve 3 or more sequential systems, or sequential testing with 3 or more classes.
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Appendix A. Results from Naive Independence Assumption
Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.957 0.668 0.963 0.756 0.860 0.553 0.929 0.545 0.841 0.555
0 0.955 0.667 0.960 0.755 0.858 0.553 0.926 0.545 0.837 0.556
0.1 0.965 0.668 0.967 0.756 0.872 0.554 0.936 0.546 0.854 0.555
0.3 0.973 0.666 0.975 0.755 0.887 0.551 0.950 0.542 0.868 0.552
0.5 0.987 0.665 0.987 0.754 0.922 0.551 0.967 0.543 0.901 0.552
0.9 1.000 0.659 1.000 0.752 0.999 0.542 1.000 0.535 0.996 0.539
20 -0.3 0.952 0.474 0.955 0.507 0.901 0.423 0.935 0.422 0.890 0.424
0 0.954 0.474 0.957 0.506 0.902 0.422 0.937 0.421 0.894 0.423
0.1 0.952 0.474 0.955 0.506 0.901 0.422 0.937 0.421 0.893 0.424
0.3 0.967 0.473 0.970 0.506 0.923 0.421 0.954 0.420 0.916 0.422
0.5 0.983 0.473 0.983 0.506 0.947 0.420 0.970 0.420 0.941 0.422
0.9 1.000 0.470 1.000 0.504 0.999 0.417 1.000 0.417 0.999 0.418
50 -0.3 0.952 0.300 0.953 0.309 0.931 0.286 0.945 0.286 0.927 0.286
0 0.953 0.300 0.953 0.308 0.934 0.285 0.946 0.285 0.930 0.285
0.1 0.953 0.300 0.955 0.309 0.934 0.285 0.947 0.286 0.932 0.286
0.3 0.966 0.300 0.969 0.308 0.950 0.285 0.962 0.285 0.947 0.286
0.5 0.982 0.300 0.982 0.309 0.968 0.285 0.977 0.285 0.965 0.286
0.9 1.000 0.299 1.000 0.308 1.000 0.284 1.000 0.284 1.000 0.284
100 -0.3 0.952 0.212 0.951 0.215 0.942 0.207 0.948 0.207 0.939 0.207
0 0.948 0.212 0.948 0.215 0.937 0.206 0.945 0.207 0.936 0.207
0.1 0.953 0.212 0.953 0.215 0.943 0.207 0.950 0.207 0.941 0.207
0.3 0.968 0.212 0.969 0.215 0.958 0.207 0.964 0.207 0.957 0.207
0.5 0.983 0.212 0.983 0.215 0.978 0.206 0.981 0.207 0.976 0.207
0.9 1.000 0.212 1.000 0.215 1.000 0.206 1.000 0.206 1.000 0.206
Table A.1. Results of Naive Independence Assumption with: Normal, 3-class,
Good:Good, Cost 1
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.963 0.439 0.968 0.536 0.875 0.374 0.930 0.368 0.839 0.385
0 0.965 0.437 0.965 0.534 0.877 0.372 0.932 0.366 0.840 0.383
0.1 0.965 0.438 0.968 0.535 0.885 0.374 0.935 0.367 0.850 0.384
0.3 0.977 0.438 0.978 0.535 0.900 0.373 0.949 0.367 0.866 0.382
0.5 0.987 0.435 0.988 0.533 0.928 0.371 0.968 0.365 0.899 0.378
0.9 0.999 0.434 1.000 0.533 0.997 0.366 1.000 0.362 0.995 0.366
20 -0.3 0.957 0.310 0.957 0.337 0.906 0.277 0.936 0.277 0.888 0.279
0 0.959 0.311 0.959 0.338 0.908 0.279 0.938 0.278 0.893 0.281
0.1 0.961 0.310 0.963 0.337 0.913 0.278 0.944 0.277 0.897 0.280
0.3 0.971 0.309 0.971 0.337 0.933 0.277 0.956 0.277 0.917 0.279
0.5 0.984 0.309 0.984 0.337 0.955 0.277 0.973 0.276 0.944 0.278
0.9 1.000 0.308 1.000 0.336 1.000 0.275 1.000 0.275 1.000 0.275
50 -0.3 0.955 0.196 0.955 0.202 0.935 0.186 0.946 0.186 0.929 0.187
0 0.953 0.196 0.954 0.202 0.931 0.186 0.945 0.187 0.927 0.187
0.1 0.958 0.196 0.958 0.202 0.939 0.187 0.948 0.187 0.931 0.187
0.3 0.966 0.196 0.966 0.202 0.950 0.187 0.959 0.187 0.944 0.187
0.5 0.982 0.195 0.982 0.202 0.969 0.186 0.976 0.186 0.966 0.187
0.9 1.000 0.196 1.000 0.202 1.000 0.186 1.000 0.186 1.000 0.187
100 -0.3 0.950 0.138 0.950 0.140 0.939 0.135 0.944 0.135 0.936 0.135
0 0.950 0.139 0.950 0.141 0.940 0.135 0.946 0.135 0.936 0.136
0.1 0.956 0.139 0.956 0.141 0.945 0.135 0.950 0.135 0.940 0.136
0.3 0.964 0.139 0.963 0.141 0.956 0.135 0.960 0.135 0.954 0.136
0.5 0.980 0.138 0.980 0.141 0.974 0.135 0.976 0.135 0.970 0.135
0.9 1.000 0.138 1.000 0.141 1.000 0.135 1.000 0.135 1.000 0.135
Table A.2. Results of Naive Independence Assumption with: Normal, 3-class,
Good:Good, Cost 2
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.936 0.805 0.957 0.846 0.876 0.713 0.909 0.707 0.880 0.707
0 0.942 0.804 0.963 0.845 0.884 0.712 0.913 0.706 0.889 0.706
0.1 0.943 0.806 0.964 0.846 0.885 0.711 0.919 0.706 0.890 0.705
0.3 0.957 0.806 0.973 0.847 0.906 0.714 0.929 0.709 0.911 0.710
0.5 0.972 0.805 0.984 0.846 0.932 0.711 0.944 0.706 0.936 0.707
0.9 0.994 0.803 0.999 0.846 0.988 0.709 0.980 0.704 0.991 0.709
20 -0.3 0.943 0.576 0.953 0.589 0.912 0.534 0.927 0.533 0.913 0.532
0 0.947 0.575 0.957 0.589 0.913 0.533 0.933 0.532 0.917 0.531
0.1 0.948 0.575 0.957 0.589 0.916 0.532 0.932 0.531 0.917 0.530
0.3 0.962 0.575 0.969 0.588 0.933 0.531 0.946 0.531 0.935 0.530
0.5 0.978 0.575 0.983 0.589 0.956 0.532 0.966 0.531 0.958 0.530
0.9 0.998 0.574 1.000 0.587 0.997 0.529 0.995 0.528 0.997 0.527
50 -0.3 0.947 0.366 0.951 0.369 0.932 0.354 0.939 0.354 0.934 0.354
0 0.943 0.366 0.948 0.369 0.928 0.353 0.936 0.353 0.931 0.353
0.1 0.953 0.366 0.956 0.369 0.938 0.353 0.943 0.354 0.939 0.354
0.3 0.965 0.366 0.966 0.369 0.952 0.354 0.958 0.354 0.952 0.354
0.5 0.977 0.366 0.979 0.370 0.970 0.354 0.973 0.354 0.970 0.354
0.9 1.000 0.366 1.000 0.369 1.000 0.353 0.999 0.353 1.000 0.353
100 -0.3 0.949 0.259 0.950 0.260 0.943 0.255 0.947 0.255 0.944 0.255
0 0.945 0.259 0.947 0.260 0.939 0.255 0.943 0.255 0.939 0.255
0.1 0.957 0.259 0.958 0.260 0.949 0.255 0.954 0.255 0.951 0.255
0.3 0.966 0.259 0.967 0.260 0.960 0.255 0.963 0.255 0.960 0.255
0.5 0.977 0.259 0.978 0.260 0.974 0.255 0.976 0.255 0.974 0.255
0.9 1.000 0.259 1.000 0.260 1.000 0.254 1.000 0.255 1.000 0.255
Table A.3. Results of Naive Independence Assumption with: Normal, 3-class
Good:Fair, Cost 1
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.941 0.552 0.962 0.626 0.887 0.493 0.908 0.490 0.874 0.501
0 0.950 0.555 0.968 0.628 0.896 0.495 0.916 0.491 0.884 0.502
0.1 0.950 0.553 0.969 0.627 0.898 0.493 0.915 0.490 0.885 0.501
0.3 0.958 0.553 0.976 0.626 0.910 0.493 0.922 0.489 0.903 0.500
0.5 0.974 0.554 0.987 0.628 0.938 0.494 0.945 0.490 0.933 0.501
0.9 0.994 0.552 0.999 0.626 0.985 0.490 0.979 0.486 0.989 0.496
20 -0.3 0.945 0.391 0.952 0.413 0.914 0.364 0.925 0.364 0.905 0.368
0 0.952 0.391 0.958 0.413 0.923 0.364 0.935 0.364 0.918 0.368
0.1 0.955 0.391 0.964 0.413 0.929 0.364 0.936 0.364 0.921 0.367
0.3 0.964 0.391 0.970 0.413 0.940 0.364 0.947 0.364 0.935 0.367
0.5 0.979 0.390 0.984 0.412 0.961 0.363 0.963 0.363 0.959 0.366
0.9 0.998 0.390 0.999 0.412 0.996 0.361 0.992 0.361 0.997 0.364
50 -0.3 0.946 0.247 0.948 0.251 0.932 0.239 0.938 0.239 0.931 0.240
0 0.950 0.247 0.953 0.252 0.935 0.239 0.941 0.239 0.933 0.240
0.1 0.953 0.247 0.954 0.252 0.944 0.239 0.947 0.239 0.941 0.240
0.3 0.964 0.247 0.966 0.252 0.955 0.239 0.959 0.239 0.953 0.240
0.5 0.980 0.247 0.982 0.251 0.974 0.238 0.976 0.239 0.972 0.240
0.9 1.000 0.246 1.000 0.251 0.999 0.238 0.999 0.239 1.000 0.239
100 -0.3 0.947 0.174 0.948 0.176 0.941 0.171 0.942 0.172 0.939 0.172
0 0.952 0.174 0.953 0.176 0.945 0.171 0.949 0.172 0.944 0.172
0.1 0.958 0.174 0.959 0.176 0.952 0.171 0.953 0.172 0.950 0.172
0.3 0.964 0.174 0.965 0.176 0.960 0.171 0.961 0.172 0.958 0.172
0.5 0.978 0.174 0.979 0.176 0.976 0.171 0.976 0.172 0.975 0.172
0.9 1.000 0.174 1.000 0.176 1.000 0.171 1.000 0.172 1.000 0.172
Table A.4. Results of Naive Independence Assumption with: Normal, 3-class
Good:Fair, Cost 2
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.938 1.106 0.932 0.868 0.902 0.805 0.899 0.804 0.894 0.786
0 0.943 1.026 0.939 0.868 0.911 0.806 0.910 0.806 0.904 0.787
0.1 0.942 1.133 0.937 0.867 0.908 0.804 0.909 0.804 0.904 0.785
0.3 0.958 1.014 0.957 0.868 0.932 0.803 0.925 0.803 0.925 0.785
0.5 0.968 1.057 0.964 0.866 0.947 0.804 0.933 0.803 0.943 0.785
0.9 0.991 1.125 0.993 0.867 0.988 0.805 0.966 0.804 0.987 0.787
20 -0.3 0.936 0.613 0.934 0.609 0.915 0.582 0.917 0.583 0.912 0.576
0 0.948 0.622 0.945 0.609 0.929 0.582 0.929 0.583 0.929 0.576
0.1 0.949 0.617 0.948 0.610 0.934 0.584 0.931 0.585 0.930 0.578
0.3 0.955 0.614 0.955 0.609 0.942 0.582 0.938 0.583 0.941 0.576
0.5 0.974 0.617 0.974 0.609 0.964 0.582 0.959 0.583 0.963 0.577
0.9 0.997 0.620 0.996 0.610 0.995 0.582 0.988 0.582 0.994 0.576
50 -0.3 0.942 0.385 0.942 0.385 0.931 0.378 0.937 0.378 0.932 0.377
0 0.953 0.386 0.951 0.386 0.945 0.378 0.946 0.379 0.944 0.377
0.1 0.950 0.385 0.948 0.386 0.942 0.378 0.941 0.379 0.941 0.377
0.3 0.965 0.386 0.963 0.386 0.959 0.378 0.958 0.379 0.958 0.378
0.5 0.980 0.385 0.979 0.386 0.974 0.378 0.974 0.379 0.974 0.377
0.9 0.999 0.386 0.999 0.386 0.999 0.378 0.997 0.379 0.999 0.377
100 -0.3 0.941 0.273 0.942 0.273 0.935 0.270 0.938 0.270 0.936 0.270
0 0.954 0.273 0.950 0.273 0.949 0.270 0.949 0.271 0.948 0.270
0.1 0.955 0.273 0.955 0.273 0.950 0.270 0.952 0.271 0.951 0.270
0.3 0.963 0.273 0.963 0.273 0.959 0.271 0.960 0.271 0.959 0.270
0.5 0.978 0.273 0.977 0.273 0.975 0.270 0.976 0.271 0.975 0.270
0.9 0.999 0.273 0.999 0.273 0.998 0.271 0.998 0.271 0.998 0.271
Table A.5. Results of Naive Independence Assumption with: Normal, 3-class Fair:Fair,
Cost 1
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.912 0.707 0.955 0.719 0.885 0.659 0.899 0.656 0.900 0.659
0 0.921 0.706 0.962 0.719 0.897 0.659 0.909 0.656 0.912 0.659
0.1 0.931 0.708 0.966 0.719 0.904 0.660 0.913 0.656 0.920 0.659
0.3 0.939 0.707 0.971 0.719 0.914 0.659 0.923 0.655 0.928 0.659
0.5 0.953 0.708 0.981 0.719 0.935 0.661 0.932 0.658 0.949 0.661
0.9 0.979 0.708 0.995 0.720 0.973 0.659 0.961 0.656 0.983 0.660
20 -0.3 0.928 0.510 0.950 0.505 0.905 0.483 0.924 0.482 0.920 0.480
0 0.939 0.510 0.959 0.506 0.912 0.483 0.936 0.481 0.929 0.480
0.1 0.933 0.509 0.953 0.505 0.911 0.481 0.931 0.480 0.926 0.478
0.3 0.953 0.510 0.971 0.505 0.932 0.483 0.947 0.481 0.945 0.480
0.5 0.961 0.510 0.977 0.505 0.946 0.482 0.954 0.480 0.958 0.479
0.9 0.989 0.510 0.995 0.505 0.983 0.481 0.980 0.479 0.988 0.479
50 -0.3 0.935 0.327 0.944 0.325 0.922 0.318 0.934 0.318 0.931 0.318
0 0.940 0.326 0.948 0.325 0.927 0.318 0.940 0.318 0.938 0.318
0.1 0.946 0.327 0.954 0.325 0.934 0.318 0.942 0.318 0.943 0.318
0.3 0.960 0.326 0.966 0.325 0.951 0.318 0.958 0.318 0.957 0.318
0.5 0.968 0.326 0.974 0.325 0.963 0.318 0.966 0.318 0.969 0.318
0.9 0.994 0.326 0.996 0.325 0.993 0.318 0.992 0.318 0.995 0.318
100 -0.3 0.940 0.232 0.945 0.231 0.935 0.229 0.939 0.229 0.940 0.229
0 0.949 0.232 0.952 0.231 0.945 0.229 0.947 0.229 0.949 0.229
0.1 0.950 0.231 0.953 0.231 0.945 0.229 0.948 0.229 0.948 0.229
0.3 0.962 0.232 0.964 0.231 0.957 0.229 0.960 0.229 0.962 0.229
0.5 0.974 0.232 0.976 0.231 0.972 0.229 0.973 0.229 0.974 0.229
0.9 0.995 0.232 0.997 0.231 0.994 0.229 0.995 0.229 0.995 0.229
Table A.6. Results of Naive Independence Assumption with: Normal, 3-class Fair:Fair,
Cost 2
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.927 0.921 0.954 0.930 0.878 0.842 0.925 0.841 0.892 0.840
0 0.938 0.921 0.959 0.930 0.893 0.843 0.935 0.841 0.906 0.840
0.1 0.942 0.920 0.963 0.930 0.894 0.841 0.935 0.839 0.905 0.838
0.3 0.957 0.920 0.974 0.930 0.919 0.840 0.952 0.837 0.927 0.837
0.5 0.972 0.920 0.985 0.930 0.945 0.839 0.968 0.838 0.949 0.838
0.9 1.000 0.921 1.000 0.930 0.999 0.837 1.000 0.836 0.999 0.837
20 -0.3 0.935 0.661 0.946 0.662 0.909 0.624 0.927 0.624 0.913 0.624
0 0.940 0.661 0.951 0.662 0.914 0.623 0.933 0.623 0.920 0.623
0.1 0.947 0.661 0.956 0.661 0.921 0.623 0.940 0.623 0.927 0.623
0.3 0.967 0.661 0.974 0.661 0.946 0.623 0.961 0.623 0.949 0.624
0.5 0.983 0.661 0.986 0.662 0.969 0.623 0.978 0.623 0.972 0.624
0.9 1.000 0.661 1.000 0.661 1.000 0.622 1.000 0.622 1.000 0.623
50 -0.3 0.938 0.422 0.942 0.421 0.929 0.410 0.935 0.411 0.931 0.411
0 0.945 0.422 0.951 0.422 0.934 0.411 0.941 0.412 0.935 0.412
0.1 0.955 0.422 0.960 0.422 0.944 0.410 0.951 0.411 0.946 0.411
0.3 0.968 0.422 0.970 0.421 0.960 0.411 0.966 0.411 0.961 0.412
0.5 0.985 0.422 0.986 0.422 0.979 0.410 0.982 0.410 0.980 0.411
0.9 1.000 0.422 1.000 0.421 1.000 0.411 1.000 0.411 1.000 0.411
100 -0.3 0.937 0.299 0.938 0.299 0.930 0.295 0.934 0.295 0.931 0.295
0 0.946 0.299 0.947 0.299 0.941 0.295 0.944 0.295 0.942 0.295
0.1 0.954 0.299 0.956 0.299 0.950 0.295 0.953 0.295 0.951 0.295
0.3 0.966 0.299 0.966 0.299 0.960 0.295 0.963 0.295 0.960 0.295
0.5 0.983 0.299 0.984 0.299 0.980 0.295 0.981 0.295 0.980 0.295
0.9 1.000 0.299 1.000 0.299 1.000 0.295 1.000 0.295 1.000 0.295
Table A.7. Results of Naive Independence Assumption with: Normal, 3-class
Good:Poor, Cost 1
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.940 0.649 0.958 0.707 0.889 0.590 0.921 0.587 0.881 0.591
0 0.947 0.649 0.963 0.708 0.899 0.591 0.931 0.588 0.894 0.592
0.1 0.957 0.649 0.973 0.709 0.914 0.590 0.940 0.588 0.905 0.592
0.3 0.963 0.647 0.975 0.706 0.925 0.588 0.950 0.586 0.919 0.589
0.5 0.981 0.647 0.989 0.707 0.951 0.587 0.972 0.585 0.948 0.588
0.9 1.000 0.645 1.000 0.706 0.999 0.582 1.000 0.581 0.999 0.583
20 -0.3 0.941 0.458 0.949 0.476 0.916 0.433 0.928 0.434 0.910 0.435
0 0.950 0.457 0.956 0.476 0.928 0.434 0.938 0.434 0.923 0.436
0.1 0.957 0.457 0.963 0.476 0.935 0.433 0.945 0.434 0.929 0.435
0.3 0.970 0.458 0.974 0.477 0.953 0.434 0.961 0.434 0.948 0.435
0.5 0.985 0.457 0.988 0.476 0.976 0.434 0.980 0.434 0.973 0.435
0.9 1.000 0.456 1.000 0.475 1.000 0.430 1.000 0.431 1.000 0.431
50 -0.3 0.938 0.289 0.940 0.293 0.928 0.281 0.931 0.282 0.924 0.282
0 0.953 0.289 0.954 0.293 0.942 0.282 0.946 0.282 0.941 0.283
0.1 0.954 0.289 0.957 0.293 0.944 0.282 0.948 0.282 0.942 0.282
0.3 0.970 0.289 0.972 0.293 0.962 0.282 0.967 0.282 0.961 0.282
0.5 0.985 0.288 0.986 0.293 0.981 0.282 0.982 0.282 0.979 0.282
0.9 1.000 0.289 1.000 0.293 1.000 0.281 1.000 0.281 1.000 0.281
100 -0.3 0.941 0.204 0.942 0.205 0.937 0.201 0.937 0.202 0.936 0.202
0 0.947 0.204 0.948 0.205 0.942 0.201 0.943 0.201 0.941 0.201
0.1 0.952 0.204 0.952 0.205 0.948 0.201 0.948 0.201 0.945 0.202
0.3 0.971 0.204 0.971 0.205 0.967 0.201 0.968 0.201 0.965 0.201
0.5 0.986 0.204 0.985 0.205 0.982 0.201 0.983 0.202 0.982 0.202
0.9 1.000 0.204 1.000 0.205 1.000 0.201 1.000 0.201 1.000 0.201
Table A.8. Results of Naive Independence Assumption with: Normal, 3-class
Good:Poor, Cost 2
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.975 0.460 0.956 0.532 0.877 0.385 0.919 0.378 0.787 0.409
0 0.979 0.460 0.963 0.533 0.887 0.383 0.932 0.377 0.805 0.405
0.1 0.983 0.460 0.967 0.535 0.898 0.385 0.933 0.379 0.818 0.406
0.3 0.989 0.459 0.976 0.533 0.914 0.383 0.949 0.377 0.839 0.402
0.5 0.995 0.456 0.986 0.532 0.940 0.380 0.965 0.375 0.876 0.396
0.9 1.000 0.448 1.000 0.529 0.998 0.371 1.000 0.369 0.988 0.378
20 -0.3 0.962 0.329 0.952 0.356 0.908 0.296 0.931 0.296 0.862 0.302
0 0.966 0.328 0.955 0.355 0.914 0.295 0.935 0.295 0.867 0.301
0.1 0.970 0.328 0.961 0.355 0.925 0.295 0.944 0.295 0.881 0.301
0.3 0.979 0.328 0.973 0.355 0.940 0.294 0.956 0.295 0.905 0.300
0.5 0.991 0.326 0.985 0.353 0.965 0.293 0.976 0.294 0.939 0.298
0.9 1.000 0.322 1.000 0.351 1.000 0.288 1.000 0.289 0.999 0.291
50 -0.3 0.945 0.208 0.941 0.215 0.924 0.199 0.933 0.200 0.904 0.201
0 0.952 0.208 0.948 0.215 0.932 0.199 0.940 0.200 0.915 0.201
0.1 0.960 0.209 0.956 0.215 0.940 0.199 0.947 0.200 0.923 0.201
0.3 0.972 0.208 0.969 0.215 0.956 0.199 0.963 0.199 0.943 0.200
0.5 0.987 0.208 0.987 0.215 0.977 0.199 0.981 0.200 0.970 0.200
0.9 1.000 0.207 1.000 0.214 1.000 0.197 1.000 0.198 1.000 0.198
100 -0.3 0.943 0.148 0.941 0.150 0.930 0.144 0.934 0.145 0.919 0.145
0 0.951 0.148 0.949 0.150 0.940 0.144 0.944 0.145 0.931 0.145
0.1 0.959 0.148 0.959 0.150 0.948 0.144 0.952 0.145 0.940 0.145
0.3 0.971 0.148 0.971 0.150 0.964 0.144 0.965 0.145 0.957 0.145
0.5 0.986 0.148 0.985 0.150 0.983 0.144 0.984 0.145 0.978 0.145
0.9 1.000 0.147 1.000 0.150 1.000 0.144 1.000 0.144 1.000 0.144
Table A.9. Results of Naive Independence Assumption with: Normal, 2-class,
Good:Good, Cost 1
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.855 0.396 0.966 0.677 0.855 0.565 0.926 0.567 0.751 0.564
0 0.866 0.395 0.972 0.675 0.861 0.560 0.937 0.563 0.771 0.563
0.1 0.871 0.396 0.974 0.679 0.865 0.561 0.942 0.563 0.780 0.560
0.3 0.882 0.395 0.984 0.677 0.875 0.557 0.956 0.562 0.797 0.558
0.5 0.895 0.393 0.993 0.679 0.886 0.553 0.976 0.562 0.833 0.559
0.9 0.935 0.388 1.000 0.691 0.927 0.539 0.999 0.567 0.930 0.558
20 -0.3 0.896 0.293 0.958 0.561 0.923 0.474 0.933 0.495 0.841 0.488
0 0.913 0.294 0.966 0.561 0.931 0.470 0.943 0.493 0.852 0.487
0.1 0.902 0.293 0.962 0.562 0.922 0.472 0.941 0.496 0.849 0.486
0.3 0.919 0.293 0.979 0.562 0.930 0.469 0.964 0.494 0.870 0.487
0.5 0.934 0.293 0.988 0.564 0.937 0.467 0.979 0.495 0.896 0.488
0.9 0.960 0.288 1.000 0.564 0.960 0.454 1.000 0.493 0.962 0.483
50 -0.3 0.932 0.192 0.939 0.335 0.977 0.302 0.926 0.303 0.899 0.315
0 0.950 0.192 0.957 0.332 0.979 0.297 0.946 0.300 0.919 0.311
0.1 0.956 0.192 0.962 0.331 0.979 0.297 0.953 0.301 0.930 0.312
0.3 0.967 0.192 0.972 0.332 0.983 0.297 0.964 0.301 0.942 0.312
0.5 0.981 0.191 0.985 0.329 0.989 0.292 0.982 0.298 0.965 0.307
0.9 0.996 0.191 1.000 0.331 0.996 0.285 1.000 0.299 0.996 0.302
100 -0.3 0.946 0.136 0.944 0.165 0.970 0.164 0.940 0.157 0.927 0.161
0 0.954 0.136 0.952 0.165 0.974 0.164 0.948 0.157 0.938 0.161
0.1 0.961 0.136 0.960 0.164 0.975 0.162 0.955 0.155 0.943 0.159
0.3 0.970 0.136 0.969 0.165 0.980 0.163 0.965 0.156 0.956 0.160
0.5 0.989 0.136 0.988 0.164 0.992 0.162 0.986 0.156 0.980 0.159
0.9 1.000 0.136 1.000 0.163 1.000 0.159 1.000 0.154 1.000 0.155
Table A.10. Results of Naive Independence Assumption with: Normal, 2-class,
Good:Good, Cost 2
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.922 0.594 0.951 0.638 0.863 0.525 0.885 0.518 0.852 0.542
0 0.939 0.595 0.962 0.639 0.880 0.520 0.902 0.515 0.871 0.531
0.1 0.939 0.594 0.965 0.638 0.881 0.518 0.905 0.513 0.877 0.529
0.3 0.950 0.593 0.974 0.638 0.900 0.524 0.911 0.518 0.893 0.538
0.5 0.964 0.592 0.983 0.636 0.922 0.515 0.929 0.510 0.926 0.526
0.9 0.979 0.588 0.995 0.635 0.963 0.511 0.958 0.507 0.980 0.522
20 -0.3 0.932 0.429 0.943 0.443 0.899 0.399 0.916 0.399 0.894 0.404
0 0.945 0.428 0.955 0.442 0.918 0.398 0.929 0.397 0.909 0.402
0.1 0.950 0.428 0.959 0.442 0.923 0.398 0.934 0.398 0.917 0.403
0.3 0.963 0.428 0.973 0.442 0.939 0.398 0.948 0.397 0.933 0.403
0.5 0.976 0.427 0.984 0.442 0.958 0.397 0.963 0.397 0.957 0.402
0.9 0.993 0.426 0.998 0.440 0.989 0.395 0.988 0.395 0.994 0.400
50 -0.3 0.941 0.274 0.943 0.277 0.927 0.266 0.932 0.266 0.923 0.267
0 0.950 0.274 0.954 0.277 0.941 0.266 0.944 0.266 0.937 0.268
0.1 0.953 0.273 0.956 0.276 0.943 0.265 0.947 0.266 0.941 0.267
0.3 0.972 0.273 0.974 0.276 0.962 0.265 0.964 0.265 0.959 0.267
0.5 0.982 0.273 0.985 0.276 0.978 0.265 0.978 0.265 0.977 0.267
0.9 0.999 0.272 0.999 0.276 0.998 0.264 0.998 0.265 0.999 0.266
100 -0.3 0.935 0.194 0.937 0.195 0.927 0.191 0.932 0.192 0.926 0.192
0 0.950 0.194 0.951 0.195 0.944 0.191 0.945 0.191 0.944 0.192
0.1 0.959 0.194 0.959 0.195 0.953 0.191 0.956 0.191 0.952 0.192
0.3 0.967 0.194 0.969 0.195 0.963 0.192 0.964 0.192 0.963 0.192
0.5 0.983 0.194 0.983 0.195 0.980 0.191 0.980 0.191 0.980 0.192
0.9 1.000 0.194 1.000 0.195 1.000 0.191 1.000 0.191 1.000 0.191
Table A.11. Results of Naive Independence Assumption with: Normal, 2-class
Good:Fair, Cost 1
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.830 0.488 0.963 0.622 0.836 0.577 0.900 0.559 0.826 0.555
0 0.840 0.487 0.969 0.621 0.845 0.575 0.915 0.557 0.837 0.551
0.1 0.846 0.486 0.971 0.622 0.850 0.574 0.920 0.558 0.843 0.551
0.3 0.858 0.486 0.977 0.622 0.865 0.572 0.922 0.554 0.854 0.552
0.5 0.876 0.488 0.987 0.625 0.883 0.572 0.942 0.557 0.875 0.553
0.9 0.913 0.481 0.997 0.628 0.928 0.558 0.966 0.552 0.939 0.548
20 -0.3 0.890 0.367 0.956 0.507 0.909 0.460 0.926 0.468 0.885 0.453
0 0.896 0.366 0.962 0.506 0.909 0.459 0.939 0.468 0.890 0.451
0.1 0.903 0.365 0.966 0.506 0.915 0.459 0.938 0.467 0.896 0.452
0.3 0.911 0.365 0.973 0.508 0.924 0.458 0.950 0.468 0.909 0.451
0.5 0.927 0.366 0.987 0.508 0.933 0.457 0.968 0.468 0.927 0.450
0.9 0.957 0.362 0.998 0.504 0.967 0.446 0.991 0.460 0.973 0.445
50 -0.3 0.932 0.238 0.944 0.315 0.956 0.292 0.932 0.295 0.922 0.294
0 0.944 0.238 0.951 0.313 0.962 0.291 0.941 0.294 0.934 0.293
0.1 0.948 0.238 0.959 0.314 0.965 0.291 0.947 0.295 0.936 0.294
0.3 0.962 0.238 0.970 0.313 0.972 0.290 0.960 0.294 0.954 0.293
0.5 0.980 0.238 0.986 0.312 0.983 0.288 0.979 0.293 0.974 0.291
0.9 0.996 0.237 1.000 0.309 0.995 0.284 0.999 0.289 0.996 0.286
100 -0.3 0.934 0.169 0.937 0.184 0.945 0.181 0.931 0.179 0.928 0.179
0 0.946 0.169 0.948 0.184 0.954 0.181 0.943 0.179 0.939 0.179
0.1 0.953 0.169 0.956 0.183 0.960 0.179 0.952 0.177 0.945 0.177
0.3 0.968 0.169 0.970 0.184 0.972 0.181 0.963 0.178 0.961 0.178
0.5 0.983 0.169 0.983 0.184 0.984 0.181 0.982 0.178 0.979 0.178
0.9 1.000 0.169 1.000 0.183 1.000 0.180 1.000 0.178 1.000 0.178
Table A.12. Results of Naive Independence Assumption with: Normal, 2-class
Good:Fair, Cost 2
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.927 0.704 0.950 0.731 0.870 0.639 0.907 0.634 0.852 0.642
0 0.946 0.704 0.962 0.732 0.892 0.633 0.929 0.629 0.879 0.635
0.1 0.951 0.703 0.967 0.731 0.897 0.631 0.934 0.627 0.883 0.632
0.3 0.971 0.703 0.981 0.730 0.932 0.638 0.956 0.633 0.914 0.640
0.5 0.987 0.700 0.990 0.729 0.952 0.628 0.974 0.624 0.941 0.630
0.9 1.000 0.696 1.000 0.726 0.999 0.622 1.000 0.620 0.997 0.622
20 -0.3 0.923 0.509 0.936 0.516 0.896 0.481 0.913 0.480 0.891 0.482
0 0.949 0.509 0.957 0.516 0.925 0.481 0.939 0.480 0.918 0.482
0.1 0.954 0.508 0.962 0.515 0.934 0.479 0.947 0.479 0.928 0.481
0.3 0.969 0.508 0.976 0.515 0.950 0.479 0.962 0.479 0.944 0.480
0.5 0.988 0.508 0.991 0.515 0.974 0.479 0.982 0.479 0.969 0.480
0.9 1.000 0.506 1.000 0.514 1.000 0.477 1.000 0.477 1.000 0.477
50 -0.3 0.928 0.326 0.933 0.327 0.918 0.318 0.925 0.319 0.914 0.319
0 0.949 0.326 0.952 0.327 0.937 0.318 0.945 0.318 0.935 0.319
0.1 0.953 0.326 0.957 0.327 0.945 0.317 0.951 0.318 0.943 0.318
0.3 0.971 0.326 0.974 0.327 0.966 0.318 0.969 0.318 0.964 0.319
0.5 0.989 0.325 0.990 0.326 0.984 0.317 0.987 0.318 0.982 0.318
0.9 1.000 0.325 1.000 0.326 1.000 0.317 1.000 0.317 1.000 0.317
100 -0.3 0.929 0.231 0.932 0.232 0.924 0.229 0.927 0.229 0.923 0.229
0 0.950 0.232 0.952 0.232 0.946 0.229 0.949 0.229 0.945 0.229
0.1 0.956 0.231 0.957 0.232 0.951 0.229 0.954 0.229 0.951 0.229
0.3 0.971 0.231 0.972 0.232 0.969 0.228 0.970 0.229 0.968 0.229
0.5 0.989 0.231 0.989 0.231 0.987 0.228 0.988 0.229 0.987 0.229
0.9 1.000 0.231 1.000 0.232 1.000 0.229 1.000 0.229 1.000 0.229
Table A.13. Results of Naive Independence Assumption with: Normal, 2-class Fair:Fair,
Cost 1
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.863 0.564 0.963 0.585 0.841 0.586 0.919 0.558 0.867 0.571
0 0.880 0.563 0.969 0.586 0.859 0.585 0.933 0.560 0.876 0.568
0.1 0.888 0.564 0.976 0.587 0.864 0.585 0.942 0.559 0.881 0.570
0.3 0.918 0.564 0.985 0.588 0.899 0.586 0.959 0.562 0.910 0.571
0.5 0.945 0.562 0.991 0.589 0.930 0.581 0.975 0.558 0.934 0.571
0.9 0.987 0.554 1.000 0.594 0.984 0.577 1.000 0.561 0.984 0.576
20 -0.3 0.900 0.426 0.952 0.458 0.888 0.442 0.927 0.441 0.901 0.439
0 0.916 0.425 0.958 0.457 0.901 0.440 0.939 0.440 0.911 0.439
0.1 0.921 0.424 0.968 0.457 0.914 0.440 0.949 0.440 0.919 0.438
0.3 0.940 0.425 0.978 0.457 0.928 0.440 0.961 0.441 0.935 0.439
0.5 0.960 0.424 0.990 0.458 0.951 0.439 0.981 0.440 0.957 0.438
0.9 0.991 0.423 1.000 0.459 0.989 0.437 1.000 0.440 0.992 0.439
50 -0.3 0.934 0.277 0.943 0.293 0.937 0.282 0.933 0.284 0.929 0.285
0 0.947 0.277 0.955 0.294 0.946 0.283 0.945 0.285 0.941 0.286
0.1 0.950 0.277 0.958 0.293 0.951 0.282 0.947 0.284 0.944 0.285
0.3 0.970 0.276 0.977 0.293 0.971 0.282 0.970 0.284 0.965 0.285
0.5 0.982 0.276 0.987 0.293 0.982 0.283 0.982 0.285 0.978 0.286
0.9 1.000 0.275 1.000 0.292 1.000 0.281 1.000 0.283 1.000 0.284
100 -0.3 0.932 0.196 0.936 0.198 0.930 0.195 0.930 0.196 0.926 0.196
0 0.952 0.196 0.953 0.198 0.948 0.195 0.950 0.195 0.947 0.195
0.1 0.955 0.196 0.957 0.198 0.952 0.195 0.952 0.195 0.950 0.195
0.3 0.969 0.196 0.970 0.198 0.965 0.195 0.966 0.195 0.964 0.196
0.5 0.987 0.196 0.988 0.198 0.986 0.195 0.985 0.195 0.983 0.195
0.9 1.000 0.196 1.000 0.198 1.000 0.194 1.000 0.195 1.000 0.195
Table A.14. Results of Naive Independence Assumption with: Normal, 2-class Fair:Fair,
Cost 2
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.915 0.697 0.944 0.700 0.865 0.648 0.892 0.643 0.895 0.639
0 0.931 0.698 0.954 0.702 0.886 0.645 0.905 0.640 0.911 0.636
0.1 0.934 0.698 0.956 0.701 0.892 0.645 0.910 0.640 0.915 0.636
0.3 0.945 0.699 0.966 0.702 0.911 0.651 0.923 0.646 0.935 0.646
0.5 0.954 0.697 0.974 0.701 0.922 0.645 0.930 0.640 0.946 0.639
0.9 0.978 0.697 0.990 0.702 0.965 0.644 0.957 0.640 0.983 0.643
20 -0.3 0.932 0.507 0.940 0.507 0.909 0.486 0.920 0.486 0.920 0.486
0 0.941 0.507 0.949 0.507 0.920 0.486 0.931 0.486 0.932 0.486
0.1 0.948 0.508 0.955 0.507 0.928 0.486 0.938 0.486 0.940 0.485
0.3 0.958 0.507 0.966 0.507 0.942 0.487 0.946 0.487 0.952 0.487
0.5 0.972 0.506 0.978 0.506 0.958 0.485 0.961 0.485 0.967 0.485
0.9 0.989 0.507 0.993 0.507 0.985 0.486 0.982 0.486 0.992 0.486
50 -0.3 0.935 0.325 0.936 0.325 0.927 0.320 0.930 0.321 0.927 0.321
0 0.951 0.325 0.952 0.325 0.945 0.320 0.947 0.320 0.947 0.321
0.1 0.951 0.325 0.953 0.325 0.944 0.320 0.945 0.320 0.947 0.320
0.3 0.968 0.325 0.970 0.325 0.963 0.320 0.963 0.321 0.965 0.321
0.5 0.975 0.325 0.976 0.325 0.972 0.319 0.972 0.320 0.975 0.320
0.9 0.995 0.325 0.996 0.325 0.995 0.320 0.994 0.320 0.996 0.320
100 -0.3 0.933 0.231 0.934 0.231 0.931 0.229 0.932 0.230 0.934 0.230
0 0.947 0.231 0.948 0.231 0.945 0.229 0.945 0.230 0.946 0.230
0.1 0.952 0.231 0.953 0.231 0.947 0.229 0.949 0.230 0.949 0.230
0.3 0.970 0.231 0.970 0.231 0.967 0.229 0.966 0.230 0.967 0.230
0.5 0.978 0.231 0.979 0.231 0.975 0.229 0.976 0.230 0.976 0.230
0.9 0.996 0.231 0.996 0.231 0.996 0.229 0.996 0.229 0.997 0.229
Table A.15. Results of Naive Independence Assumption with: Normal, 2-class
Good:Poor, Cost 1
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.827 0.415 0.943 0.532 0.891 0.549 0.915 0.505 0.883 0.498
0 0.845 0.417 0.952 0.533 0.894 0.546 0.926 0.505 0.890 0.500
0.1 0.848 0.416 0.956 0.536 0.897 0.549 0.935 0.509 0.895 0.505
0.3 0.866 0.421 0.962 0.535 0.905 0.551 0.944 0.509 0.908 0.506
0.5 0.880 0.418 0.974 0.532 0.908 0.548 0.955 0.505 0.912 0.503
0.9 0.914 0.422 0.992 0.532 0.922 0.550 0.978 0.505 0.937 0.502
20 -0.3 0.877 0.300 0.940 0.416 0.902 0.395 0.928 0.390 0.909 0.384
0 0.889 0.301 0.952 0.414 0.908 0.397 0.943 0.390 0.919 0.382
0.1 0.888 0.302 0.954 0.416 0.908 0.397 0.945 0.391 0.917 0.382
0.3 0.907 0.302 0.964 0.416 0.923 0.398 0.961 0.390 0.932 0.382
0.5 0.924 0.303 0.975 0.416 0.935 0.400 0.971 0.392 0.941 0.383
0.9 0.960 0.305 0.994 0.415 0.962 0.402 0.992 0.391 0.966 0.380
50 -0.3 0.917 0.196 0.938 0.257 0.929 0.248 0.933 0.245 0.925 0.243
0 0.929 0.196 0.954 0.259 0.934 0.250 0.949 0.247 0.938 0.245
0.1 0.930 0.197 0.954 0.259 0.937 0.250 0.951 0.246 0.940 0.245
0.3 0.955 0.197 0.969 0.257 0.955 0.249 0.968 0.245 0.959 0.243
0.5 0.965 0.198 0.978 0.260 0.966 0.252 0.978 0.247 0.970 0.245
0.9 0.993 0.198 0.996 0.259 0.993 0.252 0.997 0.248 0.994 0.244
100 -0.3 0.924 0.141 0.938 0.151 0.921 0.153 0.933 0.149 0.924 0.148
0 0.936 0.141 0.949 0.150 0.933 0.152 0.948 0.148 0.940 0.147
0.1 0.943 0.141 0.954 0.150 0.937 0.152 0.953 0.148 0.943 0.147
0.3 0.960 0.141 0.966 0.151 0.955 0.153 0.967 0.149 0.960 0.148
0.5 0.975 0.142 0.980 0.152 0.968 0.154 0.982 0.150 0.975 0.149
0.9 0.998 0.142 0.999 0.151 0.996 0.153 0.999 0.149 0.998 0.147
Table A.16. Results of Naive Independence Assumption with: Normal, 2-class
Good:Poor, Cost 2
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.860 0.641 0.996 1.349 0.978 0.937 0.978 0.955 0.924 1.000
0 0.865 0.637 0.999 1.344 0.980 0.931 0.980 0.948 0.924 NA
0.1 0.866 0.636 0.997 1.347 0.979 0.934 0.983 0.952 0.928 NA
0.3 0.866 0.640 0.998 1.346 0.979 0.932 0.985 0.945 0.934 NA
0.5 0.881 0.637 1.000 1.343 0.986 0.930 0.992 0.946 0.955 NA
0.9 0.897 0.635 1.000 1.351 0.992 0.919 1.000 0.953 0.995 0.983
20 -0.3 0.850 0.454 0.993 1.224 0.939 0.440 0.943 0.402 0.905 NA
0 0.854 0.453 0.995 1.220 0.940 0.436 0.945 0.397 0.909 NA
0.1 0.862 0.453 0.996 1.233 0.945 0.440 0.952 0.401 0.912 NA
0.3 0.863 0.452 0.994 1.228 0.948 0.437 0.959 0.398 0.919 NA
0.5 0.872 0.452 0.998 1.230 0.965 0.436 0.974 0.396 0.945 NA
0.9 0.906 0.452 1.000 1.230 0.999 0.434 1.000 0.398 0.998 0.400
50 -0.3 0.910 0.294 0.992 1.060 0.940 0.271 0.935 0.247 0.911 NA
0 0.918 0.295 0.994 1.051 0.945 0.271 0.946 0.247 0.921 NA
0.1 0.914 0.294 0.995 1.057 0.954 0.271 0.949 0.247 0.931 NA
0.3 0.922 0.295 0.996 1.058 0.957 0.271 0.956 0.248 0.934 NA
0.5 0.934 0.294 0.999 1.049 0.977 0.271 0.978 0.247 0.964 0.248
0.9 0.953 0.294 1.000 1.060 0.999 0.270 1.000 0.246 0.999 NA
100 -0.3 0.936 0.210 0.988 0.740 0.959 0.208 0.941 0.181 0.926 NA
0 0.940 0.211 0.989 0.726 0.957 0.209 0.943 0.182 0.928 0.182
0.1 0.941 0.210 0.990 0.724 0.962 0.208 0.944 0.181 0.929 0.182
0.3 0.950 0.210 0.993 0.728 0.969 0.208 0.956 0.181 0.945 NA
0.5 0.960 0.210 0.998 0.733 0.983 0.208 0.977 0.181 0.967 NA
0.9 0.972 0.210 1.000 0.725 0.999 0.206 1.000 0.181 0.999 NA
Table A.17. Results of Naive Independence Assumption with: Gamma, 3-class,
Good:Good, Cost 1
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.828 0.366 0.997 0.817 0.977 0.539 0.966 0.492 0.876 0.554
0 0.834 0.367 0.998 0.812 0.979 0.538 0.967 0.493 0.883 0.559
0.1 0.833 0.366 0.998 0.817 0.979 0.540 0.971 0.494 0.884 0.553
0.3 0.829 0.367 0.998 0.816 0.979 0.542 0.976 0.494 0.890 0.560
0.5 0.842 0.363 0.999 0.817 0.987 0.539 0.988 0.493 0.918 0.553
0.9 0.885 0.359 1.000 0.812 0.997 0.524 1.000 0.491 0.996 0.519
20 -0.3 0.911 0.264 0.991 0.504 0.909 0.220 0.942 0.207 0.877 0.212
0 0.911 0.263 0.991 0.506 0.914 0.219 0.944 0.207 0.882 0.212
0.1 0.911 0.263 0.991 0.502 0.920 0.220 0.948 0.207 0.890 0.211
0.3 0.920 0.263 0.992 0.501 0.921 0.219 0.951 0.206 0.891 0.210
0.5 0.923 0.261 0.996 0.504 0.949 0.219 0.973 0.207 0.929 0.210
0.9 0.949 0.259 1.000 0.497 0.999 0.216 1.000 0.205 0.998 0.206
50 -0.3 0.972 0.168 0.977 0.215 0.914 0.137 0.938 0.137 0.903 0.138
0 0.972 0.168 0.979 0.215 0.924 0.137 0.943 0.137 0.913 0.138
0.1 0.973 0.168 0.978 0.216 0.922 0.137 0.944 0.137 0.913 0.138
0.3 0.977 0.168 0.982 0.214 0.926 0.137 0.951 0.137 0.918 0.138
0.5 0.986 0.168 0.991 0.214 0.957 0.137 0.972 0.137 0.947 0.137
0.9 0.996 0.168 1.000 0.212 1.000 0.136 1.000 0.136 1.000 0.137
100 -0.3 0.973 0.119 0.971 0.124 0.931 0.102 0.942 0.102 0.921 0.102
0 0.974 0.119 0.972 0.124 0.933 0.102 0.945 0.102 0.923 0.102
0.1 0.977 0.119 0.975 0.124 0.935 0.101 0.947 0.102 0.926 0.102
0.3 0.977 0.119 0.976 0.124 0.940 0.101 0.951 0.101 0.932 0.102
0.5 0.990 0.119 0.990 0.124 0.966 0.101 0.974 0.101 0.960 0.102
0.9 1.000 0.119 1.000 0.124 1.000 0.101 1.000 0.101 1.000 0.101
Table A.18. Results of Naive Independence Assumption with: Gamma, 3-class,
Good:Good, Cost 2
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.520 0.789 0.920 1.256 0.745 1.061 0.720 1.062 0.741 1.101
0 0.515 0.781 0.930 1.257 0.744 1.057 0.735 1.060 0.742 1.090
0.1 0.523 0.887 0.930 1.254 0.743 1.057 0.730 1.056 0.736 1.090
0.3 0.525 0.769 0.936 1.257 0.756 1.058 0.745 1.060 0.745 NA
0.5 0.545 0.835 0.952 1.262 0.771 1.062 0.766 1.064 0.748 1.102
0.9 0.577 0.787 0.975 1.258 0.808 1.047 0.803 1.055 0.754 1.090
20 -0.3 0.278 0.545 0.818 1.074 0.425 0.635 0.275 0.632 0.277 NA
0 0.276 0.544 0.831 1.076 0.412 0.634 0.268 0.631 0.271 0.637
0.1 0.276 0.543 0.839 1.076 0.416 0.634 0.266 0.631 0.272 NA
0.3 0.261 0.560 0.846 1.072 0.406 0.634 0.258 0.632 0.264 NA
0.5 0.256 0.560 0.840 1.075 0.400 0.634 0.236 0.632 0.249 NA
0.9 0.181 0.568 0.848 1.081 0.344 0.633 0.131 0.632 0.152 0.649
50 -0.3 0.029 0.346 0.639 0.771 0.050 0.393 0.020 0.369 0.023 NA
0 0.023 0.346 0.637 0.770 0.045 0.393 0.016 0.369 0.019 0.373
0.1 0.022 0.346 0.649 0.775 0.044 0.392 0.015 0.369 0.018 0.373
0.3 0.015 0.346 0.632 0.764 0.037 0.392 0.011 0.369 0.013 NA
0.5 0.009 0.346 0.627 0.767 0.026 0.393 0.006 0.370 0.008 0.374
0.9 0.000 0.346 0.617 0.769 0.004 0.392 0.000 0.369 0.000 NA
100 -0.3 0.001 0.246 0.401 0.512 0.002 0.307 0.001 0.268 0.001 0.271
0 0.000 0.246 0.385 0.504 0.001 0.307 0.000 0.268 0.000 0.271
0.1 0.000 0.246 0.396 0.508 0.001 0.307 0.000 0.269 0.000 NA
0.3 0.000 0.246 0.400 0.511 0.001 0.307 0.000 0.268 0.000 NA
0.5 0.000 0.246 0.395 0.509 0.000 0.307 0.000 0.268 0.000 0.270
0.9 0.000 0.246 0.401 0.512 0.000 0.306 0.000 0.267 0.000 NA
Table A.19. Results of Naive Independence Assumption with: Gamma, 3-class
Good:Fair, Cost 1
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.270 0.390 0.754 0.867 0.607 0.598 0.407 0.585 0.446 0.630
0 0.268 0.389 0.753 0.864 0.602 0.597 0.404 0.585 0.439 0.625
0.1 0.267 0.389 0.751 0.865 0.602 0.599 0.411 0.584 0.445 0.627
0.3 0.258 0.389 0.745 0.868 0.600 0.598 0.399 0.585 0.437 0.629
0.5 0.253 0.389 0.745 0.865 0.611 0.596 0.390 0.584 0.428 0.623
0.9 0.228 0.382 0.718 0.863 0.572 0.586 0.323 0.580 0.361 0.615
20 -0.3 0.083 0.281 0.342 0.583 0.122 0.289 0.051 0.278 0.074 0.280
0 0.080 0.281 0.338 0.582 0.121 0.290 0.051 0.278 0.072 0.280
0.1 0.075 0.281 0.332 0.581 0.119 0.289 0.048 0.278 0.071 0.279
0.3 0.077 0.281 0.330 0.578 0.121 0.291 0.046 0.280 0.070 0.281
0.5 0.062 0.280 0.307 0.577 0.099 0.288 0.033 0.277 0.054 0.282
0.9 0.032 0.279 0.251 0.574 0.060 0.287 0.011 0.277 0.024 0.279
50 -0.3 0.001 0.182 0.035 0.276 0.001 0.174 0.001 0.173 0.002 0.174
0 0.002 0.182 0.036 0.276 0.002 0.174 0.001 0.173 0.002 0.174
0.1 0.001 0.182 0.037 0.276 0.001 0.174 0.001 0.173 0.001 0.174
0.3 0.001 0.182 0.033 0.277 0.001 0.174 0.000 0.173 0.001 0.174
0.5 0.001 0.181 0.034 0.277 0.001 0.173 0.000 0.172 0.001 0.173
0.9 0.000 0.181 0.028 0.271 0.000 0.174 0.000 0.173 0.000 0.173
100 -0.3 0.000 0.129 0.002 0.146 0.000 0.127 0.000 0.127 0.000 0.128
0 0.000 0.129 0.001 0.145 0.000 0.127 0.000 0.127 0.000 0.128
0.1 0.000 0.129 0.001 0.146 0.000 0.128 0.000 0.127 0.000 0.128
0.3 0.000 0.129 0.001 0.146 0.000 0.127 0.000 0.127 0.000 0.128
0.5 0.000 0.129 0.001 0.146 0.000 0.127 0.000 0.127 0.000 0.128
0.9 0.000 0.129 0.001 0.145 0.000 0.127 0.000 0.127 0.000 0.128
Table A.20. Results of Naive Independence Assumption with: Gamma, 3-class
Good:Fair, Cost 2
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.809 0.899 0.996 1.219 0.877 1.163 0.965 1.156 0.941 1.169
0 0.837 0.915 0.998 1.223 0.900 1.164 0.978 1.159 0.951 1.162
0.1 0.848 0.936 0.999 1.223 0.910 1.163 0.985 1.159 0.957 1.160
0.3 0.863 1.053 0.999 1.224 0.926 1.162 0.992 1.163 0.964 1.162
0.5 0.889 0.963 1.000 1.222 0.941 1.157 0.997 1.161 0.971 1.158
0.9 0.935 0.914 1.000 1.235 0.968 1.159 1.000 1.179 0.984 1.173
20 -0.3 0.871 0.622 0.992 0.932 0.914 0.785 0.941 0.801 0.924 NA
0 0.900 0.627 0.998 0.935 0.936 0.783 0.962 0.799 0.944 0.794
0.1 0.906 0.619 0.997 0.934 0.942 0.782 0.970 0.799 0.949 0.792
0.3 0.930 0.625 0.999 0.937 0.953 0.784 0.981 0.800 0.959 NA
0.5 0.950 0.626 1.000 0.938 0.966 0.780 0.993 0.797 0.970 NA
0.9 0.979 0.617 1.000 0.942 0.983 0.778 1.000 0.801 0.985 0.795
50 -0.3 0.889 0.391 0.950 0.482 0.931 0.484 0.932 0.469 0.909 NA
0 0.911 0.391 0.964 0.483 0.944 0.485 0.954 0.470 0.927 NA
0.1 0.916 0.391 0.968 0.484 0.950 0.484 0.958 0.469 0.934 NA
0.3 0.944 0.391 0.983 0.484 0.960 0.483 0.975 0.467 0.948 NA
0.5 0.972 0.391 0.993 0.484 0.974 0.484 0.990 0.468 0.968 NA
0.9 0.999 0.391 1.000 0.484 0.986 0.484 1.000 0.468 0.986 0.463
100 -0.3 0.883 0.277 0.899 0.282 0.943 0.381 0.928 0.341 0.908 0.337
0 0.912 0.277 0.924 0.282 0.959 0.381 0.955 0.342 0.935 NA
0.1 0.917 0.277 0.929 0.282 0.961 0.380 0.960 0.342 0.935 NA
0.3 0.942 0.277 0.948 0.282 0.969 0.381 0.974 0.342 0.950 0.338
0.5 0.969 0.277 0.974 0.282 0.977 0.381 0.990 0.342 0.968 0.338
0.9 1.000 0.277 1.000 0.282 0.980 0.381 1.000 0.342 0.980 0.337
Table A.21. Results of Naive Independence Assumption with:Gamma, 3-class Fair:Fair,
Cost 1
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.695 0.411 0.998 0.916 0.952 0.651 0.953 0.659 0.926 0.685
0 0.716 0.412 0.998 0.918 0.960 0.649 0.972 0.659 0.938 0.677
0.1 0.720 0.411 0.998 0.915 0.962 0.649 0.975 0.657 0.940 0.680
0.3 0.722 0.410 0.999 0.921 0.965 0.649 0.984 0.660 0.948 0.684
0.5 0.748 0.409 0.999 0.918 0.976 0.644 0.992 0.656 0.966 0.676
0.9 0.842 0.405 1.000 0.915 0.991 0.635 1.000 0.656 0.997 0.671
20 -0.3 0.777 0.299 0.989 0.659 0.917 0.345 0.925 0.338 0.895 0.337
0 0.788 0.299 0.993 0.659 0.928 0.346 0.945 0.339 0.909 0.338
0.1 0.799 0.299 0.994 0.660 0.933 0.347 0.953 0.340 0.915 0.339
0.3 0.814 0.299 0.996 0.656 0.944 0.345 0.964 0.338 0.927 0.338
0.5 0.829 0.297 0.997 0.659 0.969 0.345 0.981 0.339 0.960 0.338
0.9 0.900 0.296 1.000 0.658 1.000 0.343 1.000 0.338 1.000 0.339
50 -0.3 0.885 0.194 0.963 0.337 0.910 0.204 0.925 0.203 0.902 0.204
0 0.896 0.194 0.966 0.332 0.923 0.204 0.939 0.203 0.918 0.204
0.1 0.901 0.194 0.971 0.336 0.927 0.204 0.944 0.203 0.923 0.204
0.3 0.918 0.194 0.978 0.335 0.943 0.204 0.957 0.203 0.938 NA
0.5 0.942 0.194 0.989 0.334 0.967 0.204 0.977 0.203 0.965 0.204
0.9 0.980 0.194 1.000 0.331 1.000 0.203 1.000 0.202 1.000 0.202
100 -0.3 0.904 0.138 0.927 0.167 0.923 0.149 0.929 0.149 0.919 0.149
0 0.914 0.138 0.934 0.165 0.931 0.149 0.940 0.149 0.925 0.150
0.1 0.925 0.138 0.943 0.168 0.941 0.149 0.946 0.149 0.933 0.149
0.3 0.936 0.138 0.954 0.168 0.954 0.149 0.960 0.149 0.947 0.150
0.5 0.964 0.138 0.973 0.167 0.975 0.149 0.980 0.149 0.970 0.149
0.9 0.999 0.138 1.000 0.167 1.000 0.149 1.000 0.149 1.000 0.149
Table A.22. Results of Naive Independence Assumption with:Gamma, 3-class Fair:Fair,
Cost 2
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.197 15.647 0.608 1.352 0.351 1.169 0.425 1.213 0.393 1.228
0 0.193 3.328 0.620 1.352 0.358 1.171 0.426 1.215 0.398 NA
0.1 0.188 27.779 0.617 1.355 0.351 1.174 0.421 1.220 0.397 1.229
0.3 0.194 5.221 0.615 1.354 0.358 1.170 0.431 1.219 0.396 1.228
0.5 0.171 7.245 0.617 1.357 0.342 1.173 0.410 1.219 0.379 NA
0.9 0.124 13.852 0.602 1.357 0.317 1.164 0.391 1.220 0.344 1.238
20 -0.3 0.070 0.834 0.525 1.092 0.051 0.695 0.033 0.698 0.029 0.711
0 0.068 0.636 0.516 1.090 0.049 0.697 0.032 0.700 0.028 NA
0.1 0.067 2.108 0.512 1.085 0.050 0.694 0.028 0.696 0.027 0.709
0.3 0.061 1.577 0.511 1.091 0.051 0.694 0.029 0.697 0.031 NA
0.5 0.062 1.381 0.506 1.089 0.044 0.696 0.023 0.698 0.027 0.715
0.9 0.050 0.835 0.510 1.090 0.028 0.694 0.016 0.698 0.030 NA
50 -0.3 0.024 0.366 0.491 0.784 0.001 0.404 0.000 0.389 0.000 0.391
0 0.023 0.365 0.494 0.786 0.000 0.404 0.000 0.389 0.000 0.390
0.1 0.025 0.365 0.493 0.783 0.000 0.404 0.000 0.389 0.000 0.390
0.3 0.020 0.367 0.483 0.781 0.000 0.404 0.000 0.390 0.000 NA
0.5 0.018 0.366 0.494 0.782 0.000 0.404 0.000 0.390 0.000 0.390
0.9 0.013 0.373 0.499 0.781 0.000 0.402 0.000 0.388 0.000 NA
100 -0.3 0.012 0.259 0.308 0.517 0.000 0.290 0.000 0.279 0.000 NA
0 0.008 0.259 0.312 0.516 0.000 0.290 0.000 0.279 0.000 0.279
0.1 0.008 0.259 0.316 0.516 0.000 0.290 0.000 0.279 0.000 NA
0.3 0.008 0.259 0.326 0.522 0.000 0.290 0.000 0.279 0.000 NA
0.5 0.007 0.259 0.329 0.519 0.000 0.290 0.000 0.280 0.000 0.280
0.9 0.006 0.259 0.329 0.515 0.000 0.290 0.000 0.279 0.000 0.279
Table A.23. Results of Naive Independence Assumption with: Gamma, 3-class
Good:Poor, Cost 1
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.157 0.632 0.403 0.971 0.261 0.856 0.247 0.837 0.189 0.852
0 0.153 0.629 0.401 0.971 0.262 0.856 0.237 0.834 0.190 0.850
0.1 0.156 0.630 0.402 0.968 0.251 0.853 0.242 0.836 0.184 0.851
0.3 0.150 0.629 0.406 0.973 0.264 0.859 0.234 0.840 0.188 0.856
0.5 0.138 0.631 0.394 0.971 0.254 0.854 0.224 0.836 0.177 0.857
0.9 0.087 0.629 0.361 0.970 0.225 0.850 0.194 0.836 0.164 0.867
20 -0.3 0.039 0.470 0.154 0.696 0.015 0.513 0.007 0.512 0.003 0.525
0 0.035 0.471 0.150 0.691 0.015 0.514 0.006 0.515 0.004 0.527
0.1 0.035 0.470 0.146 0.691 0.015 0.515 0.007 0.515 0.005 0.527
0.3 0.035 0.472 0.154 0.691 0.015 0.516 0.007 0.516 0.005 0.529
0.5 0.030 0.470 0.155 0.690 0.010 0.513 0.004 0.513 0.003 0.526
0.9 0.019 0.471 0.161 0.690 0.009 0.512 0.002 0.513 0.004 0.529
50 -0.3 0.002 0.310 0.021 0.385 0.000 0.331 0.000 0.327 0.000 0.334
0 0.002 0.310 0.021 0.383 0.000 0.331 0.000 0.327 0.000 0.333
0.1 0.003 0.310 0.024 0.383 0.000 0.332 0.000 0.328 0.000 0.335
0.3 0.003 0.310 0.024 0.384 0.000 0.331 0.000 0.327 0.000 0.334
0.5 0.002 0.310 0.025 0.383 0.000 0.331 0.000 0.327 0.000 0.334
0.9 0.001 0.310 0.023 0.382 0.000 0.331 0.000 0.327 0.000 0.334
100 -0.3 0.000 0.221 0.001 0.235 0.000 0.246 0.000 0.240 0.000 0.245
0 0.000 0.221 0.001 0.234 0.000 0.246 0.000 0.240 0.000 0.245
0.1 0.000 0.221 0.001 0.234 0.000 0.246 0.000 0.240 0.000 0.246
0.3 0.000 0.221 0.001 0.234 0.000 0.247 0.000 0.241 0.000 0.246
0.5 0.000 0.221 0.001 0.234 0.000 0.247 0.000 0.241 0.000 0.246
0.9 0.000 0.221 0.001 0.235 0.000 0.246 0.000 0.240 0.000 0.246
Table A.24. Results of Naive Independence Assumption with: Gamma, 3-class
Good:Poor, Cost 2
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.993 0.280 0.950 0.387 0.947 0.334 0.931 0.263 0.735 0.403
0 0.994 0.279 0.957 0.388 0.947 0.335 0.936 0.262 0.738 0.398
0.1 0.996 0.279 0.958 0.390 0.950 0.336 0.941 0.268 0.758 0.393
0.3 0.997 0.278 0.970 0.390 0.958 0.335 0.949 0.266 0.771 0.389
0.5 0.998 0.274 0.983 0.387 0.974 0.330 0.970 0.261 0.820 0.369
0.9 1.000 0.264 1.000 0.382 0.999 0.317 0.999 0.258 0.974 0.309
20 -0.3 0.980 0.200 0.942 0.232 0.905 0.174 0.929 0.172 0.805 0.185
0 0.982 0.200 0.945 0.232 0.906 0.174 0.932 0.172 0.820 0.184
0.1 0.985 0.200 0.953 0.232 0.915 0.173 0.939 0.171 0.826 0.183
0.3 0.989 0.199 0.959 0.231 0.925 0.172 0.950 0.171 0.839 0.182
0.5 0.995 0.198 0.976 0.231 0.951 0.172 0.968 0.170 0.877 0.180
0.9 1.000 0.193 1.000 0.228 1.000 0.167 1.000 0.167 0.993 0.171
50 -0.3 0.950 0.127 0.931 0.136 0.922 0.122 0.933 0.122 0.871 0.126
0 0.957 0.127 0.939 0.136 0.931 0.122 0.940 0.122 0.878 0.126
0.1 0.959 0.127 0.941 0.136 0.932 0.121 0.942 0.122 0.883 0.125
0.3 0.968 0.127 0.954 0.136 0.946 0.122 0.954 0.122 0.901 0.125
0.5 0.983 0.127 0.973 0.136 0.966 0.121 0.973 0.122 0.933 0.125
0.9 1.000 0.125 1.000 0.134 1.000 0.119 1.000 0.119 0.999 0.120
100 -0.3 0.941 0.090 0.930 0.093 0.936 0.091 0.940 0.091 0.902 0.092
0 0.946 0.090 0.935 0.094 0.937 0.091 0.943 0.091 0.909 0.092
0.1 0.947 0.090 0.939 0.093 0.939 0.091 0.944 0.091 0.909 0.092
0.3 0.958 0.090 0.951 0.093 0.953 0.091 0.957 0.091 0.930 0.092
0.5 0.973 0.090 0.968 0.093 0.971 0.091 0.974 0.091 0.949 0.092
0.9 1.000 0.090 1.000 0.093 1.000 0.090 1.000 0.090 1.000 0.091
Table A.25. Results of Naive Independence Assumption with: Gamma, 2-class,
Good:Good, Cost 1
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.988 0.175 0.951 0.259 0.978 0.408 0.928 0.211 0.751 0.394
0 0.989 0.174 0.953 0.257 0.977 0.403 0.929 0.204 0.747 0.375
0.1 0.990 0.174 0.959 0.255 0.977 0.408 0.943 0.212 0.756 0.368
0.3 0.994 0.171 0.969 0.254 0.984 0.403 0.951 0.212 0.786 NA
0.5 0.997 0.170 0.982 0.253 0.988 0.403 0.970 0.212 0.825 0.339
0.9 1.000 0.165 1.000 0.251 0.999 0.385 0.999 0.200 0.975 0.257
20 -0.3 0.967 0.122 0.932 0.143 0.921 0.119 0.927 0.115 0.811 NA
0 0.971 0.123 0.936 0.144 0.923 0.119 0.931 0.115 0.811 NA
0.1 0.975 0.122 0.943 0.143 0.929 0.119 0.941 0.114 0.825 0.127
0.3 0.983 0.122 0.955 0.142 0.939 0.118 0.948 0.113 0.841 0.125
0.5 0.989 0.121 0.970 0.142 0.957 0.117 0.965 0.113 0.874 0.124
0.9 1.000 0.119 1.000 0.141 1.000 0.114 1.000 0.111 0.993 0.115
50 -0.3 0.935 0.078 0.918 0.083 0.929 0.081 0.932 0.081 0.866 0.085
0 0.936 0.078 0.919 0.082 0.935 0.080 0.937 0.080 0.872 0.085
0.1 0.941 0.078 0.925 0.082 0.937 0.081 0.939 0.081 0.877 0.085
0.3 0.954 0.078 0.938 0.082 0.949 0.080 0.953 0.080 0.893 0.084
0.5 0.976 0.077 0.965 0.082 0.971 0.080 0.973 0.080 0.929 0.083
0.9 1.000 0.077 1.000 0.082 1.000 0.078 1.000 0.079 0.999 0.080
100 -0.3 0.921 0.055 0.912 0.057 0.938 0.060 0.937 0.060 0.896 0.061
0 0.928 0.055 0.920 0.057 0.944 0.059 0.944 0.060 0.903 0.061
0.1 0.930 0.055 0.922 0.057 0.947 0.060 0.945 0.060 0.908 0.061
0.3 0.947 0.055 0.939 0.057 0.959 0.060 0.958 0.060 0.928 0.061
0.5 0.965 0.055 0.958 0.056 0.974 0.059 0.975 0.059 0.949 0.060
0.9 1.000 0.055 1.000 0.056 1.000 0.059 1.000 0.059 1.000 0.059
Table A.26. Results of Naive Independence Assumption with: Gamma, 2-class,
Good:Good, Cost 2
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.684 0.356 0.838 0.467 0.724 0.408 0.579 0.345 0.651 0.482
0 0.686 0.354 0.831 0.464 0.721 0.404 0.579 0.343 0.650 0.471
0.1 0.687 0.353 0.846 0.464 0.723 0.404 0.581 0.344 0.652 0.467
0.3 0.698 0.354 0.858 0.467 0.730 0.405 0.587 0.346 0.668 0.463
0.5 0.690 0.351 0.861 0.463 0.729 0.402 0.581 0.343 0.668 0.460
0.9 0.709 0.342 0.908 0.460 0.749 0.390 0.598 0.332 0.746 0.433
20 -0.3 0.599 0.256 0.700 0.281 0.527 0.226 0.501 0.222 0.579 0.236
0 0.603 0.256 0.705 0.281 0.530 0.226 0.503 0.222 0.585 0.236
0.1 0.595 0.255 0.703 0.281 0.518 0.225 0.488 0.222 0.571 0.236
0.3 0.599 0.255 0.707 0.280 0.527 0.224 0.496 0.221 0.575 0.233
0.5 0.618 0.255 0.727 0.281 0.536 0.225 0.509 0.222 0.598 0.234
0.9 0.634 0.251 0.777 0.278 0.533 0.220 0.495 0.217 0.616 0.226
50 -0.3 0.356 0.165 0.411 0.171 0.349 0.158 0.323 0.158 0.403 0.162
0 0.357 0.164 0.412 0.171 0.350 0.158 0.326 0.158 0.405 0.162
0.1 0.355 0.164 0.413 0.170 0.345 0.158 0.321 0.157 0.408 0.162
0.3 0.352 0.164 0.409 0.170 0.339 0.157 0.313 0.157 0.394 0.161
0.5 0.341 0.164 0.401 0.170 0.329 0.157 0.304 0.157 0.389 0.161
0.9 0.308 0.163 0.371 0.170 0.293 0.156 0.266 0.156 0.362 0.159
100 -0.3 0.134 0.117 0.154 0.119 0.159 0.117 0.146 0.118 0.202 0.119
0 0.131 0.117 0.153 0.119 0.152 0.118 0.140 0.118 0.200 0.120
0.1 0.128 0.117 0.150 0.119 0.153 0.118 0.139 0.118 0.196 0.119
0.3 0.127 0.117 0.150 0.119 0.149 0.118 0.136 0.118 0.198 0.120
0.5 0.106 0.117 0.125 0.119 0.132 0.117 0.117 0.117 0.177 0.119
0.9 0.045 0.116 0.056 0.118 0.079 0.116 0.069 0.116 0.117 0.118
Table A.27. Results of Naive Independence Assumption with: Gamma, 2-class
Good:Fair, Cost 1
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.542 0.219 0.740 0.303 0.811 0.465 0.452 0.271 0.554 0.446
0 0.544 0.217 0.736 0.301 0.809 0.465 0.451 0.266 0.557 0.434
0.1 0.540 0.216 0.735 0.301 0.813 0.465 0.446 0.272 0.553 0.434
0.3 0.545 0.217 0.753 0.302 0.806 0.460 0.444 0.269 0.557 0.407
0.5 0.543 0.215 0.760 0.300 0.810 0.461 0.446 0.270 0.566 0.415
0.9 0.572 0.210 0.816 0.298 0.806 0.448 0.452 0.265 0.612 0.380
20 -0.3 0.405 0.156 0.507 0.174 0.399 0.156 0.361 0.150 0.455 0.165
0 0.409 0.156 0.508 0.174 0.405 0.155 0.367 0.150 0.453 0.165
0.1 0.402 0.155 0.500 0.173 0.398 0.155 0.360 0.149 0.448 0.165
0.3 0.395 0.155 0.495 0.173 0.392 0.155 0.355 0.149 0.443 0.165
0.5 0.394 0.155 0.497 0.173 0.384 0.154 0.348 0.148 0.441 0.162
0.9 0.381 0.152 0.513 0.171 0.366 0.151 0.330 0.146 0.432 0.155
50 -0.3 0.158 0.100 0.188 0.103 0.203 0.106 0.194 0.105 0.278 0.111
0 0.151 0.100 0.180 0.103 0.196 0.105 0.189 0.105 0.267 0.110
0.1 0.154 0.100 0.180 0.103 0.199 0.105 0.190 0.105 0.268 0.111
0.3 0.135 0.099 0.163 0.103 0.183 0.105 0.174 0.104 0.252 0.110
0.5 0.129 0.099 0.152 0.103 0.177 0.105 0.171 0.105 0.245 0.109
0.9 0.073 0.099 0.093 0.102 0.138 0.103 0.133 0.103 0.203 0.106
100 -0.3 0.026 0.071 0.030 0.072 0.059 0.078 0.056 0.078 0.104 0.080
0 0.026 0.071 0.030 0.072 0.059 0.078 0.058 0.078 0.105 0.080
0.1 0.025 0.071 0.030 0.072 0.056 0.078 0.057 0.078 0.102 0.080
0.3 0.023 0.071 0.027 0.072 0.056 0.078 0.057 0.078 0.098 0.080
0.5 0.018 0.071 0.021 0.072 0.048 0.078 0.047 0.078 0.091 0.080
0.9 0.003 0.070 0.003 0.072 0.026 0.077 0.028 0.077 0.056 0.079
Table A.28. Results of Naive Independence Assumption with: Gamma, 2-class
Good:Fair, Cost 2
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.975 0.418 0.952 0.534 0.927 0.468 0.925 0.414 0.780 0.505
0 0.976 0.417 0.957 0.534 0.930 0.465 0.935 0.413 0.797 0.498
0.1 0.982 0.417 0.964 0.535 0.937 0.464 0.940 0.413 0.805 0.492
0.3 0.988 0.415 0.973 0.534 0.947 0.462 0.958 0.413 0.835 0.484
0.5 0.994 0.413 0.985 0.534 0.964 0.462 0.972 0.413 0.866 0.478
0.9 1.000 0.402 1.000 0.529 0.999 0.451 1.000 0.407 0.984 0.440
20 -0.3 0.953 0.301 0.941 0.324 0.889 0.269 0.926 0.265 0.840 0.274
0 0.962 0.302 0.951 0.325 0.901 0.269 0.934 0.265 0.853 0.274
0.1 0.961 0.303 0.947 0.325 0.899 0.271 0.935 0.266 0.852 0.275
0.3 0.974 0.302 0.965 0.325 0.920 0.269 0.954 0.265 0.879 0.273
0.5 0.986 0.300 0.980 0.324 0.950 0.268 0.975 0.264 0.916 0.272
0.9 1.000 0.297 1.000 0.322 0.999 0.262 1.000 0.260 0.997 0.263
50 -0.3 0.932 0.195 0.926 0.200 0.905 0.188 0.924 0.188 0.876 0.191
0 0.943 0.195 0.939 0.200 0.923 0.188 0.939 0.188 0.898 0.190
0.1 0.947 0.195 0.944 0.200 0.927 0.188 0.943 0.188 0.904 0.190
0.3 0.963 0.195 0.960 0.200 0.945 0.187 0.960 0.187 0.923 0.190
0.5 0.976 0.194 0.974 0.200 0.961 0.187 0.973 0.187 0.945 0.189
0.9 1.000 0.194 1.000 0.200 1.000 0.186 1.000 0.186 1.000 0.187
100 -0.3 0.929 0.139 0.928 0.140 0.925 0.139 0.934 0.139 0.908 0.141
0 0.935 0.139 0.934 0.141 0.933 0.140 0.941 0.140 0.915 0.141
0.1 0.942 0.139 0.939 0.140 0.935 0.139 0.945 0.140 0.920 0.141
0.3 0.952 0.139 0.952 0.140 0.950 0.140 0.958 0.140 0.933 0.141
0.5 0.976 0.139 0.975 0.141 0.973 0.140 0.979 0.140 0.963 0.141
0.9 1.000 0.138 1.000 0.140 1.000 0.139 1.000 0.139 1.000 0.139
Table A.29. Results of Naive Independence Assumption with: Gamma, 2-class
Fair:Fair, Cost 1
92
Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.959 0.256 0.947 0.341 0.975 0.516 0.925 0.323 0.785 0.440
0 0.966 0.255 0.952 0.345 0.977 0.520 0.936 0.328 0.806 0.421
0.1 0.970 0.255 0.958 0.341 0.979 0.508 0.941 0.316 0.818 0.412
0.3 0.977 0.255 0.966 0.342 0.982 0.514 0.953 0.327 0.837 0.408
0.5 0.987 0.253 0.982 0.338 0.988 0.507 0.972 0.319 0.876 0.392
0.9 0.999 0.246 1.000 0.337 0.999 0.488 1.000 0.311 0.989 0.344
20 -0.3 0.932 0.184 0.925 0.201 0.913 0.187 0.926 0.181 0.839 0.194
0 0.937 0.183 0.931 0.200 0.915 0.185 0.929 0.179 0.848 0.192
0.1 0.948 0.183 0.939 0.201 0.927 0.186 0.941 0.180 0.863 0.192
0.3 0.958 0.183 0.953 0.200 0.942 0.186 0.953 0.179 0.887 0.191
0.5 0.976 0.182 0.969 0.200 0.961 0.184 0.971 0.178 0.918 0.189
0.9 1.000 0.181 1.000 0.199 0.999 0.181 1.000 0.176 0.997 0.180
50 -0.3 0.906 0.117 0.902 0.120 0.920 0.126 0.926 0.126 0.879 0.130
0 0.916 0.117 0.912 0.120 0.930 0.126 0.935 0.125 0.888 0.130
0.1 0.927 0.117 0.923 0.120 0.938 0.125 0.945 0.125 0.900 0.129
0.3 0.943 0.117 0.939 0.120 0.950 0.125 0.956 0.125 0.918 0.129
0.5 0.963 0.117 0.960 0.120 0.969 0.125 0.974 0.125 0.942 0.129
0.9 1.000 0.116 1.000 0.119 1.000 0.123 1.000 0.123 1.000 0.124
100 -0.3 0.901 0.083 0.899 0.084 0.931 0.093 0.932 0.093 0.903 0.095
0 0.907 0.083 0.905 0.084 0.934 0.093 0.935 0.093 0.905 0.095
0.1 0.917 0.083 0.914 0.084 0.943 0.093 0.948 0.093 0.914 0.095
0.3 0.934 0.083 0.932 0.084 0.955 0.093 0.959 0.093 0.933 0.094
0.5 0.958 0.083 0.957 0.084 0.974 0.092 0.976 0.092 0.958 0.094
0.9 1.000 0.083 1.000 0.084 1.000 0.091 1.000 0.092 1.000 0.092
Table A.30. Results of Naive Independence Assumption with: Gamma, 2-class
Fair:Fair, Cost 2
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.876 0.595 0.938 0.716 0.876 0.692 0.898 0.672 0.902 0.721
0 0.888 0.594 0.949 0.717 0.891 0.694 0.908 0.673 0.922 0.724
0.1 0.892 0.595 0.952 0.714 0.892 0.691 0.910 0.670 0.924 0.726
0.3 0.900 0.594 0.958 0.713 0.899 0.689 0.914 0.669 0.932 0.728
0.5 0.914 0.595 0.968 0.715 0.912 0.689 0.920 0.671 0.944 0.733
0.9 0.938 0.593 0.981 0.715 0.936 0.687 0.934 0.670 0.973 0.752
20 -0.3 0.881 0.432 0.904 0.457 0.878 0.466 0.917 0.459 0.894 0.474
0 0.889 0.433 0.908 0.458 0.883 0.465 0.921 0.459 0.899 0.473
0.1 0.886 0.433 0.912 0.458 0.882 0.466 0.920 0.459 0.902 0.474
0.3 0.899 0.433 0.923 0.458 0.892 0.467 0.930 0.460 0.912 0.475
0.5 0.914 0.432 0.938 0.457 0.904 0.465 0.937 0.459 0.924 0.474
0.9 0.947 0.432 0.971 0.456 0.937 0.464 0.953 0.457 0.953 0.473
50 -0.3 0.823 0.279 0.829 0.281 0.857 0.316 0.906 0.315 0.854 0.318
0 0.835 0.279 0.845 0.280 0.876 0.316 0.921 0.314 0.870 0.318
0.1 0.840 0.279 0.848 0.280 0.871 0.316 0.921 0.314 0.870 0.318
0.3 0.847 0.279 0.856 0.280 0.883 0.316 0.930 0.315 0.881 0.318
0.5 0.867 0.278 0.876 0.280 0.898 0.315 0.940 0.314 0.897 0.318
0.9 0.911 0.278 0.921 0.280 0.935 0.315 0.967 0.313 0.940 0.317
100 -0.3 0.741 0.198 0.744 0.199 0.814 0.234 0.861 0.234 0.793 0.236
0 0.748 0.198 0.751 0.199 0.823 0.234 0.870 0.233 0.801 0.235
0.1 0.751 0.198 0.755 0.199 0.823 0.233 0.871 0.233 0.802 0.235
0.3 0.763 0.198 0.768 0.198 0.836 0.233 0.883 0.233 0.814 0.235
0.5 0.779 0.198 0.783 0.198 0.850 0.233 0.900 0.233 0.833 0.235
0.9 0.812 0.198 0.817 0.199 0.885 0.233 0.929 0.233 0.871 0.235
Table A.31. Results of Naive Independence Assumption with: Gamma, 2-class
Good:Poor, Cost 1
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.656 0.327 0.862 0.419 0.906 0.683 0.817 0.522 0.883 0.633
0 0.651 0.325 0.861 0.420 0.903 0.684 0.815 0.519 0.886 0.643
0.1 0.659 0.328 0.868 0.422 0.906 0.684 0.815 0.514 0.888 0.636
0.3 0.665 0.328 0.877 0.421 0.907 0.684 0.819 0.521 0.902 0.642
0.5 0.681 0.329 0.884 0.421 0.911 0.683 0.826 0.521 0.911 0.660
0.9 0.719 0.332 0.906 0.418 0.920 0.666 0.830 0.506 0.940 0.683
20 -0.3 0.668 0.246 0.763 0.258 0.752 0.331 0.805 0.310 0.829 0.307
0 0.667 0.247 0.767 0.258 0.753 0.331 0.801 0.309 0.831 0.307
0.1 0.673 0.247 0.775 0.258 0.762 0.329 0.808 0.309 0.834 0.306
0.3 0.677 0.246 0.775 0.258 0.769 0.331 0.810 0.310 0.843 0.308
0.5 0.696 0.247 0.795 0.259 0.780 0.331 0.816 0.310 0.855 0.309
0.9 0.722 0.248 0.824 0.259 0.800 0.328 0.824 0.309 0.869 0.306
50 -0.3 0.649 0.164 0.694 0.174 0.775 0.241 0.819 0.237 0.838 0.236
0 0.657 0.165 0.701 0.174 0.780 0.241 0.819 0.237 0.841 0.237
0.1 0.656 0.164 0.700 0.174 0.783 0.241 0.826 0.236 0.839 0.236
0.3 0.663 0.164 0.714 0.174 0.789 0.242 0.827 0.237 0.844 0.236
0.5 0.677 0.165 0.722 0.175 0.802 0.242 0.836 0.237 0.859 0.237
0.9 0.694 0.164 0.744 0.174 0.814 0.240 0.845 0.237 0.868 0.237
100 -0.3 0.611 0.118 0.658 0.138 0.789 0.191 0.812 0.193 0.837 0.198
0 0.604 0.118 0.653 0.138 0.794 0.191 0.816 0.193 0.842 0.198
0.1 0.601 0.118 0.650 0.137 0.784 0.191 0.806 0.192 0.834 0.197
0.3 0.613 0.118 0.663 0.137 0.796 0.190 0.813 0.192 0.847 0.197
0.5 0.622 0.118 0.674 0.138 0.804 0.192 0.824 0.193 0.849 0.199
0.9 0.640 0.118 0.687 0.137 0.814 0.191 0.832 0.192 0.861 0.198
Table A.32. Results of Naive Independence Assumption with: Gamma, 2-class
Good:Poor, Cost 2
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Appendix B. Derivation of partial derivatives for Delta



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Appendix C. Results from Comparisons of tests accounting
for correlation
Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.955 0.644 0.962 0.611 0.862 0.552 0.928 0.543 0.835 0.555
0 0.948 0.644 0.961 0.611 0.858 0.553 0.922 0.544 0.836 0.556
0.1 0.949 0.633 0.966 0.600 0.853 0.543 0.917 0.534 0.830 0.546
0.3 0.952 0.600 0.964 0.566 0.857 0.512 0.924 0.504 0.828 0.516
0.5 0.954 0.544 0.963 0.511 0.858 0.464 0.920 0.456 0.822 0.469
0.9 0.966 0.283 0.968 0.261 0.885 0.248 0.925 0.235 0.825 0.250
20 -0.3 0.950 0.465 0.956 0.448 0.900 0.422 0.934 0.421 0.888 0.424
0 0.948 0.464 0.954 0.447 0.897 0.422 0.935 0.420 0.886 0.423
0.1 0.950 0.458 0.957 0.440 0.901 0.414 0.933 0.413 0.891 0.416
0.3 0.952 0.433 0.961 0.416 0.901 0.391 0.935 0.390 0.888 0.393
0.5 0.949 0.390 0.961 0.375 0.900 0.352 0.931 0.352 0.883 0.355
0.9 0.958 0.198 0.956 0.188 0.907 0.177 0.936 0.177 0.884 0.179
50 -0.3 0.947 0.298 0.953 0.293 0.928 0.285 0.940 0.286 0.924 0.286
0 0.949 0.298 0.953 0.293 0.930 0.285 0.942 0.285 0.926 0.286
0.1 0.948 0.294 0.953 0.288 0.925 0.281 0.938 0.281 0.920 0.281
0.3 0.952 0.277 0.952 0.272 0.929 0.264 0.942 0.264 0.922 0.265
0.5 0.950 0.248 0.954 0.244 0.931 0.237 0.943 0.237 0.925 0.238
0.9 0.953 0.124 0.951 0.121 0.931 0.118 0.943 0.118 0.921 0.119
100 -0.3 0.947 0.212 0.953 0.209 0.938 0.207 0.945 0.207 0.935 0.207
0 0.952 0.211 0.952 0.209 0.940 0.206 0.948 0.207 0.938 0.207
0.1 0.950 0.208 0.951 0.206 0.938 0.203 0.946 0.203 0.936 0.204
0.3 0.949 0.196 0.949 0.194 0.938 0.192 0.944 0.192 0.936 0.192
0.5 0.947 0.176 0.948 0.174 0.937 0.172 0.943 0.172 0.933 0.173
0.9 0.951 0.088 0.950 0.087 0.938 0.085 0.945 0.086 0.934 0.086
Table C.1. Results adjusting for correlation with: Normal, 3-class, Good:Good, Cost 1
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.956 0.428 0.965 0.427 0.878 0.375 0.927 0.369 0.836 0.389
0 0.957 0.422 0.965 0.418 0.868 0.372 0.925 0.366 0.826 0.384
0.1 0.957 0.416 0.970 0.412 0.869 0.366 0.925 0.360 0.829 0.378
0.3 0.957 0.393 0.968 0.389 0.873 0.345 0.922 0.338 0.825 0.358
0.5 0.965 0.358 0.971 0.352 0.882 0.314 0.926 0.307 0.832 0.328
0.9 0.973 0.185 0.969 0.182 0.906 0.171 0.932 0.159 0.825 0.178
20 -0.3 0.952 0.307 0.957 0.299 0.906 0.280 0.935 0.279 0.889 0.282
0 0.953 0.304 0.956 0.295 0.902 0.277 0.932 0.276 0.884 0.279
0.1 0.954 0.300 0.956 0.291 0.910 0.273 0.937 0.272 0.891 0.275
0.3 0.954 0.282 0.954 0.273 0.901 0.256 0.929 0.255 0.879 0.258
0.5 0.954 0.254 0.956 0.245 0.902 0.229 0.930 0.229 0.878 0.232
0.9 0.963 0.129 0.956 0.123 0.912 0.116 0.935 0.115 0.878 0.117
50 -0.3 0.951 0.196 0.952 0.193 0.929 0.188 0.942 0.188 0.923 0.189
0 0.950 0.195 0.951 0.191 0.930 0.186 0.939 0.186 0.923 0.187
0.1 0.949 0.191 0.952 0.188 0.929 0.183 0.940 0.183 0.921 0.184
0.3 0.953 0.180 0.952 0.177 0.934 0.172 0.944 0.172 0.925 0.173
0.5 0.951 0.162 0.951 0.158 0.931 0.154 0.942 0.155 0.922 0.155
0.9 0.956 0.080 0.949 0.079 0.933 0.076 0.942 0.076 0.922 0.077
100 -0.3 0.952 0.139 0.949 0.138 0.940 0.136 0.947 0.136 0.937 0.137
0 0.953 0.138 0.950 0.137 0.943 0.135 0.949 0.135 0.938 0.135
0.1 0.949 0.136 0.949 0.134 0.939 0.133 0.945 0.133 0.937 0.133
0.3 0.949 0.128 0.948 0.126 0.939 0.125 0.945 0.125 0.933 0.125
0.5 0.949 0.115 0.948 0.113 0.937 0.112 0.943 0.112 0.934 0.112
0.9 0.952 0.057 0.954 0.056 0.941 0.055 0.945 0.055 0.935 0.056
Table C.2. Results adjusting for correlation with:Normal, 3-class, Good:Good, Cost 2
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.933 0.791 0.961 0.769 0.878 0.720 0.907 0.714 0.881 0.716
0 0.931 0.778 0.961 0.756 0.876 0.709 0.907 0.703 0.880 0.705
0.1 0.925 0.765 0.960 0.742 0.871 0.698 0.904 0.692 0.874 0.694
0.3 0.930 0.725 0.960 0.703 0.877 0.663 0.905 0.658 0.881 0.662
0.5 0.932 0.661 0.958 0.640 0.885 0.607 0.908 0.602 0.890 0.610
0.9 0.918 0.394 0.937 0.387 0.905 0.383 0.872 0.377 0.918 0.413
20 -0.3 0.941 0.574 0.952 0.561 0.913 0.539 0.929 0.539 0.916 0.538
0 0.944 0.565 0.951 0.551 0.911 0.531 0.930 0.530 0.913 0.529
0.1 0.942 0.556 0.951 0.542 0.910 0.522 0.928 0.521 0.912 0.521
0.3 0.939 0.525 0.951 0.512 0.907 0.493 0.921 0.493 0.909 0.493
0.5 0.939 0.477 0.953 0.465 0.912 0.448 0.924 0.448 0.916 0.449
0.9 0.933 0.277 0.943 0.274 0.917 0.267 0.906 0.267 0.925 0.270
50 -0.3 0.942 0.369 0.947 0.365 0.928 0.358 0.938 0.359 0.928 0.359
0 0.950 0.364 0.946 0.359 0.938 0.353 0.946 0.354 0.939 0.354
0.1 0.948 0.357 0.950 0.353 0.932 0.347 0.940 0.348 0.933 0.348
0.3 0.951 0.337 0.951 0.333 0.935 0.327 0.941 0.328 0.937 0.328
0.5 0.947 0.305 0.947 0.301 0.936 0.296 0.943 0.297 0.935 0.297
0.9 0.945 0.174 0.947 0.173 0.939 0.171 0.931 0.172 0.942 0.172
100 -0.3 0.946 0.262 0.948 0.260 0.939 0.259 0.942 0.259 0.939 0.259
0 0.946 0.259 0.949 0.257 0.939 0.254 0.944 0.255 0.938 0.255
0.1 0.952 0.254 0.951 0.252 0.945 0.250 0.949 0.250 0.947 0.250
0.3 0.948 0.239 0.948 0.238 0.940 0.236 0.942 0.236 0.940 0.236
0.5 0.949 0.216 0.949 0.215 0.940 0.213 0.944 0.213 0.942 0.213
0.9 0.950 0.123 0.946 0.123 0.947 0.122 0.945 0.122 0.947 0.123
Table C.3. Results adjusting for correlation with: 3-class Good:Fair, Cost 1
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.939 0.552 0.956 0.548 0.889 0.504 0.912 0.500 0.879 0.513
0 0.940 0.536 0.955 0.531 0.889 0.491 0.911 0.487 0.874 0.500
0.1 0.942 0.528 0.958 0.522 0.892 0.483 0.910 0.479 0.879 0.492
0.3 0.939 0.498 0.964 0.492 0.893 0.455 0.905 0.451 0.879 0.465
0.5 0.939 0.458 0.959 0.452 0.895 0.421 0.902 0.417 0.883 0.433
0.9 0.926 0.281 0.947 0.283 0.917 0.274 0.886 0.267 0.926 0.301
20 -0.3 0.943 0.394 0.951 0.388 0.917 0.372 0.929 0.372 0.910 0.375
0 0.949 0.386 0.949 0.379 0.919 0.364 0.930 0.364 0.912 0.368
0.1 0.949 0.378 0.947 0.371 0.920 0.356 0.932 0.356 0.911 0.360
0.3 0.948 0.356 0.949 0.350 0.918 0.335 0.927 0.335 0.911 0.339
0.5 0.948 0.324 0.955 0.318 0.924 0.305 0.927 0.305 0.916 0.310
0.9 0.944 0.194 0.947 0.193 0.936 0.187 0.916 0.187 0.941 0.195
50 -0.3 0.949 0.251 0.951 0.249 0.938 0.244 0.942 0.245 0.934 0.245
0 0.949 0.245 0.951 0.243 0.938 0.238 0.942 0.239 0.934 0.239
0.1 0.946 0.241 0.949 0.238 0.936 0.234 0.938 0.234 0.933 0.235
0.3 0.946 0.226 0.952 0.224 0.934 0.220 0.938 0.221 0.931 0.222
0.5 0.948 0.205 0.951 0.203 0.936 0.199 0.939 0.200 0.932 0.201
0.9 0.945 0.120 0.948 0.120 0.942 0.119 0.936 0.119 0.945 0.120
100 -0.3 0.950 0.178 0.945 0.177 0.944 0.175 0.944 0.175 0.942 0.176
0 0.949 0.174 0.946 0.173 0.944 0.171 0.945 0.172 0.943 0.172
0.1 0.947 0.170 0.949 0.170 0.940 0.168 0.943 0.168 0.938 0.169
0.3 0.952 0.160 0.949 0.160 0.945 0.158 0.948 0.158 0.945 0.159
0.5 0.948 0.145 0.947 0.144 0.945 0.143 0.947 0.143 0.944 0.144
0.9 0.949 0.085 0.947 0.085 0.946 0.084 0.943 0.084 0.946 0.085
Table C.4. Results adjusting for correlation with: Normal, 3-class Good:Fair, Cost 2
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.932 1.256 0.943 0.856 0.907 0.828 0.905 0.827 0.901 0.811
0 0.934 1.739 0.943 0.827 0.906 0.799 0.905 0.798 0.902 0.782
0.1 0.934 1.031 0.946 0.814 0.908 0.785 0.900 0.785 0.900 0.769
0.3 0.938 0.913 0.944 0.773 0.912 0.751 0.907 0.751 0.908 0.736
0.5 0.932 1.595 0.936 0.721 0.919 0.704 0.897 0.704 0.916 0.691
0.9 0.925 0.801 0.915 0.545 0.943 0.545 0.881 0.548 0.949 0.548
20 -0.3 0.943 0.629 0.945 0.617 0.923 0.602 0.927 0.602 0.920 0.597
0 0.943 0.606 0.948 0.596 0.926 0.581 0.928 0.582 0.924 0.576
0.1 0.943 0.602 0.949 0.586 0.927 0.571 0.927 0.571 0.922 0.566
0.3 0.943 0.569 0.946 0.555 0.929 0.542 0.927 0.543 0.925 0.537
0.5 0.942 0.519 0.943 0.513 0.931 0.501 0.924 0.502 0.932 0.498
0.9 0.938 0.377 0.932 0.371 0.948 0.367 0.912 0.369 0.947 0.369
50 -0.3 0.945 0.398 0.943 0.397 0.938 0.392 0.940 0.392 0.937 0.391
0 0.944 0.384 0.947 0.383 0.937 0.377 0.940 0.378 0.935 0.377
0.1 0.953 0.376 0.947 0.375 0.946 0.370 0.947 0.371 0.945 0.369
0.3 0.949 0.355 0.951 0.354 0.944 0.350 0.943 0.351 0.943 0.350
0.5 0.948 0.326 0.948 0.325 0.943 0.321 0.940 0.322 0.942 0.321
0.9 0.946 0.224 0.944 0.226 0.951 0.225 0.935 0.226 0.952 0.227
100 -0.3 0.949 0.283 0.951 0.282 0.947 0.280 0.946 0.281 0.945 0.280
0 0.953 0.272 0.950 0.272 0.947 0.270 0.949 0.271 0.948 0.270
0.1 0.951 0.267 0.948 0.267 0.946 0.264 0.948 0.265 0.947 0.264
0.3 0.948 0.252 0.948 0.251 0.943 0.250 0.946 0.250 0.943 0.250
0.5 0.947 0.230 0.949 0.230 0.943 0.228 0.944 0.229 0.942 0.229
0.9 0.947 0.157 0.948 0.158 0.951 0.158 0.943 0.158 0.952 0.158
Table C.5. Results adjusting for correlation with: Normal, 3-class Fair:Fair, Cost 1
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.921 0.719 0.946 0.695 0.901 0.678 0.912 0.674 0.912 0.678
0 0.919 0.696 0.950 0.673 0.893 0.657 0.904 0.654 0.910 0.658
0.1 0.921 0.685 0.950 0.659 0.899 0.647 0.907 0.644 0.914 0.650
0.3 0.918 0.654 0.947 0.631 0.897 0.620 0.903 0.616 0.913 0.625
0.5 0.926 0.616 0.948 0.594 0.904 0.588 0.907 0.584 0.924 0.595
0.9 0.918 0.488 0.933 0.478 0.919 0.483 0.896 0.482 0.942 0.505
20 -0.3 0.932 0.523 0.947 0.507 0.906 0.498 0.930 0.496 0.924 0.495
0 0.937 0.505 0.951 0.489 0.911 0.480 0.931 0.479 0.924 0.478
0.1 0.935 0.497 0.947 0.481 0.913 0.473 0.931 0.472 0.928 0.471
0.3 0.931 0.473 0.949 0.457 0.907 0.450 0.926 0.449 0.924 0.449
0.5 0.936 0.443 0.951 0.429 0.913 0.423 0.928 0.422 0.933 0.423
0.9 0.936 0.345 0.946 0.338 0.922 0.337 0.926 0.337 0.940 0.341
50 -0.3 0.945 0.337 0.949 0.332 0.932 0.329 0.943 0.329 0.941 0.329
0 0.944 0.325 0.949 0.321 0.931 0.318 0.941 0.318 0.942 0.318
0.1 0.946 0.320 0.950 0.315 0.934 0.313 0.943 0.313 0.944 0.313
0.3 0.942 0.304 0.948 0.300 0.932 0.298 0.940 0.298 0.942 0.298
0.5 0.943 0.283 0.950 0.280 0.933 0.278 0.941 0.278 0.943 0.278
0.9 0.941 0.218 0.946 0.217 0.935 0.216 0.940 0.217 0.947 0.217
100 -0.3 0.945 0.239 0.950 0.238 0.939 0.237 0.943 0.238 0.943 0.238
0 0.945 0.231 0.948 0.230 0.941 0.229 0.945 0.229 0.947 0.229
0.1 0.944 0.227 0.947 0.226 0.940 0.225 0.943 0.225 0.944 0.225
0.3 0.953 0.216 0.952 0.215 0.949 0.214 0.950 0.214 0.954 0.215
0.5 0.948 0.201 0.949 0.200 0.944 0.199 0.945 0.200 0.946 0.200
0.9 0.942 0.154 0.948 0.154 0.942 0.154 0.943 0.154 0.947 0.155
Table C.6. Results adjusting for correlation with: Normal, 3-class Fair:Fair, Cost 2
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.929 0.922 0.962 0.907 0.886 0.862 0.928 0.859 0.898 0.860
0 0.930 0.891 0.969 0.878 0.886 0.836 0.926 0.834 0.896 0.834
0.1 0.926 0.868 0.968 0.858 0.881 0.815 0.921 0.812 0.889 0.813
0.3 0.937 0.817 0.968 0.805 0.894 0.768 0.928 0.766 0.899 0.767
0.5 0.933 0.740 0.970 0.724 0.890 0.691 0.925 0.690 0.892 0.690
0.9 0.939 0.375 0.973 0.374 0.909 0.367 0.931 0.361 0.891 0.365
20 -0.3 0.938 0.672 0.951 0.662 0.913 0.642 0.931 0.641 0.917 0.642
0 0.938 0.650 0.952 0.639 0.918 0.622 0.933 0.621 0.921 0.622
0.1 0.939 0.635 0.953 0.625 0.913 0.606 0.931 0.606 0.917 0.607
0.3 0.942 0.594 0.956 0.584 0.919 0.568 0.937 0.568 0.922 0.569
0.5 0.943 0.530 0.955 0.523 0.917 0.506 0.935 0.506 0.918 0.507
0.9 0.946 0.263 0.959 0.262 0.925 0.253 0.940 0.254 0.922 0.254
50 -0.3 0.948 0.433 0.950 0.430 0.937 0.424 0.943 0.425 0.939 0.425
0 0.944 0.419 0.952 0.416 0.933 0.410 0.940 0.411 0.935 0.411
0.1 0.940 0.409 0.951 0.406 0.933 0.401 0.939 0.401 0.934 0.401
0.3 0.951 0.382 0.953 0.379 0.942 0.374 0.948 0.374 0.943 0.374
0.5 0.947 0.340 0.950 0.337 0.935 0.332 0.942 0.333 0.937 0.333
0.9 0.947 0.167 0.955 0.166 0.938 0.163 0.944 0.164 0.937 0.164
Table C.7. Results adjusting for correlation with: Normal, 3-class Good:Poor, Cost 1
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.940 0.660 0.957 0.655 0.897 0.614 0.925 0.611 0.889 0.616
0 0.940 0.630 0.961 0.623 0.893 0.588 0.924 0.585 0.885 0.590
0.1 0.938 0.616 0.957 0.609 0.893 0.572 0.921 0.570 0.881 0.574
0.3 0.941 0.573 0.959 0.566 0.895 0.532 0.924 0.530 0.884 0.535
0.5 0.945 0.513 0.969 0.505 0.898 0.477 0.925 0.475 0.882 0.481
0.9 0.954 0.263 0.969 0.258 0.920 0.251 0.933 0.246 0.889 0.251
20 -0.3 0.947 0.471 0.951 0.467 0.926 0.451 0.936 0.451 0.918 0.453
0 0.949 0.450 0.951 0.446 0.927 0.431 0.936 0.431 0.921 0.433
0.1 0.946 0.440 0.952 0.436 0.928 0.421 0.937 0.421 0.922 0.423
0.3 0.947 0.409 0.953 0.404 0.922 0.391 0.933 0.391 0.914 0.393
0.5 0.950 0.363 0.950 0.358 0.927 0.347 0.935 0.347 0.916 0.349
0.9 0.949 0.181 0.954 0.178 0.925 0.173 0.933 0.172 0.910 0.173
50 -0.3 0.947 0.299 0.952 0.298 0.939 0.294 0.942 0.294 0.937 0.295
0 0.948 0.287 0.951 0.285 0.938 0.281 0.944 0.281 0.935 0.281
0.1 0.945 0.279 0.950 0.278 0.937 0.274 0.940 0.274 0.933 0.274
0.3 0.950 0.259 0.951 0.258 0.940 0.254 0.944 0.254 0.937 0.255
0.5 0.951 0.230 0.949 0.228 0.940 0.225 0.943 0.225 0.935 0.226
0.9 0.950 0.112 0.950 0.112 0.939 0.110 0.942 0.110 0.935 0.110
100 -0.3 0.948 0.212 0.953 0.211 0.944 0.210 0.946 0.210 0.943 0.210
0 0.950 0.203 0.948 0.203 0.946 0.201 0.947 0.202 0.944 0.202
0.1 0.951 0.198 0.948 0.197 0.944 0.196 0.946 0.196 0.942 0.196
0.3 0.947 0.184 0.952 0.183 0.943 0.182 0.943 0.182 0.941 0.182
0.5 0.952 0.162 0.949 0.162 0.948 0.161 0.949 0.161 0.945 0.161
0.9 0.948 0.079 0.949 0.079 0.941 0.078 0.945 0.078 0.940 0.078
Table C.8. Results adjusting for correlation with: Normal, 3-class Good:Poor, Cost 2
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.976 0.468 0.944 0.447 0.881 0.400 0.919 0.394 0.790 0.425
0 0.978 0.447 0.944 0.423 0.878 0.381 0.915 0.375 0.780 0.406
0.1 0.978 0.436 0.944 0.412 0.880 0.372 0.918 0.366 0.784 0.398
0.3 0.982 0.406 0.941 0.381 0.890 0.345 0.918 0.339 0.790 0.370
0.5 0.985 0.365 0.949 0.339 0.883 0.309 0.913 0.303 0.771 0.333
0.9 0.986 0.185 0.948 0.170 0.909 0.161 0.918 0.153 0.766 0.176
20 -0.3 0.962 0.338 0.948 0.328 0.909 0.307 0.930 0.308 0.865 0.314
0 0.958 0.323 0.947 0.312 0.904 0.294 0.924 0.295 0.858 0.301
0.1 0.965 0.315 0.946 0.304 0.913 0.286 0.932 0.286 0.865 0.293
0.3 0.965 0.294 0.948 0.283 0.910 0.266 0.928 0.267 0.857 0.273
0.5 0.971 0.261 0.949 0.250 0.916 0.235 0.932 0.236 0.862 0.242
0.9 0.975 0.129 0.951 0.123 0.923 0.115 0.931 0.116 0.853 0.120
50 -0.3 0.956 0.217 0.948 0.214 0.936 0.209 0.945 0.209 0.920 0.210
0 0.954 0.208 0.949 0.204 0.934 0.199 0.941 0.199 0.915 0.200
0.1 0.955 0.202 0.950 0.198 0.934 0.193 0.942 0.194 0.916 0.195
0.3 0.949 0.188 0.947 0.184 0.930 0.180 0.936 0.180 0.910 0.181
0.5 0.958 0.166 0.948 0.162 0.934 0.158 0.942 0.159 0.914 0.160
0.9 0.961 0.081 0.951 0.079 0.940 0.077 0.942 0.077 0.909 0.078
100 -0.3 0.951 0.154 0.950 0.153 0.940 0.151 0.945 0.151 0.933 0.152
0 0.950 0.147 0.948 0.146 0.940 0.144 0.944 0.144 0.932 0.145
0.1 0.951 0.143 0.948 0.142 0.943 0.140 0.946 0.140 0.933 0.141
0.3 0.953 0.133 0.952 0.132 0.943 0.130 0.946 0.130 0.930 0.130
0.5 0.951 0.118 0.948 0.116 0.940 0.115 0.945 0.115 0.928 0.115
0.9 0.958 0.057 0.950 0.056 0.946 0.056 0.948 0.056 0.934 0.056
Table C.9. Results adjusting for correlation with: Normal, 2-class, Good:Good, Cost 1
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.859 0.401 0.958 0.618 0.860 0.577 0.928 0.576 0.759 0.570
0 0.870 0.387 0.956 0.604 0.865 0.557 0.928 0.559 0.760 0.554
0.1 0.861 0.378 0.956 0.596 0.858 0.555 0.927 0.557 0.753 0.556
0.3 0.878 0.358 0.962 0.575 0.871 0.530 0.933 0.539 0.754 0.535
0.5 0.884 0.324 0.962 0.543 0.870 0.497 0.935 0.510 0.741 0.515
0.9 0.923 0.181 0.976 0.412 0.910 0.364 0.957 0.399 0.759 0.415
20 -0.3 0.902 0.302 0.957 0.532 0.927 0.487 0.936 0.508 0.848 0.500
0 0.904 0.289 0.959 0.511 0.923 0.471 0.942 0.492 0.847 0.485
0.1 0.908 0.284 0.958 0.508 0.929 0.465 0.940 0.486 0.845 0.480
0.3 0.906 0.265 0.961 0.487 0.927 0.444 0.943 0.467 0.838 0.463
0.5 0.913 0.238 0.964 0.462 0.929 0.419 0.946 0.447 0.841 0.443
0.9 0.937 0.123 0.977 0.342 0.950 0.303 0.960 0.336 0.857 0.337
50 -0.3 0.945 0.198 0.953 0.314 0.978 0.308 0.944 0.309 0.918 0.320
0 0.947 0.190 0.952 0.302 0.977 0.296 0.942 0.298 0.915 0.310
0.1 0.945 0.186 0.953 0.300 0.977 0.293 0.939 0.296 0.912 0.307
0.3 0.945 0.173 0.954 0.285 0.977 0.280 0.942 0.283 0.912 0.295
0.5 0.951 0.154 0.957 0.264 0.978 0.259 0.946 0.261 0.916 0.274
0.9 0.953 0.076 0.961 0.163 0.978 0.172 0.951 0.163 0.915 0.173
100 -0.3 0.953 0.141 0.947 0.162 0.973 0.170 0.947 0.163 0.936 0.167
0 0.954 0.136 0.947 0.154 0.973 0.163 0.948 0.155 0.935 0.160
0.1 0.953 0.132 0.950 0.151 0.971 0.160 0.947 0.152 0.934 0.157
0.3 0.952 0.123 0.951 0.142 0.972 0.150 0.946 0.143 0.930 0.148
0.5 0.951 0.109 0.946 0.128 0.966 0.136 0.941 0.127 0.928 0.132
0.9 0.956 0.053 0.955 0.065 0.968 0.078 0.947 0.065 0.931 0.068
Table C.10. Results adjusting for correlation with: Normal, 2-class, Good:Good, Cost
2
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.927 0.612 0.944 0.593 0.876 0.552 0.896 0.545 0.862 0.569
0 0.930 0.582 0.941 0.560 0.878 0.524 0.892 0.518 0.863 0.543
0.1 0.927 0.566 0.942 0.544 0.878 0.511 0.893 0.504 0.867 0.531
0.3 0.929 0.531 0.942 0.507 0.876 0.477 0.889 0.471 0.870 0.499
0.5 0.922 0.479 0.940 0.455 0.873 0.432 0.879 0.425 0.871 0.456
0.9 0.897 0.296 0.933 0.283 0.876 0.281 0.859 0.273 0.918 0.317
20 -0.3 0.941 0.448 0.942 0.437 0.915 0.420 0.929 0.419 0.909 0.425
0 0.944 0.424 0.943 0.412 0.916 0.397 0.927 0.397 0.909 0.403
0.1 0.938 0.411 0.946 0.399 0.910 0.385 0.919 0.385 0.903 0.391
0.3 0.941 0.385 0.946 0.373 0.912 0.361 0.921 0.360 0.908 0.367
0.5 0.939 0.345 0.947 0.334 0.909 0.323 0.916 0.323 0.911 0.331
0.9 0.925 0.210 0.941 0.206 0.914 0.203 0.907 0.202 0.938 0.213
50 -0.3 0.947 0.288 0.950 0.285 0.935 0.280 0.941 0.280 0.931 0.281
0 0.947 0.273 0.947 0.269 0.935 0.265 0.940 0.265 0.931 0.266
0.1 0.945 0.265 0.944 0.262 0.933 0.257 0.939 0.258 0.932 0.259
0.3 0.945 0.247 0.948 0.243 0.932 0.240 0.936 0.240 0.929 0.242
0.5 0.945 0.221 0.950 0.218 0.933 0.214 0.936 0.215 0.931 0.217
0.9 0.939 0.133 0.946 0.132 0.934 0.131 0.930 0.131 0.945 0.134
100 -0.3 0.951 0.205 0.951 0.204 0.946 0.202 0.949 0.202 0.943 0.203
0 0.949 0.194 0.950 0.192 0.943 0.191 0.944 0.191 0.942 0.192
0.1 0.947 0.188 0.948 0.187 0.940 0.186 0.941 0.186 0.938 0.187
0.3 0.948 0.175 0.946 0.174 0.941 0.172 0.942 0.172 0.938 0.173
0.5 0.951 0.157 0.954 0.155 0.942 0.154 0.945 0.154 0.941 0.155
0.9 0.946 0.094 0.949 0.094 0.944 0.094 0.942 0.094 0.949 0.095
Table C.11. Results adjusting for correlation with: Normal, 2-class Good:Fair, Cost 1
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.830 0.494 0.952 0.600 0.844 0.592 0.906 0.570 0.832 0.568
0 0.837 0.477 0.954 0.586 0.844 0.574 0.911 0.554 0.832 0.554
0.1 0.833 0.467 0.954 0.575 0.846 0.565 0.906 0.547 0.831 0.545
0.3 0.837 0.441 0.954 0.552 0.847 0.536 0.906 0.524 0.828 0.520
0.5 0.845 0.407 0.955 0.517 0.854 0.500 0.902 0.491 0.835 0.492
0.9 0.835 0.264 0.943 0.380 0.856 0.373 0.888 0.374 0.869 0.390
20 -0.3 0.895 0.377 0.954 0.495 0.912 0.472 0.931 0.480 0.889 0.465
0 0.894 0.362 0.957 0.483 0.912 0.459 0.932 0.468 0.886 0.451
0.1 0.897 0.353 0.956 0.474 0.912 0.448 0.930 0.457 0.885 0.441
0.3 0.898 0.330 0.959 0.449 0.911 0.425 0.934 0.437 0.888 0.419
0.5 0.895 0.301 0.959 0.421 0.916 0.396 0.929 0.410 0.888 0.392
0.9 0.882 0.184 0.957 0.308 0.916 0.287 0.920 0.304 0.916 0.282
50 -0.3 0.945 0.249 0.952 0.312 0.964 0.303 0.941 0.307 0.933 0.305
0 0.945 0.237 0.953 0.299 0.965 0.293 0.944 0.296 0.936 0.295
0.1 0.939 0.231 0.954 0.293 0.958 0.286 0.937 0.290 0.928 0.289
0.3 0.942 0.215 0.949 0.275 0.960 0.268 0.939 0.271 0.930 0.269
0.5 0.946 0.193 0.957 0.251 0.964 0.245 0.945 0.248 0.938 0.245
0.9 0.932 0.114 0.959 0.171 0.956 0.171 0.940 0.169 0.948 0.158
100 -0.3 0.947 0.177 0.954 0.187 0.955 0.189 0.945 0.186 0.942 0.186
0 0.946 0.168 0.950 0.178 0.951 0.180 0.944 0.177 0.937 0.178
0.1 0.949 0.164 0.951 0.175 0.955 0.177 0.944 0.174 0.939 0.174
0.3 0.946 0.153 0.950 0.162 0.953 0.165 0.943 0.162 0.938 0.162
0.5 0.944 0.137 0.951 0.146 0.950 0.149 0.940 0.145 0.936 0.145
0.9 0.943 0.080 0.953 0.089 0.953 0.095 0.944 0.089 0.950 0.087
Table C.12. Results adjusting for correlation with: Normal, 2-class Good:Fair, Cost 2
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.931 0.742 0.944 0.728 0.888 0.687 0.915 0.682 0.868 0.693
0 0.940 0.689 0.946 0.672 0.888 0.634 0.919 0.630 0.864 0.641
0.1 0.943 0.666 0.949 0.648 0.894 0.611 0.921 0.607 0.867 0.617
0.3 0.943 0.611 0.949 0.593 0.883 0.560 0.910 0.556 0.855 0.568
0.5 0.947 0.540 0.951 0.522 0.885 0.493 0.911 0.489 0.845 0.501
0.9 0.961 0.268 0.954 0.258 0.909 0.250 0.921 0.245 0.849 0.255
20 -0.3 0.945 0.543 0.951 0.535 0.918 0.518 0.935 0.517 0.913 0.519
0 0.944 0.503 0.947 0.493 0.919 0.478 0.934 0.478 0.912 0.480
0.1 0.946 0.486 0.948 0.476 0.921 0.462 0.934 0.461 0.911 0.464
0.3 0.949 0.444 0.951 0.434 0.920 0.420 0.935 0.420 0.906 0.422
0.5 0.950 0.390 0.947 0.380 0.917 0.368 0.931 0.368 0.902 0.370
0.9 0.954 0.189 0.948 0.184 0.929 0.178 0.936 0.178 0.902 0.180
50 -0.3 0.947 0.350 0.950 0.348 0.937 0.343 0.944 0.344 0.937 0.344
0 0.942 0.325 0.953 0.322 0.932 0.318 0.936 0.318 0.929 0.318
0.1 0.943 0.313 0.946 0.310 0.932 0.306 0.938 0.306 0.929 0.306
0.3 0.951 0.286 0.951 0.283 0.939 0.278 0.945 0.279 0.935 0.279
0.5 0.951 0.250 0.948 0.247 0.940 0.243 0.945 0.244 0.936 0.244
0.9 0.954 0.119 0.953 0.117 0.942 0.115 0.945 0.116 0.934 0.116
100 -0.3 0.947 0.250 0.948 0.249 0.942 0.247 0.944 0.247 0.941 0.247
0 0.950 0.231 0.946 0.230 0.945 0.228 0.948 0.229 0.946 0.229
0.1 0.947 0.223 0.947 0.222 0.941 0.220 0.945 0.221 0.941 0.221
0.3 0.947 0.203 0.951 0.202 0.940 0.200 0.942 0.201 0.937 0.201
0.5 0.948 0.177 0.950 0.176 0.945 0.174 0.946 0.175 0.942 0.175
0.9 0.954 0.084 0.952 0.083 0.948 0.083 0.949 0.083 0.943 0.083
Table C.13. Results adjusting for correlation with: Normal, 2-class Fair:Fair, Cost 1
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.865 0.579 0.956 0.602 0.849 0.614 0.925 0.582 0.874 0.596
0 0.872 0.549 0.959 0.577 0.849 0.580 0.927 0.553 0.865 0.567
0.1 0.877 0.537 0.960 0.565 0.851 0.569 0.929 0.543 0.863 0.558
0.3 0.893 0.505 0.961 0.536 0.858 0.534 0.930 0.513 0.850 0.529
0.5 0.910 0.453 0.969 0.487 0.877 0.486 0.936 0.469 0.848 0.491
0.9 0.952 0.247 0.979 0.297 0.916 0.304 0.958 0.295 0.835 0.343
20 -0.3 0.911 0.446 0.955 0.476 0.903 0.467 0.938 0.464 0.916 0.463
0 0.911 0.421 0.958 0.451 0.899 0.439 0.936 0.438 0.905 0.437
0.1 0.918 0.409 0.956 0.440 0.905 0.426 0.938 0.427 0.908 0.425
0.3 0.918 0.379 0.957 0.411 0.903 0.397 0.940 0.399 0.902 0.398
0.5 0.929 0.337 0.962 0.370 0.913 0.355 0.942 0.360 0.900 0.360
0.9 0.946 0.170 0.972 0.216 0.940 0.203 0.956 0.213 0.903 0.219
50 -0.3 0.944 0.293 0.952 0.307 0.946 0.301 0.942 0.303 0.941 0.304
0 0.946 0.275 0.950 0.289 0.948 0.282 0.942 0.284 0.938 0.285
0.1 0.945 0.267 0.949 0.280 0.948 0.274 0.942 0.276 0.937 0.277
0.3 0.945 0.245 0.950 0.258 0.946 0.252 0.942 0.254 0.936 0.255
0.5 0.949 0.216 0.950 0.228 0.953 0.223 0.946 0.225 0.939 0.226
0.9 0.948 0.105 0.958 0.117 0.954 0.115 0.943 0.115 0.931 0.116
100 -0.3 0.949 0.208 0.949 0.209 0.946 0.208 0.947 0.208 0.945 0.208
0 0.946 0.196 0.949 0.196 0.945 0.195 0.944 0.195 0.941 0.195
0.1 0.945 0.190 0.949 0.190 0.942 0.189 0.942 0.189 0.940 0.189
0.3 0.951 0.174 0.950 0.175 0.948 0.173 0.948 0.174 0.943 0.174
0.5 0.952 0.153 0.947 0.153 0.948 0.152 0.947 0.152 0.943 0.153
0.9 0.954 0.074 0.951 0.074 0.949 0.074 0.948 0.073 0.941 0.073
Table C.14. Results adjusting for correlation with: Normal, 2-class Fair:Fair, Cost 2
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.926 0.730 0.942 0.705 0.887 0.685 0.908 0.678 0.912 0.676
0 0.916 0.689 0.938 0.663 0.876 0.647 0.897 0.641 0.905 0.641
0.1 0.922 0.672 0.942 0.648 0.885 0.633 0.904 0.628 0.913 0.628
0.3 0.923 0.634 0.938 0.611 0.887 0.600 0.899 0.596 0.918 0.600
0.5 0.922 0.586 0.939 0.567 0.890 0.557 0.895 0.554 0.920 0.562
0.9 0.927 0.447 0.934 0.446 0.915 0.449 0.900 0.452 0.940 0.464
20 -0.3 0.936 0.536 0.947 0.527 0.918 0.517 0.929 0.517 0.927 0.515
0 0.938 0.504 0.947 0.496 0.921 0.486 0.927 0.485 0.928 0.485
0.1 0.944 0.491 0.945 0.483 0.923 0.472 0.933 0.472 0.934 0.473
0.3 0.943 0.461 0.944 0.452 0.920 0.444 0.929 0.444 0.934 0.446
0.5 0.936 0.423 0.946 0.416 0.920 0.411 0.924 0.411 0.935 0.414
0.9 0.936 0.317 0.940 0.318 0.932 0.317 0.922 0.319 0.947 0.322
50 -0.3 0.944 0.346 0.948 0.344 0.938 0.340 0.938 0.341 0.940 0.341
0 0.948 0.324 0.948 0.323 0.940 0.320 0.943 0.320 0.944 0.320
0.1 0.946 0.316 0.948 0.314 0.940 0.311 0.941 0.312 0.943 0.312
0.3 0.943 0.296 0.950 0.294 0.938 0.292 0.939 0.292 0.941 0.293
0.5 0.942 0.271 0.950 0.269 0.937 0.268 0.939 0.268 0.941 0.269
0.9 0.945 0.200 0.947 0.201 0.946 0.201 0.940 0.202 0.950 0.203
100 -0.3 0.950 0.246 0.952 0.245 0.947 0.244 0.948 0.244 0.947 0.244
0 0.945 0.231 0.947 0.229 0.942 0.229 0.945 0.229 0.942 0.229
0.1 0.950 0.224 0.944 0.224 0.946 0.223 0.946 0.223 0.946 0.223
0.3 0.950 0.210 0.952 0.209 0.946 0.209 0.948 0.209 0.950 0.209
0.5 0.945 0.192 0.947 0.191 0.943 0.191 0.945 0.191 0.948 0.192
0.9 0.948 0.142 0.949 0.142 0.950 0.142 0.945 0.142 0.951 0.143
Table C.15. Results adjusting for correlation with: Normal, 2-class Good:Poor, Cost 1
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.833 0.426 0.951 0.534 0.892 0.565 0.927 0.519 0.893 0.521
0 0.836 0.410 0.949 0.523 0.889 0.547 0.923 0.503 0.883 0.502
0.1 0.838 0.403 0.947 0.512 0.889 0.539 0.921 0.496 0.880 0.494
0.3 0.847 0.390 0.950 0.498 0.893 0.518 0.923 0.480 0.887 0.473
0.5 0.851 0.370 0.948 0.475 0.892 0.497 0.919 0.461 0.884 0.453
0.9 0.869 0.309 0.943 0.404 0.901 0.436 0.921 0.401 0.891 NA
20 -0.3 0.876 0.311 0.953 0.415 0.902 0.408 0.941 0.400 0.917 0.397
0 0.890 0.300 0.955 0.402 0.908 0.395 0.940 0.389 0.913 0.381
0.1 0.895 0.294 0.952 0.394 0.916 0.389 0.941 0.383 0.918 NA
0.3 0.892 0.279 0.952 0.386 0.909 0.379 0.939 0.373 0.910 0.358
0.5 0.904 0.264 0.951 0.368 0.922 0.361 0.939 0.356 0.913 0.335
0.9 0.917 0.211 0.951 0.322 0.934 0.318 0.942 0.311 0.918 NA
50 -0.3 0.919 0.205 0.949 0.257 0.930 0.257 0.943 0.253 0.935 0.254
0 0.928 0.196 0.952 0.249 0.937 0.249 0.948 0.246 0.935 0.245
0.1 0.931 0.192 0.950 0.244 0.939 0.246 0.947 0.242 0.939 0.240
0.3 0.937 0.182 0.952 0.235 0.942 0.236 0.948 0.232 0.938 0.227
0.5 0.938 0.169 0.956 0.223 0.943 0.226 0.943 0.221 0.930 0.213
0.9 0.948 0.127 0.955 0.189 0.960 0.193 0.951 0.184 0.942 0.163
100 -0.3 0.931 0.147 0.953 0.155 0.929 0.159 0.946 0.155 0.936 0.156
0 0.939 0.141 0.950 0.148 0.932 0.153 0.949 0.149 0.937 0.149
0.1 0.936 0.137 0.951 0.145 0.935 0.150 0.948 0.145 0.939 0.144
0.3 0.940 0.129 0.948 0.137 0.934 0.142 0.950 0.137 0.939 0.136
0.5 0.943 0.119 0.953 0.128 0.938 0.132 0.947 0.127 0.936 0.124
0.9 0.951 0.087 0.956 0.098 0.949 0.103 0.955 0.097 0.945 0.093
Table C.16. Results adjusting for correlation with: Normal, 2-class Good:Poor, Cost 2
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.856 0.650 0.976 1.505 0.978 0.948 0.973 0.961 0.914 1.005
0 0.850 0.617 0.977 1.485 0.977 0.935 0.973 0.952 0.913 NA
0.1 0.855 0.610 0.976 1.471 0.978 0.919 0.976 0.928 0.915 NA
0.3 0.852 0.586 0.980 1.462 0.980 0.899 0.978 0.907 0.913 NA
0.5 0.851 0.518 0.985 1.414 0.981 0.862 0.976 0.858 0.901 NA
0.9 0.867 0.288 0.990 1.247 0.991 0.685 0.971 0.609 0.873 NA
20 -0.3 0.856 0.466 0.916 1.228 0.941 0.447 0.944 0.408 0.905 NA
0 0.856 0.448 0.930 1.216 0.940 0.436 0.945 0.398 0.904 NA
0.1 0.853 0.437 0.929 1.210 0.941 0.431 0.944 0.392 0.904 NA
0.3 0.862 0.418 0.932 1.197 0.941 0.415 0.947 0.374 0.901 NA
0.5 0.854 0.366 0.939 1.176 0.944 0.384 0.943 0.338 0.896 NA
0.9 0.861 0.195 0.962 1.090 0.975 0.264 0.942 0.183 0.885 NA
50 -0.3 0.919 0.305 0.872 1.057 0.946 0.277 0.944 0.254 0.922 NA
0 0.919 0.293 0.884 1.039 0.948 0.271 0.947 0.247 0.924 NA
0.1 0.912 0.285 0.884 1.039 0.948 0.267 0.947 0.243 0.923 NA
0.3 0.909 0.272 0.897 1.032 0.947 0.258 0.943 0.232 0.916 0.233
0.5 0.905 0.237 0.899 1.004 0.945 0.235 0.934 0.207 0.908 NA
0.9 0.906 0.121 0.927 0.917 0.970 0.152 0.941 0.107 0.911 0.107
100 -0.3 0.941 0.219 0.864 0.849 0.961 0.212 0.943 0.185 0.926 NA
0 0.941 0.210 0.866 0.820 0.959 0.208 0.944 0.182 0.928 NA
0.1 0.938 0.205 0.868 0.812 0.959 0.205 0.943 0.178 0.928 NA
0.3 0.940 0.195 0.871 0.791 0.964 0.199 0.944 0.171 0.926 0.172
0.5 0.930 0.169 0.880 0.761 0.964 0.184 0.943 0.153 0.925 NA
0.9 0.922 0.085 0.890 0.603 0.978 0.124 0.940 0.079 0.922 NA
Table C.17. Results adjusting for correlation with: Gamma, 3-class, Good:Good, Cost
1
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.826 0.362 0.966 0.950 0.976 0.538 0.965 0.491 0.881 0.553
0 0.825 0.356 0.969 0.940 0.977 0.540 0.963 0.493 0.872 0.555
0.1 0.826 0.348 0.969 0.937 0.978 0.534 0.963 0.484 0.865 0.555
0.3 0.830 0.348 0.971 0.930 0.977 0.526 0.964 0.478 0.863 0.549
0.5 0.840 0.293 0.977 0.886 0.980 0.503 0.966 0.443 0.855 0.523
0.9 0.875 0.153 0.978 0.753 0.991 0.409 0.964 0.306 0.846 0.413
20 -0.3 0.911 0.262 0.904 0.547 0.908 0.221 0.936 0.208 0.874 0.212
0 0.909 0.259 0.914 0.546 0.910 0.219 0.940 0.207 0.877 0.211
0.1 0.912 0.253 0.912 0.536 0.909 0.216 0.939 0.203 0.875 0.208
0.3 0.908 0.253 0.912 0.543 0.909 0.215 0.939 0.203 0.874 0.207
0.5 0.914 0.212 0.914 0.506 0.914 0.191 0.943 0.177 0.870 0.182
0.9 0.934 0.107 0.915 0.382 0.928 0.114 0.944 0.093 0.866 0.101
50 -0.3 0.973 0.169 0.839 0.199 0.920 0.138 0.943 0.138 0.908 0.138
0 0.971 0.168 0.844 0.200 0.918 0.137 0.943 0.137 0.910 0.138
0.1 0.969 0.164 0.840 0.195 0.916 0.135 0.940 0.135 0.904 0.136
0.3 0.972 0.163 0.847 0.199 0.915 0.134 0.941 0.134 0.903 0.135
0.5 0.967 0.136 0.851 0.176 0.914 0.117 0.941 0.117 0.898 0.118
0.9 0.959 0.068 0.848 0.113 0.913 0.060 0.938 0.060 0.895 0.060
100 -0.3 0.973 0.121 0.818 0.120 0.929 0.102 0.942 0.102 0.921 0.102
0 0.975 0.119 0.829 0.120 0.931 0.101 0.942 0.102 0.923 0.102
0.1 0.970 0.116 0.832 0.116 0.929 0.100 0.941 0.100 0.922 0.101
0.3 0.972 0.116 0.832 0.116 0.935 0.099 0.945 0.099 0.925 0.100
0.5 0.965 0.097 0.836 0.097 0.930 0.087 0.943 0.087 0.921 0.087
0.9 0.958 0.048 0.830 0.050 0.929 0.045 0.943 0.045 0.916 0.045
Table C.18. Results adjusting for correlation with: Gamma, 3-class, Good:Good, Cost
2
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.505 0.828 0.578 1.372 0.734 1.091 0.694 1.090 0.722 1.128
0 0.468 0.758 0.560 1.353 0.719 1.055 0.678 1.054 0.692 1.087
0.1 0.463 0.736 0.544 1.340 0.709 1.037 0.668 1.036 0.677 NA
0.3 0.425 0.722 0.546 1.339 0.701 1.012 0.640 1.013 0.629 1.049
0.5 0.350 0.702 0.521 1.304 0.677 0.976 0.575 0.976 0.561 NA
0.9 0.085 0.490 0.436 1.256 0.563 0.845 0.228 0.837 0.216 NA
20 -0.3 0.276 0.564 0.166 0.815 0.407 0.656 0.268 0.654 0.268 NA
0 0.230 0.537 0.150 0.786 0.364 0.634 0.227 0.631 0.225 NA
0.1 0.211 0.523 0.148 0.787 0.345 0.621 0.202 0.617 0.209 0.626
0.3 0.180 0.500 0.129 0.758 0.317 0.602 0.167 0.600 0.181 NA
0.5 0.108 0.452 0.116 0.726 0.258 0.568 0.105 0.562 0.119 0.577
0.9 0.008 0.303 0.069 0.629 0.126 0.476 0.008 0.465 0.019 0.502
50 -0.3 0.019 0.365 0.002 0.305 0.035 0.407 0.014 0.386 0.016 0.390
0 0.015 0.345 0.003 0.290 0.031 0.392 0.010 0.369 0.011 0.375
0.1 0.010 0.336 0.002 0.283 0.024 0.386 0.006 0.362 0.008 NA
0.3 0.005 0.319 0.002 0.272 0.015 0.372 0.004 0.346 0.005 NA
0.5 0.001 0.284 0.001 0.249 0.009 0.352 0.001 0.322 0.001 NA
0.9 0.000 0.186 0.001 0.182 0.000 0.291 0.000 0.246 0.000 NA
100 -0.3 0.000 0.259 0.000 0.148 0.001 0.316 0.000 0.279 0.000 0.283
0 0.000 0.245 0.000 0.141 0.000 0.307 0.000 0.268 0.000 NA
0.1 0.000 0.239 0.000 0.138 0.000 0.303 0.000 0.263 0.000 0.268
0.3 0.000 0.226 0.000 0.129 0.000 0.294 0.000 0.253 0.000 0.259
0.5 0.000 0.201 0.000 0.119 0.000 0.279 0.000 0.234 0.000 NA
0.9 0.000 0.130 0.000 0.095 0.000 0.239 0.000 0.180 0.000 NA
Table C.19. Results adjusting for correlation with: Gamma, 3-class Good:Fair, Cost 1
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.001 0.389 0.082 1.031 0.001 0.603 0.001 0.588 0.003 0.630
0 0.000 0.382 0.075 1.015 0.001 0.596 0.001 0.584 0.004 0.626
0.1 0.000 0.374 0.073 1.012 0.002 0.592 0.001 0.577 0.003 0.617
0.3 0.000 0.372 0.065 0.998 0.001 0.581 0.001 0.564 0.003 0.606
0.5 0.000 0.320 0.049 0.957 0.002 0.563 0.001 0.541 0.004 0.592
0.9 0.000 0.204 0.010 0.833 0.001 0.473 0.001 0.433 0.003 0.490
20 -0.3 0.000 0.284 0.004 0.526 0.000 0.295 0.000 0.285 0.000 0.287
0 0.000 0.278 0.004 0.526 0.000 0.289 0.000 0.279 0.000 0.280
0.1 0.000 0.272 0.003 0.522 0.000 0.286 0.000 0.275 0.000 0.278
0.3 0.000 0.271 0.002 0.516 0.000 0.281 0.000 0.269 0.000 0.272
0.5 0.000 0.232 0.001 0.513 0.000 0.258 0.000 0.245 0.000 0.250
0.9 0.000 0.143 0.000 0.482 0.000 0.201 0.000 0.184 0.000 0.194
50 -0.3 0.000 0.185 0.000 0.200 0.000 0.177 0.000 0.177 0.000 0.178
0 0.000 0.181 0.000 0.201 0.000 0.173 0.000 0.173 0.000 0.174
0.1 0.000 0.177 0.000 0.202 0.000 0.171 0.000 0.170 0.000 0.171
0.3 0.000 0.175 0.000 0.203 0.000 0.168 0.000 0.167 0.000 0.168
0.5 0.000 0.150 0.000 0.202 0.000 0.153 0.000 0.152 0.000 0.153
0.9 0.000 0.090 0.000 0.200 0.000 0.111 0.000 0.110 0.000 0.111
100 -0.3 0.000 0.131 0.000 0.113 0.000 0.130 0.000 0.130 0.000 0.130
0 0.000 0.129 0.000 0.112 0.000 0.128 0.000 0.127 0.000 0.128
0.1 0.000 0.126 0.000 0.112 0.000 0.126 0.000 0.126 0.000 0.127
0.3 0.000 0.125 0.000 0.111 0.000 0.124 0.000 0.123 0.000 0.124
0.5 0.000 0.106 0.000 0.109 0.000 0.113 0.000 0.112 0.000 0.113
0.9 0.000 0.063 0.000 0.106 0.000 0.082 0.000 0.081 0.000 0.082
Table C.20. Results adjusting for correlation with: Gamma, 3-class Good:Fair, Cost 2
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.822 1.021 0.953 1.275 0.886 1.230 0.969 1.215 0.953 1.232
0 0.830 0.880 0.962 1.240 0.892 1.159 0.977 1.155 0.941 1.159
0.1 0.825 0.836 0.966 1.221 0.903 1.134 0.979 1.134 0.944 1.138
0.3 0.839 0.856 0.970 1.190 0.905 1.074 0.982 1.084 0.933 NA
0.5 0.838 0.780 0.978 1.126 0.909 0.998 0.987 1.019 0.930 1.024
0.9 0.871 0.422 0.993 0.918 0.935 0.726 0.990 0.768 0.904 NA
20 -0.3 0.896 0.666 0.964 1.012 0.933 0.839 0.956 0.855 0.944 0.853
0 0.893 0.618 0.966 0.976 0.929 0.780 0.961 0.795 0.937 0.788
0.1 0.891 0.589 0.972 0.961 0.939 0.758 0.959 0.775 0.941 0.769
0.3 0.896 0.550 0.976 0.931 0.938 0.713 0.964 0.730 0.935 0.724
0.5 0.898 0.482 0.983 0.883 0.943 0.651 0.967 0.665 0.929 NA
0.9 0.899 0.247 0.994 0.709 0.967 0.445 0.973 0.429 0.924 NA
50 -0.3 0.916 0.422 0.987 0.679 0.942 0.517 0.949 0.506 0.927 0.499
0 0.915 0.390 0.988 0.641 0.943 0.484 0.954 0.469 0.924 NA
0.1 0.912 0.376 0.990 0.626 0.948 0.472 0.951 0.454 0.928 0.451
0.3 0.908 0.348 0.990 0.588 0.946 0.442 0.953 0.419 0.923 NA
0.5 0.902 0.299 0.989 0.537 0.949 0.401 0.953 0.368 0.918 NA
0.9 0.902 0.144 0.971 0.297 0.979 0.272 0.958 0.186 0.920 NA
100 -0.3 0.912 0.299 0.981 0.388 0.951 0.402 0.947 0.369 0.928 NA
0 0.910 0.276 0.973 0.354 0.958 0.382 0.953 0.342 0.931 NA
0.1 0.905 0.266 0.971 0.340 0.956 0.372 0.947 0.330 0.925 NA
0.3 0.910 0.246 0.963 0.310 0.961 0.352 0.953 0.305 0.929 NA
0.5 0.904 0.212 0.957 0.260 0.965 0.325 0.955 0.268 0.928 0.269
0.9 0.891 0.101 0.921 0.112 0.976 0.241 0.956 0.133 0.921 0.142
Table C.21. Results adjusting for correlation with: Gamma, 3-class Fair:Fair, Cost 1
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.701 0.413 0.966 0.914 0.959 0.673 0.962 0.680 0.939 0.704
0 0.707 0.402 0.969 0.907 0.957 0.647 0.967 0.654 0.927 0.673
0.1 0.708 0.392 0.973 0.903 0.959 0.639 0.966 0.644 0.931 0.667
0.3 0.713 0.389 0.980 0.900 0.956 0.615 0.967 0.621 0.916 0.641
0.5 0.720 0.335 0.987 0.871 0.960 0.583 0.972 0.587 0.911 0.617
0.9 0.792 0.186 0.994 0.771 0.975 0.439 0.976 0.413 0.887 0.465
20 -0.3 0.780 0.304 0.955 0.703 0.929 0.361 0.941 0.354 0.911 0.353
0 0.786 0.296 0.964 0.698 0.929 0.347 0.945 0.339 0.907 0.338
0.1 0.791 0.288 0.965 0.695 0.925 0.339 0.946 0.331 0.906 0.331
0.3 0.792 0.284 0.965 0.691 0.928 0.326 0.947 0.318 0.902 0.318
0.5 0.798 0.240 0.973 0.659 0.930 0.293 0.950 0.283 0.897 0.285
0.9 0.846 0.126 0.978 0.542 0.947 0.183 0.950 0.158 0.884 0.169
50 -0.3 0.892 0.200 0.929 0.383 0.921 0.213 0.936 0.212 0.917 0.212
0 0.894 0.193 0.926 0.372 0.923 0.204 0.939 0.202 0.918 0.203
0.1 0.897 0.188 0.926 0.369 0.925 0.199 0.941 0.198 0.919 0.199
0.3 0.902 0.184 0.922 0.366 0.921 0.189 0.937 0.188 0.913 0.189
0.5 0.899 0.155 0.930 0.334 0.924 0.166 0.941 0.165 0.916 0.166
0.9 0.892 0.077 0.927 0.234 0.926 0.085 0.938 0.083 0.905 0.083
100 -0.3 0.914 0.142 0.900 0.187 0.932 0.156 0.939 0.155 0.927 0.156
0 0.915 0.138 0.895 0.182 0.935 0.149 0.943 0.149 0.927 0.149
0.1 0.912 0.134 0.900 0.177 0.931 0.145 0.938 0.145 0.923 0.146
0.3 0.922 0.131 0.892 0.174 0.933 0.139 0.942 0.138 0.928 0.139
0.5 0.909 0.110 0.898 0.152 0.934 0.122 0.942 0.122 0.926 0.122
0.9 0.905 0.054 0.883 0.088 0.936 0.061 0.941 0.061 0.923 0.061
Table C.22. Results adjusting for correlation with: Gamma, 3-class Fair:Fair, Cost 2
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.059 4.974 0.102 1.425 0.074 1.183 0.097 1.228 0.097 NA
0 0.058 5.914 0.094 1.412 0.069 1.170 0.090 1.212 0.088 NA
0.1 0.059 5.098 0.086 1.405 0.068 1.157 0.085 1.203 0.083 1.214
0.3 0.055 4.925 0.072 1.389 0.064 1.143 0.077 1.187 0.074 1.202
0.5 0.054 9.341 0.052 1.376 0.053 1.102 0.061 1.146 0.061 1.164
0.9 0.056 4.995 0.015 1.367 0.032 0.984 0.044 1.021 0.040 1.077
20 -0.3 0.030 0.713 0.004 1.148 0.002 0.704 0.002 0.706 0.001 NA
0 0.031 0.819 0.003 1.134 0.002 0.694 0.002 0.696 0.001 0.710
0.1 0.034 0.678 0.002 1.129 0.003 0.689 0.002 0.691 0.001 NA
0.3 0.035 0.784 0.002 1.127 0.002 0.679 0.001 0.681 0.001 0.699
0.5 0.031 0.629 0.001 1.121 0.002 0.643 0.001 0.641 0.001 0.669
0.9 0.030 0.616 0.000 1.141 0.001 0.561 0.000 0.551 0.001 NA
50 -0.3 0.003 0.428 0.000 0.792 0.000 0.407 0.000 0.393 0.000 NA
0 0.003 0.364 0.000 0.780 0.000 0.403 0.000 0.389 0.000 0.390
0.1 0.003 0.358 0.000 0.775 0.000 0.400 0.000 0.385 0.000 NA
0.3 0.005 0.356 0.000 0.763 0.000 0.393 0.000 0.377 0.000 NA
0.5 0.003 0.316 0.000 0.752 0.000 0.370 0.000 0.353 0.000 0.356
0.9 0.004 0.242 0.000 0.717 0.000 0.308 0.000 0.286 0.000 0.291
100 -0.3 0.000 0.262 0.000 0.473 0.000 0.292 0.000 0.282 0.000 NA
0 0.000 0.259 0.000 0.468 0.000 0.290 0.000 0.279 0.000 0.279
0.1 0.000 0.253 0.000 0.466 0.000 0.287 0.000 0.276 0.000 0.276
0.3 0.000 0.250 0.000 0.463 0.000 0.281 0.000 0.270 0.000 NA
0.5 0.000 0.224 0.000 0.449 0.000 0.265 0.000 0.253 0.000 NA
0.9 0.000 0.167 0.000 0.407 0.000 0.218 0.000 0.203 0.000 0.204
Table C.23. Results adjusting for correlation with: Gamma, 3-class Good:Poor, Cost 1
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.000 0.619 0.089 0.888 0.000 0.855 0.000 0.834 0.001 0.850
0 0.000 0.626 0.081 0.869 0.001 0.854 0.001 0.834 0.001 0.846
0.1 0.000 0.614 0.073 0.857 0.000 0.843 0.001 0.824 0.001 0.842
0.3 0.000 0.620 0.062 0.833 0.000 0.843 0.001 0.824 0.001 0.844
0.5 0.000 0.562 0.046 0.800 0.000 0.820 0.001 0.800 0.002 0.825
0.9 0.000 0.483 0.010 0.698 0.000 0.743 0.000 0.721 0.001 0.768
20 -0.3 0.000 0.467 0.004 0.460 0.000 0.514 0.000 0.515 0.000 0.528
0 0.000 0.468 0.005 0.462 0.000 0.515 0.000 0.515 0.000 0.529
0.1 0.000 0.461 0.003 0.456 0.000 0.510 0.000 0.509 0.000 0.524
0.3 0.000 0.467 0.002 0.455 0.000 0.508 0.000 0.508 0.000 0.522
0.5 0.000 0.421 0.001 0.442 0.000 0.485 0.000 0.485 0.000 0.503
0.9 0.000 0.357 0.000 0.430 0.000 0.444 0.000 0.443 0.000 0.469
50 -0.3 0.000 0.308 0.000 0.202 0.000 0.331 0.000 0.327 0.000 0.334
0 0.000 0.309 0.000 0.197 0.000 0.330 0.000 0.326 0.000 0.334
0.1 0.000 0.304 0.000 0.199 0.000 0.329 0.000 0.325 0.000 0.332
0.3 0.000 0.308 0.000 0.194 0.000 0.329 0.000 0.324 0.000 0.332
0.5 0.000 0.278 0.000 0.190 0.000 0.313 0.000 0.308 0.000 0.317
0.9 0.000 0.235 0.000 0.171 0.000 0.285 0.000 0.279 0.000 0.289
100 -0.3 0.000 0.220 0.000 0.094 0.000 0.246 0.000 0.240 0.000 0.245
0 0.000 0.221 0.000 0.089 0.000 0.246 0.000 0.241 0.000 0.247
0.1 0.000 0.217 0.000 0.089 0.000 0.244 0.000 0.238 0.000 0.245
0.3 0.000 0.220 0.000 0.084 0.000 0.244 0.000 0.238 0.000 0.244
0.5 0.000 0.198 0.000 0.077 0.000 0.234 0.000 0.227 0.000 0.234
0.9 0.000 0.167 0.000 0.062 0.000 0.213 0.000 0.205 0.000 0.213
Table C.24. Results adjusting for correlation with: Gamma, 3-class Good:Poor, Cost 2
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.994 0.280 0.912 0.670 0.952 0.341 0.925 0.271 0.730 0.415
0 0.994 0.272 0.920 0.639 0.944 0.332 0.923 0.260 0.723 0.405
0.1 0.993 0.267 0.913 0.629 0.949 0.331 0.920 0.262 0.726 0.401
0.3 0.994 0.253 0.916 0.602 0.942 0.318 0.924 0.247 0.713 0.389
0.5 0.993 0.229 0.923 0.533 0.951 0.305 0.919 0.229 0.709 0.381
0.9 0.994 0.120 0.911 0.244 0.966 0.228 0.924 0.139 0.694 0.282
20 -0.3 0.986 0.202 0.881 0.281 0.911 0.175 0.933 0.174 0.815 0.186
0 0.982 0.196 0.884 0.263 0.904 0.171 0.929 0.170 0.812 0.182
0.1 0.980 0.193 0.877 0.250 0.906 0.170 0.929 0.168 0.806 0.180
0.3 0.983 0.182 0.879 0.231 0.901 0.161 0.925 0.159 0.802 0.171
0.5 0.984 0.164 0.876 0.192 0.912 0.144 0.931 0.142 0.803 0.154
0.9 0.983 0.085 0.877 0.081 0.923 0.076 0.926 0.073 0.778 0.081
50 -0.3 0.956 0.130 0.858 0.129 0.928 0.124 0.939 0.124 0.877 0.127
0 0.954 0.127 0.861 0.125 0.924 0.122 0.934 0.122 0.868 0.126
0.1 0.954 0.124 0.862 0.122 0.929 0.120 0.941 0.120 0.877 0.124
0.3 0.954 0.116 0.864 0.114 0.928 0.112 0.937 0.113 0.874 0.116
0.5 0.951 0.105 0.861 0.102 0.924 0.102 0.931 0.102 0.866 0.105
0.9 0.958 0.054 0.856 0.051 0.938 0.052 0.940 0.052 0.866 0.054
100 -0.3 0.947 0.093 0.855 0.092 0.936 0.092 0.943 0.093 0.905 0.094
0 0.947 0.090 0.859 0.089 0.938 0.090 0.941 0.091 0.905 0.092
0.1 0.940 0.088 0.858 0.087 0.934 0.089 0.939 0.089 0.902 0.091
0.3 0.942 0.083 0.869 0.082 0.938 0.085 0.942 0.085 0.906 0.086
0.5 0.939 0.075 0.857 0.073 0.937 0.076 0.940 0.077 0.901 0.078
0.9 0.939 0.038 0.857 0.036 0.936 0.039 0.936 0.039 0.893 0.040
Table C.25. Results adjusting for correlation with: Gamma, 2-class, Good:Good, Cost
1
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.991 0.174 0.931 0.878 0.980 0.406 0.925 0.210 0.744 0.410
0 0.989 0.168 0.935 0.839 0.976 0.402 0.919 0.208 0.730 0.392
0.1 0.988 0.166 0.933 0.803 0.978 0.407 0.922 0.217 0.733 0.398
0.3 0.991 0.155 0.934 0.739 0.975 0.392 0.922 0.195 0.736 0.374
0.5 0.991 0.141 0.933 0.625 0.978 0.377 0.918 0.179 0.720 0.373
0.9 0.992 0.075 0.920 0.201 0.981 0.325 0.927 0.120 0.713 0.320
20 -0.3 0.971 0.124 0.876 0.223 0.926 0.121 0.933 0.117 0.812 0.131
0 0.969 0.121 0.882 0.208 0.918 0.120 0.924 0.115 0.803 0.129
0.1 0.969 0.119 0.885 0.188 0.925 0.117 0.928 0.112 0.806 0.125
0.3 0.971 0.111 0.883 0.162 0.918 0.110 0.923 0.105 0.798 0.119
0.5 0.970 0.101 0.881 0.125 0.921 0.100 0.923 0.095 0.792 0.109
0.9 0.975 0.052 0.869 0.050 0.938 0.055 0.928 0.049 0.786 0.059
50 -0.3 0.941 0.080 0.861 0.079 0.934 0.082 0.934 0.082 0.870 0.086
0 0.935 0.077 0.850 0.076 0.932 0.081 0.933 0.081 0.868 0.085
0.1 0.935 0.076 0.861 0.074 0.933 0.079 0.935 0.079 0.870 0.084
0.3 0.938 0.071 0.861 0.069 0.935 0.074 0.936 0.074 0.872 0.078
0.5 0.939 0.064 0.863 0.062 0.937 0.067 0.936 0.067 0.867 0.071
0.9 0.941 0.033 0.856 0.031 0.942 0.034 0.935 0.034 0.858 0.037
100 -0.3 0.929 0.057 0.849 0.056 0.942 0.061 0.942 0.061 0.902 0.063
0 0.922 0.055 0.858 0.054 0.943 0.060 0.941 0.060 0.901 0.061
0.1 0.923 0.054 0.862 0.053 0.942 0.059 0.940 0.059 0.905 0.060
0.3 0.928 0.051 0.860 0.050 0.946 0.056 0.944 0.056 0.906 0.057
0.5 0.920 0.046 0.855 0.044 0.945 0.050 0.941 0.050 0.898 0.052
0.9 0.921 0.023 0.849 0.022 0.947 0.025 0.940 0.026 0.894 0.026
Table C.26. Results adjusting for correlation with: Gamma, 2-class, Good:Good, Cost
2
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.684 0.360 0.838 0.763 0.728 0.415 0.591 0.353 0.655 0.493
0 0.667 0.344 0.828 0.726 0.718 0.405 0.579 0.344 0.653 0.479
0.1 0.659 0.337 0.830 0.712 0.715 0.398 0.570 0.338 0.652 0.474
0.3 0.636 0.320 0.826 0.680 0.704 0.387 0.554 0.324 0.647 0.465
0.5 0.603 0.293 0.801 0.627 0.685 0.367 0.520 0.301 0.646 0.453
0.9 0.377 0.175 0.631 0.335 0.570 0.278 0.324 0.195 0.627 0.411
20 -0.3 0.610 0.262 0.731 0.365 0.539 0.231 0.513 0.228 0.585 0.243
0 0.585 0.252 0.713 0.339 0.526 0.225 0.498 0.222 0.576 0.236
0.1 0.583 0.248 0.718 0.324 0.520 0.221 0.492 0.218 0.576 0.232
0.3 0.555 0.234 0.697 0.304 0.499 0.210 0.467 0.207 0.560 0.222
0.5 0.494 0.213 0.653 0.260 0.446 0.192 0.416 0.188 0.528 0.203
0.9 0.215 0.127 0.379 0.131 0.222 0.117 0.179 0.111 0.335 0.129
50 -0.3 0.380 0.170 0.549 0.168 0.365 0.162 0.342 0.162 0.416 0.166
0 0.356 0.164 0.519 0.161 0.352 0.158 0.326 0.158 0.403 0.162
0.1 0.349 0.160 0.503 0.157 0.348 0.155 0.322 0.155 0.405 0.159
0.3 0.308 0.151 0.470 0.148 0.312 0.147 0.288 0.147 0.373 0.151
0.5 0.239 0.138 0.421 0.134 0.248 0.134 0.227 0.134 0.322 0.138
0.9 0.030 0.082 0.125 0.084 0.053 0.080 0.040 0.079 0.107 0.085
100 -0.3 0.150 0.121 0.343 0.119 0.166 0.120 0.151 0.120 0.212 0.122
0 0.140 0.117 0.316 0.115 0.164 0.118 0.149 0.118 0.213 0.120
0.1 0.121 0.115 0.310 0.113 0.150 0.116 0.134 0.116 0.197 0.118
0.3 0.102 0.108 0.270 0.106 0.125 0.110 0.114 0.110 0.174 0.112
0.5 0.067 0.098 0.204 0.096 0.095 0.100 0.084 0.100 0.139 0.102
0.9 0.001 0.058 0.017 0.061 0.005 0.060 0.004 0.059 0.016 0.062
Table C.27. Results adjusting for correlation with: Gamma, 2-class Good:Fair, Cost 1
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.552 0.221 0.779 0.978 0.814 0.465 0.470 0.272 0.573 0.463
0 0.526 0.212 0.768 0.935 0.802 0.461 0.451 0.272 0.563 0.448
0.1 0.522 0.209 0.756 0.889 0.803 0.454 0.441 0.260 0.565 0.450
0.3 0.491 0.197 0.738 0.828 0.786 0.444 0.420 0.249 0.551 0.453
0.5 0.447 0.179 0.686 0.721 0.775 0.433 0.384 0.230 0.541 0.437
0.9 0.225 0.109 0.372 0.277 0.691 0.369 0.235 0.162 0.529 0.459
20 -0.3 0.413 0.160 0.549 0.287 0.408 0.160 0.369 0.154 0.452 0.170
0 0.402 0.153 0.511 0.251 0.404 0.155 0.365 0.149 0.457 0.165
0.1 0.377 0.150 0.499 0.230 0.386 0.151 0.349 0.145 0.440 0.162
0.3 0.347 0.142 0.462 0.202 0.359 0.144 0.325 0.137 0.428 0.154
0.5 0.300 0.129 0.397 0.167 0.323 0.132 0.290 0.126 0.397 0.143
0.9 0.088 0.077 0.132 0.077 0.146 0.084 0.122 0.075 0.250 0.096
50 -0.3 0.156 0.103 0.245 0.100 0.200 0.108 0.192 0.108 0.263 0.113
0 0.154 0.099 0.227 0.096 0.202 0.105 0.193 0.105 0.265 0.110
0.1 0.145 0.097 0.208 0.093 0.188 0.102 0.180 0.102 0.260 0.108
0.3 0.116 0.091 0.186 0.088 0.165 0.098 0.160 0.097 0.240 0.103
0.5 0.085 0.083 0.136 0.079 0.137 0.089 0.132 0.089 0.211 0.094
0.9 0.006 0.049 0.013 0.049 0.027 0.053 0.025 0.053 0.073 0.059
100 -0.3 0.031 0.073 0.077 0.072 0.064 0.080 0.062 0.080 0.108 0.082
0 0.027 0.071 0.058 0.069 0.061 0.078 0.061 0.078 0.106 0.080
0.1 0.021 0.069 0.056 0.067 0.054 0.076 0.054 0.077 0.096 0.079
0.3 0.018 0.065 0.042 0.063 0.046 0.072 0.045 0.072 0.090 0.075
0.5 0.010 0.059 0.023 0.057 0.031 0.066 0.033 0.066 0.071 0.069
0.9 0.000 0.035 0.001 0.035 0.002 0.040 0.002 0.040 0.012 0.042
Table C.28. Results adjusting for correlation with: Gamma, 2-class Good:Fair, Cost 2
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.973 0.425 0.911 0.838 0.934 0.479 0.930 0.427 0.788 0.521
0 0.974 0.405 0.914 0.811 0.931 0.462 0.927 0.411 0.779 0.500
0.1 0.977 0.396 0.919 0.795 0.932 0.455 0.930 0.401 0.779 0.492
0.3 0.974 0.370 0.920 0.751 0.933 0.438 0.929 0.384 0.775 0.477
0.5 0.975 0.332 0.928 0.689 0.938 0.409 0.928 0.349 0.764 0.450
0.9 0.977 0.173 0.925 0.359 0.957 0.293 0.931 0.211 0.748 0.326
20 -0.3 0.960 0.313 0.877 0.436 0.900 0.280 0.931 0.276 0.851 0.285
0 0.955 0.298 0.876 0.404 0.889 0.269 0.927 0.265 0.837 0.275
0.1 0.954 0.292 0.874 0.386 0.894 0.265 0.929 0.261 0.843 0.270
0.3 0.954 0.271 0.878 0.350 0.896 0.246 0.929 0.242 0.843 0.252
0.5 0.954 0.244 0.875 0.301 0.893 0.221 0.927 0.217 0.835 0.226
0.9 0.955 0.123 0.865 0.119 0.896 0.115 0.923 0.110 0.811 0.117
50 -0.3 0.947 0.203 0.854 0.201 0.924 0.195 0.942 0.195 0.903 0.197
0 0.938 0.194 0.852 0.190 0.914 0.187 0.933 0.187 0.892 0.190
0.1 0.939 0.189 0.858 0.185 0.919 0.184 0.937 0.184 0.893 0.186
0.3 0.939 0.177 0.855 0.171 0.920 0.173 0.938 0.173 0.891 0.176
0.5 0.939 0.158 0.854 0.151 0.921 0.155 0.938 0.155 0.891 0.157
0.9 0.936 0.079 0.851 0.075 0.925 0.078 0.939 0.078 0.887 0.080
100 -0.3 0.940 0.145 0.858 0.143 0.934 0.144 0.943 0.144 0.919 0.145
0 0.935 0.139 0.850 0.136 0.929 0.139 0.937 0.140 0.909 0.141
0.1 0.933 0.135 0.857 0.133 0.928 0.137 0.936 0.137 0.912 0.138
0.3 0.931 0.126 0.847 0.123 0.932 0.129 0.940 0.129 0.911 0.130
0.5 0.926 0.113 0.851 0.109 0.927 0.116 0.934 0.116 0.904 0.117
0.9 0.929 0.056 0.838 0.054 0.933 0.058 0.942 0.058 0.905 0.059
Table C.29. Results adjusting for correlation with: Gamma, 2-class Fair:Fair, Cost 1
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.961 0.261 0.936 1.061 0.980 0.524 0.930 0.332 0.799 0.459
0 0.957 0.250 0.937 1.010 0.973 0.508 0.926 0.317 0.796 0.429
0.1 0.960 0.243 0.939 0.975 0.977 0.504 0.924 0.313 0.784 0.420
0.3 0.962 0.227 0.944 0.922 0.975 0.492 0.927 0.296 0.786 0.406
0.5 0.965 0.205 0.941 0.807 0.979 0.476 0.927 0.276 0.781 NA
0.9 0.970 0.108 0.926 0.306 0.985 0.390 0.927 0.174 0.767 0.313
20 -0.3 0.936 0.190 0.889 0.332 0.918 0.194 0.931 0.188 0.845 0.201
0 0.938 0.181 0.888 0.297 0.916 0.185 0.928 0.179 0.843 0.192
0.1 0.937 0.177 0.887 0.276 0.918 0.182 0.928 0.175 0.843 0.189
0.3 0.931 0.165 0.883 0.234 0.911 0.171 0.922 0.164 0.832 0.178
0.5 0.934 0.148 0.873 0.196 0.922 0.155 0.928 0.148 0.834 0.163
0.9 0.943 0.076 0.879 0.073 0.931 0.084 0.925 0.075 0.820 0.086
50 -0.3 0.919 0.122 0.856 0.121 0.930 0.130 0.935 0.130 0.890 0.134
0 0.913 0.117 0.852 0.113 0.930 0.126 0.936 0.126 0.886 0.130
0.1 0.917 0.114 0.860 0.110 0.931 0.123 0.936 0.123 0.894 0.127
0.3 0.911 0.106 0.846 0.102 0.927 0.115 0.934 0.115 0.880 0.119
0.5 0.908 0.095 0.851 0.091 0.929 0.104 0.931 0.103 0.878 0.108
0.9 0.904 0.048 0.848 0.045 0.928 0.052 0.930 0.052 0.872 0.055
100 -0.3 0.914 0.087 0.855 0.086 0.938 0.096 0.940 0.096 0.911 0.098
0 0.908 0.083 0.850 0.082 0.937 0.092 0.938 0.093 0.909 0.094
0.1 0.909 0.081 0.851 0.080 0.937 0.090 0.939 0.090 0.908 0.092
0.3 0.905 0.076 0.844 0.074 0.935 0.085 0.937 0.085 0.905 0.087
0.5 0.902 0.067 0.841 0.065 0.936 0.076 0.939 0.076 0.904 0.078
0.9 0.898 0.034 0.840 0.032 0.941 0.039 0.940 0.039 0.901 0.040
Table C.30. Results adjusting for correlation with: Gamma, 2-class Fair:Fair, Cost 2
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.889 0.608 0.716 0.671 0.889 0.709 0.907 0.688 0.915 0.733
0 0.883 0.589 0.705 0.649 0.888 0.691 0.906 0.670 0.918 0.722
0.1 0.882 0.580 0.702 0.646 0.889 0.682 0.902 0.661 0.923 0.723
0.3 0.873 0.559 0.695 0.628 0.882 0.664 0.902 0.642 0.922 0.709
0.5 0.873 0.533 0.680 0.608 0.883 0.646 0.902 0.623 0.927 0.701
0.9 0.869 0.456 0.637 0.555 0.883 0.585 0.902 0.568 0.928 0.666
20 -0.3 0.888 0.447 0.363 0.387 0.884 0.481 0.918 0.474 0.897 0.487
0 0.881 0.432 0.348 0.380 0.875 0.467 0.916 0.460 0.893 0.475
0.1 0.878 0.424 0.341 0.376 0.875 0.460 0.917 0.454 0.897 0.470
0.3 0.877 0.410 0.333 0.367 0.874 0.447 0.918 0.441 0.893 0.457
0.5 0.881 0.388 0.332 0.355 0.879 0.428 0.917 0.422 0.903 0.441
0.9 0.855 0.331 0.303 0.315 0.865 0.385 0.918 0.379 0.898 0.397
50 -0.3 0.846 0.288 0.033 0.178 0.880 0.325 0.924 0.323 0.879 0.326
0 0.836 0.278 0.037 0.172 0.868 0.316 0.921 0.314 0.869 0.318
0.1 0.826 0.274 0.033 0.172 0.866 0.312 0.916 0.310 0.863 0.314
0.3 0.829 0.264 0.029 0.165 0.870 0.302 0.917 0.300 0.864 0.305
0.5 0.819 0.251 0.028 0.156 0.862 0.290 0.916 0.289 0.860 0.293
0.9 0.774 0.212 0.023 0.139 0.843 0.257 0.910 0.255 0.848 0.258
100 -0.3 0.760 0.204 0.000 0.104 0.827 0.239 0.880 0.239 0.809 0.241
0 0.757 0.198 0.001 0.103 0.824 0.232 0.869 0.232 0.803 0.234
0.1 0.751 0.195 0.000 0.102 0.821 0.230 0.866 0.229 0.800 0.232
0.3 0.733 0.188 0.000 0.101 0.815 0.224 0.864 0.223 0.789 0.226
0.5 0.711 0.178 0.000 0.099 0.803 0.215 0.860 0.215 0.777 0.218
0.9 0.649 0.151 0.001 0.097 0.767 0.189 0.833 0.188 0.746 0.190
Table C.31. Results adjusting for correlation with: Gamma, 2-class Good:Poor, Cost 1
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Delta Generalized AN BP BCa
nj Corr Cov Len Cov Len Cov Len Cov Len Cov Len
10 -0.3 0.654 0.332 0.930 1.064 0.911 0.689 0.820 0.520 0.888 0.632
0 0.655 0.325 0.930 1.047 0.904 0.679 0.820 0.514 0.889 0.636
0.1 0.654 0.320 0.923 1.013 0.903 0.679 0.817 0.511 0.890 0.639
0.3 0.633 0.309 0.911 0.998 0.899 0.673 0.807 0.507 0.893 0.668
0.5 0.647 0.302 0.901 0.919 0.900 0.654 0.812 0.491 0.908 0.678
0.9 0.640 0.276 0.830 0.649 0.901 0.618 0.818 0.464 0.911 0.717
20 -0.3 0.678 0.254 0.783 0.376 0.764 0.338 0.809 0.316 0.837 0.312
0 0.671 0.245 0.777 0.354 0.758 0.330 0.815 0.308 0.837 0.305
0.1 0.665 0.242 0.769 0.340 0.759 0.328 0.806 0.306 0.835 0.306
0.3 0.669 0.236 0.741 0.308 0.761 0.319 0.809 0.299 0.839 0.298
0.5 0.643 0.226 0.716 0.280 0.742 0.310 0.791 0.289 0.819 0.291
0.9 0.637 0.204 0.647 0.150 0.755 0.289 0.807 0.272 0.825 0.275
50 -0.3 0.666 0.169 0.582 0.090 0.784 0.247 0.826 0.242 0.843 0.240
0 0.657 0.164 0.573 0.088 0.780 0.241 0.819 0.237 0.839 0.236
0.1 0.655 0.162 0.570 0.088 0.783 0.239 0.823 0.234 0.846 0.235
0.3 0.648 0.157 0.560 0.085 0.779 0.234 0.820 0.230 0.845 0.231
0.5 0.628 0.151 0.560 0.081 0.768 0.227 0.813 0.223 0.838 0.224
0.9 0.595 0.134 0.528 0.078 0.762 0.209 0.808 0.206 0.828 0.210
100 -0.3 0.615 0.122 0.439 0.059 0.789 0.195 0.813 0.196 0.836 0.200
0 0.613 0.118 0.434 0.058 0.798 0.191 0.819 0.193 0.844 0.199
0.1 0.607 0.117 0.446 0.058 0.790 0.190 0.812 0.191 0.836 0.197
0.3 0.588 0.113 0.435 0.057 0.781 0.185 0.804 0.187 0.833 0.193
0.5 0.568 0.108 0.433 0.056 0.774 0.180 0.794 0.181 0.826 0.189
0.9 0.533 0.096 0.411 0.055 0.763 0.166 0.785 0.169 0.821 0.178
Table C.32. Results adjusting for correlation with: Gamma, 2-class Good:Poor, Cost 2
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Appendix D. Delta Method Variance Calculations for BP
and BN Strategies in Sequential Testing
D.1 Derivation of BP
PTP = P (S = 1|T = 1) = P1 [(X1 > θ1) ∪ [(X1 < θ1 ∩ (X2 > θ2))]]
= P1(X1 > θ1) + P1 [(X1 < θ1 ∩ (X2 > θ2))]




= 1− FXa,1Xa,2(θ1, θ2)
PFP = P (S = 1|T = 0) = 1− FXb,1(θ1) + FXb,1(θ1)− FXb,1,Xb,2(θ1, θ2)
= 1− FXb,1Xb,2(θ1, θ2)
Therefore the BP function would be given by:





















D.1.1 Partial Derivatives - Multivariate Chain Rule.









































































































































































































































































































































































































































































































































































































− σ−2b,2 (θ2 − µb,2)
))
Finally, using the identity:
∂
∂ρ
Φ(z1, z2) = φ(z1, z2)
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D.1.2 Variance and Covariance and the Delta Application.





∀i ∈ {a, b}, j ∈ {1, 2}.
Similarly, variance for the variance terms is a well known result:
V ar(σ2i,j) =
σ2i,j
2(nj − 1)∀i ∈ {a, b}, j ∈ {1, 2}.





)2 ∀i ∈ {a, b}.
Covariances must be computed for terms that are not mutually independent.
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Those are given by:
Cov(µi,1, µi,2) = ρˆ
√
V ar(µi,1)V ar(µi,1)∀i ∈ {a, b},
Cov(σi,1, σi,2) = ρˆ
2
√
V ar(σi,1)V ar(σi,1)∀i ∈ {a, b}.
The second result is defined using the law of total variance from Fisher’s ANOVA
work. Thus, we can find the variance of BC as an application of the Delta Method
















































D.2 Derivation of BN
PTP =1− FXa,1(θ1)− FXa,2(θ2) + FXa,1,Xa,2(θ1, θ2)
PFP =1− FXb,1(θ1)− FXb,2(θ2) + FXb,1,Xb,2(θ1, θ2)
Therefore the BN function would be given by:
BC =cb|1pa
(




1− FXb,1(θ1)− FXb,2(θ2) + FXb,1,Xb,2(θ1, θ2)
)
=capb|a [Φ(za,1) + Φ(za,2)− Φ(za,1, za,1)]
+ cbpa|b [1− Φ(zb,1)− Φ(zb,2) + Φ(zb,1, zb,2)]
144
D.2.1 Partial Derivatives.

































































































































































































































































































































































































































































































































































































































Appendix E. Results from Sequential Testing
E.1 BP Strategy Result Tables
Generlized Delta Generlized Delta
ρ nj Cov Len Cov Len ρ nj Cov Len Cov Len
0 1000 0.935 0.056 0.5 1000 0.922 0.566
500 0.946 0.084 0.933 0.079 500 0.95 0.089 0.912 0.08
250 0.943 0.119 0.928 0.112 250 0.942 0.126 0.925 0.114
100 0.939 0.187 0.926 0.178 100 0.945 0.198 0.932 0.184
50 0.93 0.263 0.933 0.253 50 0.923 0.281 0.916 0.263
0.2 1000 0.920 0.056 0.8 1000 0.914 0.057
500 0.954 0.087 0.936 0.08 500 0.946 0.091 0.912 0.082
250 0.948 0.122 0.929 0.113 250 0.946 0.129 0.923 0.118
100 0.935 0.192 0.927 0.18 100 0.943 0.204 0.934 0.19
50 0.922 0.271 0.916 0.256 50 0.945 0.291 0.931 0.271
Table E.1. Results for the BP strategy for a Poor, Poor test comparison at equal cost
Generlized Delta Generlized Delta
ρ nj Cov Len Cov Len ρ nj Cov Len Cov Len
0 1000 0.944 0.049 0.5 1000 0.944 0.052
500 0.952 0.07 0.947 0.069 500 0.951 0.073 0.95 0.073
250 0.951 0.098 0.948 0.097 250 0.939 0.103 0.939 0.103
100 0.951 0.155 0.943 0.153 100 0.951 0.164 0.946 0.163
50 0.937 0.217 0.931 0.214 50 0.945 0.231 0.935 0.228
0.2 1000 0.945 0.051 0.8 1000 0.953 0.052
500 0.953 0.072 0.952 0.072 500 0.955 0.073 0.956 0.073
250 0.957 0.102 0.955 0.101 250 0.95 0.104 0.947 0.104
100 0.946 0.16 0.94 0.159 100 0.949 0.165 0.945 0.163
50 0.95 0.225 0.938 0.221 50 0.958 0.234 0.95 0.23
Table E.2. Results for the BP strategy for a Poor, Good test comparison at equal cost
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Generlized Delta Generlized Delta
ρ nj Cov Len Cov Len ρ nj Cov Len Cov Len
0 1000 0.927 0.037 0.5 1000 0.919 0.041
500 0.955 0.056 0.929 0.052 500 0.944 0.066 0.906 0.058
250 0.947 0.079 0.928 0.073 250 0.934 0.093 0.905 0.082
100 0.941 0.125 0.921 0.115 100 0.942 0.147 0.917 0.131
50 0.929 0.175 0.906 0.163 50 0.934 0.205 0.902 0.187
0.2 1000 0.917 0.038 0.8 1000 0.912 0.044
500 0.936 0.06 0.909 0.054 500 0.948 0.071 0.915 0.062
250 0.953 0.085 0.921 0.077 250 0.946 0.100 0.910 0.088
100 0.941 0.134 0.912 0.121 100 0.939 0.157 0.910 0.142
50 0.931 0.187 0.9 0.172 50 0.936 0.221 0.907 0.204
Table E.3. Results for the BP strategy for a Good, Good test comparison at equal cost
Generlized Delta Generlized Delta
ρ nj Cov Len Cov Len ρ nj Cov Len Cov Len
0 1000 0.915 0.064 0.5 1000 0.903 0.064
500 0.953 0.103 0.917 0.091 500 0.940 0.110 0.887 0.092
250 0.941 0.145 0.902 0.129 250 0.939 0.154 0.889 0.132
100 0.940 0.228 0.920 0.207 100 0.934 0.243 0.905 0.215
50 0.924 0.322 0.918 0.297 50 0.918 0.342 0.897 0.310
0.2 1000 0.910 0.064 0.8 1000 0.895 0.067
500 0.947 0.106 0.905 0.091 500 0.948 0.112 0.905 0.096
250 0.939 0.150 0.901 0.129 250 0.943 0.158 0.908 0.140
100 0.947 0.235 0.917 0.209 100 0.947 0.249 0.922 0.228
50 0.927 0.331 0.909 0.301 50 0.933 0.345 0.911 0.324
Table E.4. Results for the BP strategy for a Poor, Poor test comparison at unequal
cost
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Generlized Delta Generlized Delta
ρ nj Cov Len Cov Len ρ nj Cov Len Cov Len
0 1000 0.946 0.064 0.5 1000 0.952 0.071
500 0.951 0.093 0.947 0.091 500 0.950 0.100 0.948 0.100
250 0.943 0.131 0.936 0.128 250 0.945 0.141 0.941 0.141
100 0.949 0.206 0.939 0.201 100 0.943 0.222 0.941 0.221
50 0.941 0.288 0.931 0.282 50 0.945 0.313 0.933 0.308
0.2 1000 0.944 0.068 0.8 1000 0.955 0.071
500 0.948 0.097 0.945 0.096 500 0.955 0.100 0.957 0.100
250 0.942 0.137 0.936 0.135 250 0.954 0.141 0.952 0.141
100 0.945 0.215 0.942 0.212 100 0.950 0.223 0.945 0.222
50 0.932 0.301 0.921 0.294 50 0.945 0.317 0.935 0.313
Table E.5. Results for the BP strategy for a Poor, Good test comparison at unequal
cost
Generlized Delta Generlized Delta
ρ nj Cov Len Cov Len ρ nj Cov Len Cov Len
0 1000 0.916 0.047 0.5 1000 0.910 0.054
500 0.936 0.075 0.899 0.067 500 0.958 0.090 0.908 0.076
250 0.946 0.106 0.915 0.095 250 0.952 0.126 0.916 0.108
100 0.936 0.166 0.911 0.149 100 0.937 0.198 0.899 0.172
50 0.932 0.232 0.897 0.211 50 0.924 0.277 0.883 0.245
0.2 1000 0.914 0.050 0.8 1000 0.896 0.058
500 0.950 0.082 0.912 0.071 500 0.950 0.096 0.906 0.082
250 0.947 0.115 0.911 0.100 250 0.938 0.136 0.903 0.118
100 0.946 0.181 0.906 0.159 100 0.933 0.213 0.906 0.190
50 0.938 0.252 0.906 0.225 50 0.939 0.300 0.915 0.273
Table E.6. Results for the BP strategy for a Good, Good test comparison at unequal
cost
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E.2 BN Strategy Result Tables
Generlized Delta Generlized Delta
ρ nj Cov Len Cov Len ρ nj Cov Len Cov Len
0 1000 0.935 0.056 0.5 1000 0.922 0.057
500 0.952 0.084 0.935 0.079 500 0.950 0.089 0.927 0.081
250 0.939 0.119 0.926 0.113 250 0.951 0.126 0.937 0.116
100 0.937 0.187 0.932 0.181 100 0.933 0.198 0.927 0.190
50 0.924 0.263 0.929 0.259 50 0.931 0.281 0.929 0.276
0.2 1000 0.921 0.056 0.8 1000 0.914 0.057
500 0.947 0.087 0.922 0.080 500 0.940 0.091 0.921 0.084
250 0.949 0.122 0.930 0.114 250 0.938 0.129 0.922 0.133
100 0.941 0.192 0.932 0.183 100 0.938 0.204 0.934 0.202
50 0.926 0.270 0.923 0.264 50 0.910 0.290 0.909 0.289
Table E.7. Results for the BN strategy for a Poor, Poor test comparison at equal cost
Generlized Delta Generlized Delta
ρ nj Cov Len Cov Len ρ nj Cov Len Cov Len
0 1000 0.943 0.049 0.5 1000 0.944 0.052
500 0.948 0.070 0.943 0.068 500 0.946 0.073 0.944 0.073
250 0.942 0.098 0.937 0.095 250 0.948 0.104 0.943 0.104
100 0.946 0.155 0.934 0.151 100 0.950 0.164 0.947 0.163
50 0.942 0.217 0.928 0.211 50 0.944 0.232 0.932 0.228
0.2 1000 0.945 0.051 0.8 1000 0.953 0.052
500 0.948 0.072 0.938 0.071 500 0.958 0.073 0.958 0.073
250 0.948 0.102 0.945 0.100 250 0.942 0.104 0.940 0.104
100 0.939 0.160 0.927 0.157 100 0.948 0.165 0.943 0.163
50 0.937 0.224 0.922 0.218 50 0.953 0.233 0.937 0.230
Table E.8. Results for the BN strategy for a Poor, Good test comparison at equal cost
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Generlized Delta Generlized Delta
ρ nj Cov Len Cov Len ρ nj Cov Len Cov Len
0 1000 0.928 0.037 0.5 1000 0.919 0.041
500 0.947 0.056 0.928 0.052 500 0.943 0.066 0.901 0.058
250 0.948 0.079 0.928 0.073 250 0.950 0.093 0.905 0.082
100 0.942 0.125 0.924 0.116 100 0.940 0.146 0.909 0.131
50 0.935 0.175 0.905 0.163 50 0.931 0.206 0.905 0.188
0.2 1000 0.917 0.038 0.8 1000 0.912 0.0436
500 0.949 0.060 0.916 0.054 500 0.940 0.071 0.908 0.062
250 0.946 0.085 0.919 0.077 250 0.946 0.100 0.909 0.088
100 0.945 0.134 0.914 0.122 100 0.937 0.157 0.907 0.142
50 0.925 0.188 0.891 0.171 50 0.935 0.220 0.911 0.204
Table E.9. Results for the BN strategy for a Good, Good test comparison at equal cost
Generlized Delta Generlized Delta
ρ nj Cov Len Cov Len ρ nj Cov Len Cov Len
0 1000 0.940 0.077 0.5 1000 0.934 0.075
500 0.958 0.110 0.954 0.109 500 0.942 0.111 0.931 0.107
250 0.952 0.156 0.951 0.155 250 0.949 0.157 0.945 0.170
100 0.948 0.243 0.952 0.248 100 0.944 0.246 0.944 0.259
50 0.931 0.341 0.937 0.356 50 0.924 0.345 0.931 0.354
0.2 1000 0.948 0.076 0.8 1000 0.939 0.075
500 0.949 0.111 0.942 0.108 500 0.949 0.112 0.936 0.122
250 0.940 0.156 0.930 0.153 250 0.947 0.158 0.944 0.155
100 0.947 0.244 0.949 0.247 100 0.940 0.249 0.943 0.256
50 0.937 0.343 0.941 0.354 50 0.933 0.347 0.936 0.709
Table E.10. Results for the BN strategy for a Poor, Poor test comparison at unequal
cost
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Generlized Delta Generlized Delta
ρ nj Cov Len Cov Len ρ nj Cov Len Cov Len
0 1000 0.946 0.064 0.5 1000 0.952 0.071
500 0.942 0.096 0.947 0.098 500 0.951 0.100 0.958 0.103
250 0.948 0.136 0.950 0.138 250 0.955 0.141 0.959 0.146
100 0.944 0.214 0.945 0.218 100 0.952 0.223 0.951 0.229
50 0.932 0.300 0.924 0.304 50 0.937 0.315 0.933 0.321
0.2 1000 0.944 0.068 0.8 1000 0.955 0.071
500 0.954 0.098 0.958 0.101 500 0.954 0.100 0.963 0.103
250 0.945 0.139 0.949 0.143 250 0.943 0.141 0.949 0.146
100 0.945 0.219 0.942 0.224 100 0.951 0.224 0.952 0.230
50 0.942 0.308 0.937 0.312 50 0.946 0.317 0.941 0.323
Table E.11. Results for the BN strategy for a Poor, Good test comparison at unequal
cost
Generlized Delta Generlized Delta
ρ nj Cov Len Cov Len ρ nj Cov Len Cov Len
0 1000 0.925 0.053 0.5 1000 0.925 0.058
500 0.947 0.079 0.935 0.075 500 0.952 0.090 0.928 0.082
250 0.950 0.112 0.936 0.106 250 0.948 0.128 0.924 0.116
100 0.943 0.176 0.929 0.167 100 0.941 0.201 0.915 0.185
50 0.937 0.247 0.916 0.236 50 0.934 0.282 0.908 0.264
0.2 1000 0.933 0.055 0.8 1000 0.914 0.061
500 0.956 0.084 0.934 0.078 500 0.947 0.096 0.926 0.086
250 0.945 0.118 0.926 0.110 250 0.951 0.136 0.927 0.123
100 0.949 0.186 0.928 0.174 100 0.947 0.214 0.933 0.260
50 0.941 0.262 0.920 0.247 50 0.928 0.301 0.908 0.284
Table E.12. Results for the BN strategy for a Good, Good test comparison at unequal
cost
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Appendix F. R Code
F.1 Correlated Delta Method for 2 classes
1
p1 <#Set Prevalence Class 1
p2 <#Set Prevalence Class 2
w21 <# Set cost 2|1
w12 <# Set cost 1|2
6 YA=#Class 1 for Test 1
XA=#Class 2 for Test 1
Y=#Class 1 for Test 2
X=#Class 2 for Test 2
n1=#Size of Class 1 (both tests)









21 abs(pnorm(par ,gmu2 ,gsig2))*(p2*w12)}




26 vm2=( gsig2 ^2)/n2
vs1=( gsig1 ^2)/(2*(n1 -1))
vs2=( gsig2 ^2)/(2*(n2 -1))
#calculate Partial Derivatives
g=function(par){abs(1-pnorm(par ,mux ,sigx))*(p1*w21)+






















































##calc dbcmu1 using equation to compare to estimate
dp1 <-(1/gsig1)*(-w21*p1*dnorm((c1 -gmu1)/gsig1)*(dc1m1 -1))
86 dp2 <-(1/gsig2)*(w12*p2*dnorm((c1 -gmu2)/gsig2)*dc1m1)
dbcm1 <-dp1+dp2
##calc dbcmu2 using equation to compare to estimate
dp1 <-(1/gsig1)*(-w21*p1*dnorm((c1 -gmu1)/gsig1)*dc1m2)
dp2 <-(1/gsig2)*(w12*p2*dnorm((c1 -gmu2)/gsig2)*(dc1m2 -1))
91 dbcm2 <-dp1+dp2

































vs1=( gsig1 ^2)/(2*(n1 -1))
vs2=( gsig2 ^2)/(2*(n2 -1))























































##calc dbcmu1 using equation to compare to estimate
181 dp1 <-(1/gsig1)*(-w21*p1*dnorm((c1 -gmu1)/gsig1)*(dc1m1 -1))
dp2 <-(1/gsig2)*(w12*p2*dnorm((c1 -gmu2)/gsig2)*dc1m1)
dbcm1 <-dp1+dp2
##calc dbcmu2 using equation to compare to estimate
dp1 <-(1/gsig1)*(-w21*p1*dnorm((c1 -gmu1)/gsig1)*dc1m2)
186 dp2 <-(1/gsig2)*(w12*p2*dnorm((c1 -gmu2)/gsig2)*(dc1m2 -1))
dbcm2 <-dp1+dp2
##calc dbcs1 using equation to compare to estimate
dp1 <-(1/gsig1)*(-w21*p1*dnorm((c1 -gmu1)/gsig1)*
(dc1s1 -((c1 -gmu1)/gsig1)))
191 dp2 <-(1/gsig2)*(w12*p2*dnorm((c1 -gmu2)/gsig2)*dc1s1)
dbcs1 <-dp1+dp2
##calc dbcs2 using equation to compare to estimate
dp1 <-(1/gsig1)*(-w21*p1*dnorm((c1 -gmu1)/gsig1)*dc1s2)
dp2 <-(1/gsig2)*(w12*p2*dnorm((c1 -gmu2)/gsig2)*
196 (dc1s2 -((c1 -gmu2)/gsig2)))
dbcs2 <-dp1+dp2














211 lowconf=EETA -qnorm(.025 ,lower.tail=F)*sqrt(VETA)
highconf=EETA+qnorm(.025 ,lower.tail=F)*sqrt(VETA)
F.2 Correlated Generalized Method for 2 Classes
library(mvtnorm)
2
p1 <#Set Prevalence Class 1
p2 <#Set Prevalence Class 2
w21 <# Set cost 2|1
w12 <# Set cost 1|2
7 YA=#Class 1 for Test 1
XA=#Class 2 for Test 1
Y=#Class 1 for Test 2
X=#Class 2 for Test 2
n1=#Size of Class 1 (both tests)

















draw1=rWishart(K,n1 -1,matrix(c(1,co1 ,co1 ,1) ,2,2))
draw2=rWishart(K,n2 -1,matrix(c(1,co2 ,co2 ,1) ,2,2))
t1=rmvt(K,matrix(c(1,co1 ,co1 ,1),ncol =2)*(n1 -3)/(n1 -1),df=n1 -1)

























F.3 Correlated Delta Method for 3 classes
p1 <#Set Prevalence Class 1
p2 <#Set Prevalence Class 2
p3 <#Set Prevalence Class 3
w21 <# Set cost 2|1
5 w31 <# Set cost 3|1
w12 <# Set cost 1|2
w32 <# Set cost 3|2
w13 <# Set cost 1|3
w23 <# Set cost 2|3
10 YA=#Class 1 for Test 1
XA=#Class 2 for Test 1
ZA=#Class 3 for Test 1
Y=#Class 1 for Test 2
X=#Class 2 for Test 2
15 Z=#Class 3 for Test 2
n1=#Size of Class 1 (both tests)
n2=#Size of Class 2 (both tests)
n3=#Size of Class 3 (both tests)
start=c(.1 ,0)





















40 vm1=( gsig1 ^2)/n1
vm2=( gsig2 ^2)/n2
vm3=( gsig3 ^2)/n3
vs1=( gsig1 ^2)/(2*(n1 -1))
vs2=( gsig2 ^2)/(2*(n2 -1))



































































































































##calc dbcmu1 using equation to compare to estimate









##calc dbcmu2 using equation to compare to estimate
dp1 <-(1/gsig1)*(( dc2m2)*dnorm((c2 -gmu1)/gsig1)*(w21*p1 -w31*p1)...
-
185 w21*p1*dnorm((c1 -gmu1)/gsig1)*dc1m2)
dp2 <-(1/gsig2)*(w12*p2*dnorm((c1 -gmu2)/gsig2)*(dc1m2 -1)+
w32*p2*dnorm((gmu2 -c2)/gsig2)*(1-dc2m2))




##calc dbcmu3 using equation to compare to estimate
















dp3 <-(1/gsig3)*(dnorm((c1 -gmu3)/gsig3)*dc1s1*(w13*p3 -w23*p3)+
w23*p3*dnorm((c2 -gmu3)/gsig3)*dc2s1)
210 dbcs1 <-dp1+dp2+dp3
##calc dbcs2 using equation to compare to estimate






dp3 <-(1/gsig3)*(dnorm((c1 -gmu3)/gsig3)*dc1s2*(w13*p3 -w23*p3)+
w23*p3*dnorm((c2 -gmu3)/gsig3)*dc2s2)
220 dbcs2 <-dp1+dp2+dp3
##calc dbcs3 using equation to compare to estimate
dp1 <-(1/gsig1)*(dnorm((c2 -gmu1)/gsig1)*dc2s3*(w21*p1 -w31*p1)-
w21*p1*dnorm((c1 -gmu1)/gsig1)*dc1s3)
dp2 <-(1/gsig2)*(w12*p2*dnorm((c1 -gmu2)/gsig2)*
225 dc1s3+w32*p2*dnorm ((gmu2 -c2)/gsig2)*(-dc2s3))





VBCA=( dbcm1 ^2)*vm1+( dbcs1 ^2)*vs1+( dbcm2 ^2)*vm2+


































265 vm2=( gsig2 ^2)/n2
vm3=( gsig3 ^2)/n3
vs1=( gsig1 ^2)/(2*(n1 -1))
vs2=( gsig2 ^2)/(2*(n2 -1))



























































































































390 ##calc dbcmu1 using equation to compare to estimate









##calc dbcmu2 using equation to compare to estimate
400 dp1 <-(1/gsig1)*(( dc2m2)*dnorm((c2 -gmu1)/gsig1)*(w21*p1 -w31*p1)...
-
w21*p1*dnorm((c1 -gmu1)/gsig1)*dc1m2)
dp2 <-(1/gsig2)*(w12*p2*dnorm((c1 -gmu2)/gsig2)*(dc1m2 -1)+
w32*p2*dnorm((gmu2 -c2)/gsig2)*(1-dc2m2))
dp3 <-(1/gsig3)*(dc1m2*dnorm((c1 -gmu3)/gsig3)*(w13*p3 -w23*p3)+
405 w23*p3*dnorm((c2 -gmu3)/gsig3)*dc2m2)
dbcm2 <-dp1+dp2+dp3
##calc dbcmu3 using equation to compare to estimate
dp1 <-(1/gsig1)*(dc2m3*dnorm((c2 -gmu1)/gsig1)*(w21*p1 -w31*p1)-
w21*p1*dnorm((c1 -gmu1)/gsig1)*dc1m3)
410 dp2 <-(1/gsig2)*(w12*p2*dnorm((c1 -gmu2)/gsig2)*dc1m3+
w32*p2*dnorm((gmu2 -c2)/gsig2)*(-dc2m3))










dp2 <-(1/gsig2)*(w12*p2*dnorm((c1 -gmu2)/gsig2)*dc1s1 -
w32*p2*dnorm((gmu2 -c2)/gsig2)*dc2s1)
dp3 <-(1/gsig3)*(dnorm((c1 -gmu3)/gsig3)*dc1s1*(w13*p3 -w23*p3)+
425 w23*p3*dnorm((c2 -gmu3)/gsig3)*dc2s1)
dbcs1 <-dp1+dp2+dp3
##calc dbcs2 using equation to compare to estimate
dp1 <-(1/gsig1)*(dnorm((c2 -gmu1)/gsig1)*dc2s2*(w21*p1 -w31*p1)-
w21*p1*dnorm((c1 -gmu1)/gsig1)*dc1s2)




dp3 <-(1/gsig3)*(dnorm((c1 -gmu3)/gsig3)*dc1s2*(w13*p3 -w23*p3)+
435 w23*p3*dnorm((c2 -gmu3)/gsig3)*dc2s2)
dbcs2 <-dp1+dp2+dp3
##calc dbcs3 using equation to compare to estimate
dp1 <-(1/gsig1)*(dnorm((c2 -gmu1)/gsig1)*dc2s3*(w21*p1 -w31*p1)-
w21*p1*dnorm((c1 -gmu1)/gsig1)*dc1s3)








VBC=( dbcm1 ^2)*vm1+( dbcs1 ^2)*vs1+( dbcm2 ^2)*vm2+

















F.4 Correlated Generalized Method for 3 Classes
1 p1 <#Set Prevalence Class 1
p2 <#Set Prevalence Class 2
p3 <#Set Prevalence Class 3
w21 <# Set cost 2|1
w31 <# Set cost 3|1
6 w12 <# Set cost 1|2
w32 <# Set cost 3|2
w13 <# Set cost 1|3
w23 <# Set cost 2|3
YA=#Class 1 for Test 1
11 XA=#Class 2 for Test 1
ZA=#Class 3 for Test 1
Y=#Class 1 for Test 2
X=#Class 2 for Test 2
Z=#Class 3 for Test 2
16 n1=#Size of Class 1 (both tests)
n2=#Size of Class 2 (both tests)
n3=#Size of Class 3 (both tests)
start=c(.1 ,0)



















draw1=rWishart(K,n1 -1,matrix(c(var1a ,cov1 ,cov1 ,var1)/
(n1 -1) ,2,2))
draw2=rWishart(K,n2 -1,matrix(c(var2a ,cov2 ,cov2 ,var2)/
41 (n2 -2) ,2,2))

















































F.5 Sequential Delta Method, BP Strategy
1 #Calculate and Set Parameters
p1 <#Set Prevalence Class 1
p2 <#Set Prevalence Class 2
w21 <# Set cost 2|1
w12 <# Set cost 1|2
6 YA=#Class 1 for Test 1
XA=#Class 2 for Test 1
Y=#Class 1 for Test 2
X=#Class 2 for Test 2
n1=#Size of Class 1 (both tests)
11 n2=#Size of Class 2 (both tests)
start=c(.1 ,0)













26 vma2=( gsiga2 ^2)/n1
vmb1=( gsigb1 ^2)/n2
vmb2=( gsigb2 ^2)/n2
vsa1=( gsiga1 ^2)/(2*(n1 -1))
vsa2=( gsiga2 ^2)/(2*(n1 -1))
31 vsb1=( gsigb1 ^2)/(2*(n2 -1))
























































































116 dc2sa1 =(o2p -o2m)/.0002
siga1=gsiga1


































151 dc1sb2 =(o1p -o1m)/.0002
dc2sb2 =(o2p -o2m)/.0002
sigb2=gsigb2




























##Full Partial Derivative Calculations
##calc dbcmua1 using equation to compare to estimate
dp1 <-w21*p1*dnorm(za1)*pnorm(za2 ,mean=gRhoa*za1 ,
sd=sqrt(1-gRhoa ^2))*(dc1ma1 -1)/gsiga1
186 dp2 <-w21*p1*dnorm(za2)*pnorm(za1 ,mean=gRhoa*za2 ,
sd=sqrt(1-gRhoa ^2))*(dc2ma1)/gsiga2
dp3 <-w12*p2*dnorm(zb1)*pnorm(zb2 ,mean=gRhob*zb1 ,
sd=sqrt(1-gRhob ^2))*(dc1ma1)/gsigb1
dp4 <-w12*p2*dnorm(zb2)*pnorm(zb1 ,mean=gRhob*zb2 ,
191 sd=sqrt(1-gRhob ^2))*(dc2ma1)/gsigb2
dbcma1 <-dp3+dp4 -dp1 -dp2
##calc dbcmua2 using equation to compare to estimate
dp1 <-w21*p1*dnorm(za1)*pnorm(za2 ,mean=gRhoa*za1 ,
sd=sqrt(1-gRhoa ^2))*(dc1ma2)/gsiga1
196 dp2 <-w21*p1*dnorm(za2)*pnorm(za1 ,mean=gRhoa*za2 ,
sd=sqrt(1-gRhoa ^2))*(dc2ma2 -1)/gsiga2
175
dp3 <-w12*p2*dnorm(zb1)*pnorm(zb2 ,mean=gRhob*zb1 ,
sd=sqrt(1-gRhob ^2))*(dc1ma2)/gsigb1
dp4 <-w12*p2*dnorm(zb2)*pnorm(zb1 ,mean=gRhob*zb2 ,
201 sd=sqrt(1-gRhob ^2))*(dc2ma2)/gsigb2
dbcma2 <-dp3+dp4 -dp1 -dp2
##calc dbcmub1 using equation to compare to estimate
dp1 <-w21*p1*dnorm(za1)*pnorm(za2 ,mean=gRhoa*za1 ,
sd=sqrt(1-gRhoa ^2))*(dc1mb1)/gsiga1
206 dp2 <-w21*p1*dnorm(za2)*pnorm(za1 ,mean=gRhoa*za2 ,
sd=sqrt(1-gRhoa ^2))*(dc2mb1)/gsiga2
dp3 <-w12*p2*dnorm(zb1)*pnorm(zb2 ,mean=gRhob*zb1 ,
sd=sqrt(1-gRhob ^2))*(dc1mb1 -1)/gsigb1
dp4 <-w12*p2*dnorm(zb2)*pnorm(zb1 ,mean=gRhob*zb2 ,
211 sd=sqrt(1-gRhob ^2))*(dc2mb1)/gsigb2
dbcmb1 <-dp3+dp4 -dp1 -dp2
##calc dbcmub2 using equation to compare to estimate
dp1 <-w21*p1*dnorm(za1)*pnorm(za2 ,mean=gRhoa*za1 ,
sd=sqrt(1-gRhoa ^2))*(dc1mb2)/gsiga1
216 dp2 <-w21*p1*dnorm(za2)*pnorm(za1 ,mean=gRhoa*za2 ,
sd=sqrt(1-gRhoa ^2))*(dc2mb2)/gsiga2
dp3 <-w12*p2*dnorm(zb1)*pnorm(zb2 ,mean=gRhob*zb1 ,
sd=sqrt(1-gRhob ^2))*(dc1mb2)/gsigb1
dp4 <-w12*p2*dnorm(zb2)*pnorm(zb1 ,mean=gRhob*zb2 ,
221 sd=sqrt(1-gRhob ^2))*(dc2mb2 -1)/gsigb2
dbcmb2 <-dp3+dp4 -dp1 -dp2
##calc dbcsa1 using equation to compare to estimate
dp1 <-w21*p1*dnorm(za1)*pnorm(za2 ,mean=gRhoa*za1 ,
sd=sqrt(1-gRhoa ^2))*(dc1sa1 -(c1 -gmua1)/gsiga1)/gsiga1
226 dp2 <-w21*p1*dnorm(za2)*pnorm(za1 ,mean=gRhoa*za2 ,
sd=sqrt(1-gRhoa ^2))*(dc2sa1)/gsiga2
dp3 <-w12*p2*dnorm(zb1)*pnorm(zb2 ,mean=gRhob*zb1 ,
sd=sqrt(1-gRhob ^2))*(dc1sa1)/gsigb1
dp4 <-w12*p2*dnorm(zb2)*pnorm(zb1 ,mean=gRhob*zb2 ,
231 sd=sqrt(1-gRhob ^2))*(dc2sa1)/gsigb2
dbcsa1 <-dp3+dp4 -dp1 -dp2
##calc dbcsa2 using equation to compare to estimate
dp1 <-w21*p1*dnorm(za1)*pnorm(za2 ,mean=gRhoa*za1 ,
236 sd=sqrt(1-gRhoa ^2))*(dc1sa2)/gsiga1
dp2 <-w21*p1*dnorm(za2)*pnorm(za1 ,mean=gRhoa*za2 ,
sd=sqrt(1-gRhoa ^2))*(dc2sa2 -(c2 -gmua2)/gsiga2)/gsiga2
dp3 <-w12*p2*dnorm(zb1)*pnorm(zb2 ,mean=gRhob*zb1 ,
sd=sqrt(1-gRhob ^2))*(dc1sa2)/gsigb1
241 dp4 <-w12*p2*dnorm(zb2)*pnorm(zb1 ,mean=gRhob*zb2 ,
sd=sqrt(1-gRhob ^2))*(dc2sa2)/gsigb2
dbcsa2 <-dp3+dp4 -dp1 -dp2
##calc dbcsb1 using equation to compare to estimate
dp1 <-w21*p1*dnorm(za1)*pnorm(za2 ,mean=gRhoa*za1 ,
246 sd=sqrt(1-gRhoa ^2))*(dc1sb1)/gsiga1
dp2 <-w21*p1*dnorm(za2)*pnorm(za1 ,mean=gRhoa*za2 ,
sd=sqrt(1-gRhoa ^2))*(dc2sb1)/gsiga2
dp3 <-w12*p2*dnorm(zb1)*pnorm(zb2 ,mean=gRhob*zb1 ,
176
sd=sqrt(1-gRhob ^2))*(dc1sb1 -(c1 -gmub1)/gsigb1)/gsigb1
251 dp4 <-w12*p2*dnorm(zb2)*pnorm(zb1 ,mean=gRhob*zb2 ,
sd=sqrt(1-gRhob ^2))*(dc2sb1)/gsigb2
dbcsb1 <-dp3+dp4 -dp1 -dp2
##calc dbcsb2 using equation to compare to estimate
dp1 <-w21*p1*dnorm(za1)*pnorm(za2 ,mean=gRhoa*za1 ,
256 sd=sqrt(1-gRhoa ^2))*(dc1sb2)/gsiga1
dp2 <-w21*p1*dnorm(za2)*pnorm(za1 ,mean=gRhoa*za2 ,
sd=sqrt(1-gRhoa ^2))*(dc2sb2)/gsiga2
dp3 <-w12*p2*dnorm(zb1)*pnorm(zb2 ,mean=gRhob*zb1 ,
sd=sqrt(1-gRhob ^2))*(dc1sb2)/gsigb1
261 dp4 <-w12*p2*dnorm(zb2)*pnorm(zb1 ,mean=gRhob*zb2 ,
sd=sqrt(1-gRhob ^2))*(dc2sb2 -(c2 -gmub2)/gsigb2)/gsigb2
dbcsb2 <-dp3+dp4 -dp1 -dp2
##calc dbcra using equation to compare to estimate
dp1 <-w21*p1*dnorm(za1)*pnorm(za2 ,mean=gRhoa*za1 ,
266 sd=sqrt(1-gRhoa ^2))*(dc1ra)/gsiga1
dp2 <-w21*p1*dnorm(za2)*pnorm(za1 ,mean=gRhoa*za2 ,
sd=sqrt(1-gRhoa ^2))*(dc2ra)/gsiga2
dp3 <-w12*p2*dnorm(zb1)*pnorm(zb2 ,mean=gRhob*zb1 ,
sd=sqrt(1-gRhob ^2))*(dc1ra)/gsigb1
271 dp4 <-w12*p2*dnorm(zb2)*pnorm(zb1 ,mean=gRhob*zb2 ,
sd=sqrt(1-gRhob ^2))*(dc2ra)/gsigb2
dbcra <-dp3+dp4 -dp1 -dp2
##calc dbcrb using equation to compare to estimate
dp1 <-w21*p1*dnorm(za1)*pnorm(za2 ,mean=gRhoa*za1 ,
276 sd=sqrt(1-gRhoa ^2))*(dc1rb)/gsiga1
dp2 <-w21*p1*dnorm(za2)*pnorm(za1 ,mean=gRhoa*za2 ,
sd=sqrt(1-gRhoa ^2))*(dc2rb)/gsiga2
dp3 <-w12*p2*dnorm(zb1)*pnorm(zb2 ,mean=gRhob*zb1 ,
sd=sqrt(1-gRhob ^2))*(dc1rb)/gsigb1
281 dp4 <-w12*p2*dnorm(zb2)*pnorm(zb1 ,mean=gRhob*zb2 ,
sd=sqrt(1-gRhob ^2))*(dc2rb)/gsigb2
dbcrb <-dp3+dp4 -dp1 -dp2
#Calculate Variance
VBC=( dbcma1)^2*vma1+( dbcma2)^2*vma2+( dbcmb1)^2*vmb1+











F.6 Sequential Delta Method, BN Strategy
#Calculate and Set Parameters
p1 <#Set Prevalence Class 1
177
p2 <#Set Prevalence Class 2
4 w21 <# Set cost 2|1
w12 <# Set cost 1|2
YA=#Class 1 for Test 1
XA=#Class 2 for Test 1
Y=#Class 1 for Test 2
9 X=#Class 2 for Test 2
n1=#Size of Class 1 (both tests)


















29 vsa1=( gsiga1 ^2)/(2*(n1 -1))
vsa2=( gsiga2 ^2)/(2*(n1 -1))
vsb1=( gsigb1 ^2)/(2*(n2 -1))
vsb2=( gsigb2 ^2)/(2*(n2 -1))
vrhoa =(1-gRhoa ^2)^2/sqrt(n1)




(pmvnorm(lower=-Inf ,upper=par , mean=c(mua1 ,mua2),
39 sigma=matrix(c(siga1^2,Rhoa*siga1*siga2 ,
Rhoa*siga1*siga2 ,siga2 ^2),nrow =2)))}
tp=function(par){1-pnorm(par[1],mean=mub1 ,sd=sigb1)-
pnorm(par[2],mean=mub2 ,sd=sigb2)+
(pmvnorm(lower=-Inf ,upper=par , mean=c(mub1 ,mub2),
44 sigma=matrix(c(sigb1^2,Rhob*sigb1*sigb2 ,








































84 dc2ma2 =(o2p -o2m)/.0002
mua2=gmua2


































119 dc1sa1 =(o1p -o1m)/.0002
dc2sa1 =(o2p -o2m)/.0002
siga1=gsiga1






















144 dc2sb1 =(o2p -o2m)/.0002
sigb1=gsigb1










































##calc dbcmua1 using equation to compare to estimate
dp1=dnorm(za1)*(dc1ma1 -1)/gsiga1
189 dp2=dnorm(za2)*(dc2ma1)/gsiga2
dp3=dnorm(za2)*pnorm(za1 ,mean=gRhoa*za2 ,sd=sqrt(1-gRhoa ^2))*
(dc2ma1)/gsiga2




dp7=dnorm(zb1)*pnorm(zb2 ,mean=gRhob*zb1 ,sd=sqrt(1-gRhob ^2))*
(dc1ma1)/gsigb1
dp8=dnorm(zb2)*pnorm(zb1 ,mean=gRhob*zb2 ,sd=sqrt(1-gRhob ^2))*
199 (dc2ma1)/gsigb2
dbcma1 <-p1*w21*(dp1+dp2 -dp3 -dp4)-p2*w12*(dp5+dp6 -dp7 -dp8)
##calc dbcmua2 using equation to compare to estimate
dp1=dnorm(za1)*(dc1ma2)/gsiga1
dp2=dnorm(za2)*(dc2ma2 -1)/gsiga2
204 dp3=dnorm(za2)*pnorm(za1 ,mean=gRhoa*za2 ,sd=sqrt(1-gRhoa ^2))*
(dc2ma2 -1)/gsiga2




dp7=dnorm(zb1)*pnorm(zb2 ,mean=gRhob*zb1 ,sd=sqrt(1-gRhob ^2))*
181
(dc1ma2)/gsigb1
dp8=dnorm(zb2)*pnorm(zb1 ,mean=gRhob*zb2 ,sd=sqrt(1-gRhob ^2))*
(dc2ma2)/gsigb2
214 dbcma2 <-p1*w21*(dp1+dp2 -dp3 -dp4)-p2*w12*(dp5+dp6 -dp7 -dp8)
##calc dbcmub1 using equation to compare to estimate
dp1=dnorm(za1)*(dc1mb1)/gsiga1
dp2=dnorm(za2)*(dc2mb1)/gsiga2
dp3=dnorm(za2)*pnorm(za1 ,mean=gRhoa*za2 ,sd=sqrt(1-gRhoa ^2))*
219 (dc2mb1)/gsiga2




224 dp7=dnorm(zb1)*pnorm(zb2 ,mean=gRhob*zb1 ,sd=sqrt(1-gRhob ^2))*
(dc1mb1 -1)/gsigb1
dp8=dnorm(zb2)*pnorm(zb1 ,mean=gRhob*zb2 ,sd=sqrt(1-gRhob ^2))*
(dc2mb1)/gsigb2
dbcmb1 <-p1*w21*(dp1+dp2 -dp3 -dp4)-p2*w12*(dp5+dp6 -dp7 -dp8)
229 ##calc dbcmub2 using equation to compare to estimate
dp1=dnorm(za1)*(dc1mb2)/gsiga1
dp2=dnorm(za2)*(dc2mb2)/gsiga2
dp3=dnorm(za2)*pnorm(za1 ,mean=gRhoa*za2 ,sd=sqrt(1-gRhoa ^2))*
(dc2mb2)/gsiga2




dp7=dnorm(zb1)*pnorm(zb2 ,mean=gRhob*zb1 ,sd=sqrt(1-gRhob ^2))*
239 (dc1mb2)/gsigb1
dp8=dnorm(zb2)*pnorm(zb1 ,mean=gRhob*zb2 ,sd=sqrt(1-gRhob ^2))*
(dc2mb2 -1)/gsigb2
dbcmb2 <-p1*w21*(dp1+dp2 -dp3 -dp4)-p2*w12*(dp5+dp6 -dp7 -dp8)
##calc dbcsa1 using equation to compare to estimate
244 dp1=dnorm(za1)*(dc1sa1 -(c1 -gmua1)/gsiga1)/gsiga1
dp2=dnorm(za2)*(dc2sa1)/gsiga2
dp3=dnorm(za2)*pnorm(za1 ,mean=gRhoa*za2 ,sd=sqrt(1-gRhoa ^2))*
(dc2sa1)/gsiga2




dp7=dnorm(zb1)*pnorm(zb2 ,mean=gRhob*zb1 ,sd=sqrt(1-gRhob ^2))*
(dc1sa1)/gsigb1
254 dp8=dnorm(zb2)*pnorm(zb1 ,mean=gRhob*zb2 ,sd=sqrt(1-gRhob ^2))*
(dc2sa1)/gsigb2
dbcsa1 <-p1*w21*(dp1+dp2 -dp3 -dp4)-p2*w12*(dp5+dp6 -dp7 -dp8)
##calc dbcsa2 using equation to compare to estimate
dp1=dnorm(za1)*(dc1sa2)/gsiga1
259 dp2=dnorm(za2)*(dc2sa2 -(c2 -gmua2)/gsiga2)/gsiga2
dp3=dnorm(za2)*pnorm(za1 ,mean=gRhoa*za2 ,sd=sqrt(1-gRhoa ^2))*
(dc2sa2 -(c2-gmua2)/gsiga2)/gsiga2





dp7=dnorm(zb1)*pnorm(zb2 ,mean=gRhob*zb1 ,sd=sqrt(1-gRhob ^2))*
(dc1sa1)/gsigb1
dp8=dnorm(zb2)*pnorm(zb1 ,mean=gRhob*zb2 ,sd=sqrt(1-gRhob ^2))*
269 (dc2sa1)/gsigb2
dbcsa2 <-p1*w21*(dp1+dp2 -dp3 -dp4)-p2*w12*(dp5+dp6 -dp7 -dp8)
##calc dbcsb1 using equation to compare to estimate
dp1=dnorm(za1)*(dc1sb1)/gsiga1
dp2=dnorm(za2)*(dc2sb1)/gsiga2
274 dp3=dnorm(za2)*pnorm(za1 ,mean=gRhoa*za2 ,sd=sqrt(1-gRhoa ^2))*
(dc2sb1)/gsiga2




dp7=dnorm(zb1)*pnorm(zb2 ,mean=gRhob*zb1 ,sd=sqrt(1-gRhob ^2))*
(dc1sb1 -(c1-gmub1)/gsigb1)/gsigb1
dp8=dnorm(zb2)*pnorm(zb1 ,mean=gRhob*zb2 ,sd=sqrt(1-gRhob ^2))*
(dc2sb1)/gsigb2
284 dbcsb1 <-p1*w21*(dp1+dp2 -dp3 -dp4)-p2*w12*(dp5+dp6 -dp7 -dp8)
##calc dbcsb2 using equation to compare to estimate
dp1=dnorm(za1)*(dc1sb2)/gsiga1
dp2=dnorm(za2)*(dc2sb2)/gsiga2
dp3=dnorm(za2)*pnorm(za1 ,mean=gRhoa*za2 ,sd=sqrt(1-gRhoa ^2))*
289 (dc2sb2)/gsiga2




294 dp7=dnorm(zb1)*pnorm(zb2 ,mean=gRhob*zb1 ,sd=sqrt(1-gRhob ^2))*
(dc1sb2)/gsigb1
dp8=dnorm(zb2)*pnorm(zb1 ,mean=gRhob*zb2 ,sd=sqrt(1-gRhob ^2))*
(dc2sb2 -(c2-gmub2)/gsigb2)/gsigb2
dbcsb2 <-p1*w21*(dp1+dp2 -dp3 -dp4)-p2*w12*(dp5+dp6 -dp7 -dp8)
299 ##calc dbcra using equation to compare to estimate
dp1=dnorm(za1)*(dc1ra)/gsiga1
dp2=dnorm(za2)*(dc2ra)/gsiga2
dp3=dnorm(za2)*pnorm(za1 ,mean=gRhoa*za2 ,sd=sqrt(1-gRhoa ^2))*
(dc2ra)/gsiga2




dp7=dnorm(zb1)*pnorm(zb2 ,mean=gRhob*zb1 ,sd=sqrt(1-gRhob ^2))*
309 (dc1ra)/gsigb1
dp8=dnorm(zb2)*pnorm(zb1 ,mean=gRhob*zb2 ,sd=sqrt(1-gRhob ^2))*
(dc2ra)/gsigb2
dbcra <-p1*w21*(dp1+dp2 -dp3 -dp4)-p2*w12*(dp5+dp6 -dp7 -dp8)




dp3=dnorm(za2)*pnorm(za1 ,mean=gRhoa*za2 ,sd=sqrt(1-gRhoa ^2))*
(dc2rb)/gsiga2




dp7=dnorm(zb1)*pnorm(zb2 ,mean=gRhob*zb1 ,sd=sqrt(1-gRhob ^2))*
(dc1rb)/gsigb1
324 dp8=dnorm(zb2)*pnorm(zb1 ,mean=gRhob*zb2 ,sd=sqrt(1-gRhob ^2))*
(dc2rb)/gsigb2
dbcrb <-p1*w21*(dp1+dp2 -dp3 -dp4)-p2*w12*(dp5+dp6 -dp7 -dp8)
#Calculate Variance
VBC=( dbcma1)^2*vma1+( dbcma2)^2*vma2+( dbcmb1)^2*vmb1+











F.7 Sequential Generalized Method, BP Strategy
1 #Calculate and Set Parameters
p1 <#Set Prevalence Class 1
p2 <#Set Prevalence Class 2
w21 <# Set cost 2|1
w12 <# Set cost 1|2
6 YA=#Class 1 for Test 1
XA=#Class 2 for Test 1
Y=#Class 1 for Test 2
X=#Class 2 for Test 2
n1=#Size of Class 1 (both tests)
11 n2=#Size of Class 2 (both tests)
start=c(0,.1)









Sigma1=matrix(c(var(XA),covx ,covx ,var(X)),nrow =2)
Sigma2=matrix(c(var(YA),covy ,covy ,var(Y)),nrow =2)
sigma1=matrix(c(1,corx ,corx ,1),nrow =2)
184
sigma2=matrix(c(1,cory ,cory ,1),nrow =2)
26 #Draw from multivariate T distribution
t1=rmvt(K,sigma=sigma1*((n1 -1)/(n1 -3)),df=n1 -1)




























F.8 Sequential Generalized Method, BN Strategy
#Calculate and Set Parameters
p1 <#Set Prevalence Class 1
p2 <#Set Prevalence Class 2
w21 <# Set cost 2|1
5 w12 <# Set cost 1|2
YA=#Class 1 for Test 1
XA=#Class 2 for Test 1
Y=#Class 1 for Test 2
X=#Class 2 for Test 2
10 n1=#Size of Class 1 (both tests)
n2=#Size of Class 2 (both tests)
start=c(0,.1)










Sigma1=matrix(c(var(XA),covx ,covx ,var(X)),nrow =2)
Sigma2=matrix(c(var(YA),covy ,covy ,var(Y)),nrow =2)
sigma1=matrix(c(1,corx ,corx ,1),nrow =2)
25 sigma2=matrix(c(1,cory ,cory ,1),nrow =2)
#Draw from multivariate T
t1=rmvt(K,sigma=sigma1*((n1 -1)/(n1 -3)),df=n1 -1)
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